
<html lang="en"     class="pb-page"  data-request-id="e2529817-7175-433e-af88-73c054bc046f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00085;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure–Activity Relationship, In Vitro and In Vivo Investigations of Jamunones" /></meta><meta name="dc.Creator" content="Caijuan  Hu" /></meta><meta name="dc.Creator" content="Guoxun  Li" /></meta><meta name="dc.Creator" content="Yu  Mu" /></meta><meta name="dc.Creator" content="Wenxi  Wu" /></meta><meta name="dc.Creator" content="Bixuan  Cao" /></meta><meta name="dc.Creator" content="Zixuan  Wang" /></meta><meta name="dc.Creator" content="Hainan  Yu" /></meta><meta name="dc.Creator" content="Peipei  Guan" /></meta><meta name="dc.Creator" content="Li  Han" /></meta><meta name="dc.Creator" content="Liya  Li" /></meta><meta name="dc.Creator" content="Xueshi  Huang" /></meta><meta name="dc.Description" content="Twenty-three natural jamunone analogues along with a series of jamunone-based derivatives were synthesized and evaluated for their inhibitory effects against breast cancer (BC) MDA-MB-231 and MCF-7..." /></meta><meta name="Description" content="Twenty-three natural jamunone analogues along with a series of jamunone-based derivatives were synthesized and evaluated for their inhibitory effects against breast cancer (BC) MDA-MB-231 and MCF-7..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 16, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00085" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00085" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00085" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00085" /></link>
        
    
    

<title>Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure–Activity Relationship, In Vitro and In Vivo Investigations of Jamunones | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00085" /></meta><meta property="og:title" content="Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure–Activity Relationship, In Vitro and In Vivo Investigations of Jamunones" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0014.jpeg" /></meta><meta property="og:description" content="Twenty-three natural jamunone analogues along with a series of jamunone-based derivatives were synthesized and evaluated for their inhibitory effects against breast cancer (BC) MDA-MB-231 and MCF-7 cells. The preliminary structure–activity relationship revealed that the length of aliphatic side chain and free phenolic hydroxyl group at the scaffold played a vital role in anti-BC activities and the methyl group on chromanone affected the selectivity of molecules against MDA-MB-231 and MCF-7 cells. Among them, jamunone M (JM) was screened as the most effective anti-triple-negative breast cancer (anti-TNBC) candidate with a high selectivity against BC cells over normal human cells. Mechanistic investigations indicated that JM could induce mitochondria-mediated apoptosis and cause G0/G1 phase arrest in BC cells. Furthermore, JM significantly restrained tumor growth in MDA-MB-231 xenograft mice without apparent toxicity. Interestingly, JM could downregulate phosphatidylinositide 3-kinase (PI3K)/Akt pathway by suppressing protein-tyrosine phosphatase 1B (PTP1B) expression. These findings revealed the potential of JM as an appealing therapeutic drug candidate for TNBC." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00085"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00085">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00085&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00085&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00085&amp;href=/doi/10.1021/acs.jmedchem.1c00085" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 6008-6020</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00078" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00120" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure–Activity Relationship, <i>In Vitro</i> and <i>In Vivo</i> Investigations of Jamunones</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Caijuan Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Caijuan Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Caijuan++Hu">Caijuan Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guoxun Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guoxun Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guoxun++Li">Guoxun Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu Mu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Mu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Mu">Yu Mu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenxi Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenxi Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenxi++Wu">Wenxi Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bixuan Cao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bixuan Cao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bixuan++Cao">Bixuan Cao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zixuan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zixuan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zixuan++Wang">Zixuan Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hainan Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hainan Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hainan++Yu">Hainan Yu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peipei Guan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peipei Guan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peipei++Guan">Peipei Guan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Li Han</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#076f66696b6e476a666e6b2969627229626372296469"><span class="__cf_email__" data-cfemail="ea828b848683aa878b8386c4848f9fc48f8e9fc48984">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li++Han">Li Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Liya Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Liya Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#127e6b7e7b527f737b7e3c7c77673c7776673c717c"><span class="__cf_email__" data-cfemail="80ecf9ece9c0ede1e9ecaeeee5f5aee5e4f5aee3ee">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Liya++Li">Liya Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1894-9500" title="Orcid link">http://orcid.org/0000-0002-1894-9500</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xueshi Huang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xueshi Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#eb839e8a858c9398ab868a8287c5858e9ec58e8f9ec58885"><span class="__cf_email__" data-cfemail="98f0edf9f6ffe0ebd8f5f9f1f4b6f6fdedb6fdfcedb6fbf6">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xueshi++Huang">Xueshi Huang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1561-8108" title="Orcid link">http://orcid.org/0000-0002-1561-8108</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00085&amp;href=/doi/10.1021%2Facs.jmedchem.1c00085" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 6008–6020</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 16, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 January 2021</li><li><span class="item_label"><b>Published</b> online</span>16 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00085</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6008%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCaijuan%2BHu%252C%2BGuoxun%2BLi%252C%2BYu%2BMu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.1c00085%26title%3DDiscovery%2Bof%2BAnti-TNBC%2BAgents%2BTargeting%2BPTP1B%253A%2BTotal%2BSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%252C%2BIn%2BVitro%2Band%2BIn%2BVivo%2BInvestigations%2Bof%2BJamunones%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6020%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00085"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">742</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00085" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure–Activity Relationship, In Vitro and In Vivo Investigations of Jamunones&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Caijuan&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Guoxun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Mu&quot;},{&quot;first_name&quot;:&quot;Wenxi&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Bixuan&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Zixuan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hainan&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Peipei&quot;,&quot;last_name&quot;:&quot;Guan&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Liya&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Xueshi&quot;,&quot;last_name&quot;:&quot;Huang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6008-6020&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00085&quot;},&quot;abstract&quot;:&quot;Twenty-three natural jamunone analogues along with a series of jamunone-based derivatives were synthesized and evaluated for their inhibitory effects against breast cancer (BC) MDA-MB-231 and MCF-7 cells. The preliminary structure–activity relationship revealed that the length of aliphatic side chain and free phenolic hydroxyl group at the scaffold played a vital role in anti-BC activities and the methyl group on chromanone affected the selectivity of molecules against MDA-MB-231 and MCF-7 cells. Among them, jamunone M (JM) was screened as the most effective anti-triple-negative breast cancer (anti-TNBC) candidate with a high selectivity against BC cells over normal human cells. Mechanistic investigations indicated that JM could induce mitochondria-mediated apoptosis and cause G0/G1 phase arrest in BC cells. Furthermore, JM significantly restrained tumor growth in MDA-MB-231 xenograft mice without apparent toxicity. Interestingly, JM could downregulate phosphatidylinositide 3-kinase (PI3K)/Akt pathway by supp&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00085" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00085&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00085" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00085&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00085" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00085&amp;href=/doi/10.1021/acs.jmedchem.1c00085" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00085" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00085" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00085%26sid%3Dliteratum%253Aachs%26pmid%3D33860662%26genre%3Darticle%26aulast%3DHu%26date%3D2021%26atitle%3DDiscovery%2Bof%2BAnti-TNBC%2BAgents%2BTargeting%2BPTP1B%253A%2BTotal%2BSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%252C%2BIn%2BVitro%2Band%2BIn%2BVivo%2BInvestigations%2Bof%2BJamunones%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D6008%26epage%3D6020%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291967" title="Cluster chemistry">Cluster chemistry</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Twenty-three natural jamunone analogues along with a series of jamunone-based derivatives were synthesized and evaluated for their inhibitory effects against breast cancer (BC) MDA-MB-231 and MCF-7 cells. The preliminary structure–activity relationship revealed that the length of aliphatic side chain and free phenolic hydroxyl group at the scaffold played a vital role in anti-BC activities and the methyl group on chromanone affected the selectivity of molecules against MDA-MB-231 and MCF-7 cells. Among them, jamunone M (JM) was screened as the most effective anti-triple-negative breast cancer (anti-TNBC) candidate with a high selectivity against BC cells over normal human cells. Mechanistic investigations indicated that JM could induce mitochondria-mediated apoptosis and cause G0/G1 phase arrest in BC cells. Furthermore, JM significantly restrained tumor growth in MDA-MB-231 xenograft mice without apparent toxicity. Interestingly, JM could downregulate phosphatidylinositide 3-kinase (PI3K)/Akt pathway by suppressing protein-tyrosine phosphatase 1B (PTP1B) expression. These findings revealed the potential of JM as an appealing therapeutic drug candidate for TNBC.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Breast cancer (BC) has posed overwhelming threats to female health and quality of life with a high incidence and mortality.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> As a complicated and heterogeneous malignant tumor, BC can be classified into distinct subtypes according to three immunophenotypes (ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor receptor 2).<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> Triple-negative breast cancer (TNBC) lacking the expression of ER, PR, and HER2 is regarded as an aggressive and intractable subtype of BC.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> In fact, approximately 20% of invasive infection in breast cancer patients are caused by TNBC.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Although the current guidelines for BC treatment are mainly <i>via</i> surgery and chemotherapy,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> there is still a significant challenge of clinical practices owing to lacking the effective target therapies and serious side effects.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> The discovery of novel anti-BC agents to overcome or reduce multiple adverse effects remains an urgent priority.</div><div class="NLM_p">Protein tyrosine phosphatases (PTPs) and protein tyrosine kinases (PTKs) are responsible for maintaining the balance of protein tyrosine phosphorylation levels and are involved in a host of cellular processes such as proliferation, differentiation, apoptosis, and survival.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> As an important member of the PTP superfamily, PTP1B has been initially recognized as a negative regulator of insulin and leptin receptor signaling,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which has recently been verified to be overexpressed in TNBC and ER<sup>+</sup> BC.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> A growing number of studies have confirmed that the frequent overexpression and amplification of PTP1B in BC cells are accountable for promoting proliferation, mitosis, and invasion.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20−23)</a> Importantly, silencing PTP1B gene or down-regulating PTP1B protein level in BC cells can trigger cell cycle arrest and a series of apoptosis cascades.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> PTP1B could be an effective target for the treatment of BC.</div><div class="NLM_p last">Recently, 16 plant-derived jamunone analogues (jamunones A–O and spiralisone C) with PTP1B inhibitory activity were reported by our research group.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In light of the important roles of PTP1B in cancer biology, we suspected that jamunones might have the potential of anti-BC effects. As expected, a preliminary bioassay screening discovered that these jamunones possessed antiproliferation activity against MDA-MB-231 (TNBC) and MCF-7 (ER<sup>+</sup> BC) at different thresholds. However, the lack of structural diversity and quantities of jamunones purified from natural source limited their further investigations on the structure–activity relationship (SAR) and the underlying mechanisms of anti-BC effect. To resolve the above queries, we had designed a novel and concise approach to synthesize 23 natural jamunone analogues, including jamunones A–O (<b>1</b>–<b>8</b> and <b>10</b>–<b>16</b>, respectively), spiralisone C (<b>9</b>), jambones E–G (<b>1a</b>, <b>3a</b>, <b>5a</b>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> samarones B–D (<b>6a</b>, <b>8a</b>, <b>2a</b>),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and 5,7-dihydroxy-2-pentadecylchromone (<b>9a</b>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Meanwhile, a series of jamunone-based derivatives (JBs) were obtained using the same approach. As a consequence, jamunone M (JM; <b>14</b>) was identified as the most efficacious drug lead for treating BC. Note that the highly selective activity of JM against BC cells was mainly due to restricting protein expression of PTP1B and downstream signaling pathway of phosphatidylinositide 3-kinase (PI3K)/Akt.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The retrosynthetic analysis of jamunones <b>1</b>–<b>16</b> is illustrated in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. The disconnection of O1–C2 linkage leads to the formation of keto-enol tautomers <b>S1</b>/<b>S1</b>′. The pretarget molecules <b>S1</b>/<b>S1</b>′ require the assembly from aliphatic acids and aromatic building block <b>S2</b>, which in turn originate from the acetylation and O-etherification of phloroglucinol (PG). With respect to methylated molecules, an extra methyl group is introduced onto the aromatic ring to eventually match the completion of their retrosynthetic approach.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and retrosynthetic analysis of jamunones <b>1</b>–<b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Guided by the foregoing retrosynthetic strategy, our initial efforts were focused on the syntheses of jamunones <b>1</b>, <b>5</b>, <b>9</b>, and <b>13</b>. As outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the synthetic protocol began with the preparation of the precursor <b>18a</b> from commercially available PG. PG was reacted with acetic anhydride to give the acetylation phenol <b>17</b> and subsequently treated with <i>tert</i>-butyldimethylsilyl chloride (TBSCl) to obtain <i>tert</i>-butyldimethylsilyl (TBS) ether <b>18a</b>. To introduce aliphatic side chains into the C-2 position of target molecules, aliphatic aldehydes <b>20a</b>–<b>d</b> were used in the following step. Aliphatic aldehydes <b>20a</b>–<b>c</b> were synthesized from fatty acids by a two-step sequence (reduction and oxidation reactions), and <b>20d</b> (<i>cis</i>-11-hexadecenal) was directly purchased from a commercial supplier. The aldol condensation of <b>18a</b> with <b>20a</b>–<b>d</b> furnished the key alcohols <b>21a</b>–<b>d</b> using lithium diisopropylamide (LDA) in tetrahydrofuran (THF) at −78 °C. These desired alcohols were further converted to inseparable keto–enol tautomers <b>22a</b>/<b>a</b>′–<b>d</b>/<b>d</b>′ by Dess–Martin oxidation. Finally, the removal of TBS groups in the isomers <b>22a</b>/<b>a</b>′–<b>d</b>/<b>d</b>′ using tetrabutylammonium fluoride (TBAF) proceeded smoothly to yield the desired jamunones <b>1</b>, <b>5</b>, <b>9</b>, and <b>13</b>. According to the similar synthetic strategy, nonadecyl, undecyl, and butyl groups were successfully grafted on the 5,7-dihydroxy chromanone scaffold to form JBs <b>9d</b>–<b>f</b>, respectively.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Completion of Syntheses of Jamunones (<b>1</b>, <b>5</b>, <b>9</b>, <b>13</b>) and JBs (<b>1a</b>–<b>c</b>, <b>5a</b>–<b>c</b>, <b>9a</b>–<b>f</b>, <b>13a</b>–<b>c</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (I) Ac<sub>2</sub>O, BF<sub>3</sub>-OEt<sub>2</sub>, AcOH, 100 °C, 6 h; (II) NaH, TBSCl/bromomethyl methyl ether (MOMBr), THF, 0 °C, 3 h; (III) lithium aluminum hydride (LAH), THF, 0 °C, 3 h; (IV) Dess–Martin periodinane (DMP), dichloromethane (DCM), 0 °C, 3 h; (V) LDA, THF, −78 °C, 12 h; (VI) TBAF, THF, room temperature (rt), 1 h; (VII) HCl/MeOH, 65 °C, 12 h; (VIII) TFA, DCM, 0 °C, 3 h.</p></p></figure><div class="NLM_p">Following the synthetic methodologies of the isomers <b>22a</b>/<b>a</b>′–<b>d</b>/<b>d</b>′, the key precursors <b>22e</b>/<b>e</b>′–<b>h</b>/<b>h</b>′ containing methoxymethyl (MOM) protecting groups were prepared. Afterward, the isomers <b>22e</b>/<b>e</b>′–<b>h</b>/<b>h</b>′ degraded the MOM groups using trifluoroacetic acid (TFA) in one pot to give their structural analogues 7-OH-JBs (<b>1a</b>, <b>5a</b>, <b>9a</b>, <b>13a</b>) and 7-OMOM-JBs (<b>1b</b>, <b>5b</b>, <b>9b</b>, <b>13b</b>; <b>1c</b>, <b>5c</b>, <b>9c</b>, <b>13c</b>). Remarkably, these 7-OH-JBs (<b>1a</b>, <b>5a</b>, <b>9a</b>, <b>13a</b>) could be generated in a high yield under the HCl-catalyzed condition (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">Adhering to the similar logic to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the total syntheses of methylated jamunones (<b>2</b>–<b>4</b>, <b>6</b>–<b>8</b>, <b>10</b>–<b>12</b>, <b>14</b>–<b>16</b>), 7-OH-methylated JBs (<b>2a</b> to <b>4a</b>, <b>6a</b> to <b>8a</b>, <b>10a</b> to <b>12a</b>, <b>14a</b> to <b>16a</b>) and 7-OMOM-methylated JBs (<b>2b</b> to <b>4b</b>, <b>6b</b> to <b>8b</b>, <b>10b</b> to <b>12b</b>, <b>14b</b> to <b>16b</b>) were prospectively performed through using methylated PG instead of PG (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). To implant a methyl group into PG skeleton, the starting material PG needed to undergo Vilsmeier–Haack formylation<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> and subsequent reduction with sodium cyanoborohydride<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> to provide the methylated intermediates (<b>24a</b>, <b>24b</b>), which allowed for the preparation of all associated intermediates.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Completion of Syntheses of Jamunones (<b>2</b>–<b>4</b>, <b>6–8</b>, <b>10</b>–<b>12</b>, <b>14–16</b>) and JBs (<b>2a</b> to <b>4a</b>, <b>2b</b> to <b>4b</b>, <b>6a</b> to <b>8a</b>, <b>6b</b> to <b>8b</b>, <b>10a</b> to <b>12a</b>, <b>10b</b> to <b>12b</b>, <b>14a</b> to <b>16a</b>, <b>14b</b> to <b>16b</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (I) POCl<sub>3</sub>, <i>N</i>,<i>N</i>-dimethylformamide (DMF), 1,4-dioxane, 0 to 25 °C, 3 h; (II) NaBH<sub>3</sub>CN, HCl, THF, 0 to 25 °C, 12 h; (III) Ac<sub>2</sub>O, BF<sub>3</sub>-OEt<sub>2</sub>, AcOH, 100 °C, 3 h; (IV) NaH, TBSCl, THF, 0 °C, 2 h; (V) LAH, THF, 0 °C, 3 h; (VI) DMP, DCM, 0 °C, 3 h; (VII) LDA, THF, −78 °C, 12 h; (VIII) TBAF, THF, 0 °C, 1 h; (IX) TFA, DCM, 0 °C, 3 h; (X) HCl/MeOH, 65 °C, 12 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Anti-BC Activity and Structure–Activity Relationships Studies of JBs</h3><div class="NLM_p">To investigate the inhibitory effects of synthesized JBs on TNBC MDA-MB 231 and ER<sup>+</sup> BC MCF-7 cells, an 3-(4,5-dimethylthiazol-2-yl)-3,5-phenytetrazoliumromide (MTT) assay was carried out. The half-maximal inhibitory concentration (IC<sub>50</sub>) values of test compounds against BC cells are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Table S1</a>. To analyze and characterize their anti-BC efficacy, a cluster dendrogram (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S1</a>) was established in terms of their structural features and IC<sub>50</sub> values. Taking their inhibitory effect and sensitivity against two BC cells as a standard, they were generally divided into four different clusters: cluster I, cluster II, cluster III, and cluster IV. Apparently, there was an overall trend for the anti-BC potency of JBs as follows: cluster II > cluster I > cluster IV ≈ cluster III.</div><div class="NLM_p">Concretely, the JBs in cluster II had a diversity of chemical structures and preferable antiproliferative activity against MDA-MB-231 (IC<sub>50</sub> = 6.79–38.73 μM) and MCF-7 (IC<sub>50</sub> = 17.47–44.18 μM), which made cluster II play a predominant role in all of the clusters. By contrast, the JBs of cluster I possessed poor inhibitory effects on both MDA-MB-231 (IC<sub>50</sub> = 42.77–54.31 μM) and MCF-7 cells (IC<sub>50</sub> = 43.18–61.61 μM). Although the JBs in cluster IV were nearly noncytotoxic to ER<sup>+</sup> BC cell line MCF-7 (IC<sub>50</sub> > 84.14 μM), they exhibited different susceptibility profiles against TNBC cell line (MDA-MB-231 IC<sub>50</sub> = 16.09–65.95 μM), most notably jamunone I (<b>10</b>, MDA-MB-231: IC<sub>50</sub> = 16.09 μM; MCF-7: IC<sub>50</sub> > 100 μM). Different from other clusters, the JBs in cluster III were turned out to show extremely weak or no resistance to both BC cells (MDA-MB-231: IC<sub>50</sub> > 87.02 μM; MCF-7: IC<sub>50</sub> > 67.26 μM).</div><div class="NLM_p">In accordance with the different potencies and sensitivities of JBs against MDA-MB-231 and MCF-7 cells, the cluster II could be further classified into four subclusters. Only jamunone L (<b>13</b>) distributing in subcluster 1 was more active against MCF-7 (IC<sub>50</sub> = 18.73 μM) cell than MDA-MB-231 cell (IC<sub>50</sub> = 33.93 μM). Furthermore, the inhibitory activity of JBs in subcluster 2 against TNBC cell (IC<sub>50</sub> = 25.39–38.73 μM) was moderate and almost equivalent to their anti-ER<sup>+</sup> BC capacity (IC<sub>50</sub> = 29.80–39.81 μM). Compared with other subclusters, the JBs in subclusters 3 and 4 had greater sensitiveness to MDA-MB-231 cell than MCF-7 cell. Impressively, jamunone M (<b>14</b>) in subcluster 3 displayed the highest sensitivity to MDA-MB-231 cell in synthesized JBs.</div><div class="NLM_p">The chromanone-JBs (<b>1</b>, <b>5</b>, <b>9</b>, <b>13</b>) and chromone JBs (<b>1a</b>, <b>5a</b>, <b>9a</b>, <b>13a</b>) were randomly distributed in the different subclusters of cluster II. This phenomenon indicated that the fundamental structural units of chromanone and chromone played equally important roles in the pharmacophore of JBs, which encouraged us to further investigate the anti-BC SAR of JBs based on both structural scaffolds. To explore the effects of alkyl side chain on anti-BC potency, we constructed the derivatives <b>9d</b>–<b>f</b>. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S1</a>, they were individually scattered in cluster I (<b>9e</b>) and cluster III (<b>9d</b>, <b>9f</b>), the inhibition effects of which on BC cells dramatically decreased or disappeared comparing to spiralisone C (<b>9</b>). It was deduced that extending/shortening the length of alkyl side chain at the C-2 site was unfavorable for promoting the antiproliferative activity (<b>9d</b>–<b>f</b><i>vs</i><b>9</b>). The number of carbon atoms of aliphatic chain ranging from 11 to 19 benefitted the inhibitory efficacy (<b>9</b><i>vs</i><b>9d</b>, <b>9e</b>). After that, the OMOM group was introduced onto the C-7 position to discuss the effect of the hydroxyl group on the activity. Among them, a majority of the 7-OMOM analogues (<b>5b</b> to <b>16b</b>, <b>2b</b>, <b>5c</b>, <b>9c</b>, and <b>13c</b>) were basically disseminated in clusters I, III, and IV, which indicated that the introduction of the OMOM moiety led to a sharp drop or loss of activity. From this, a hydrogen-bond donor group at the C-7 site was enormously favorable for improving the inhibitory potency.</div><div class="NLM_p">To investigate the effect of methyl substitution on the anti-BC efficiency, a variety of methyl-substituted JBs were synthesized. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S1</a>, they were scattered in different clusters with a rather distant phylogenetic relationship. The results indicated that the methyl substitution greatly affected the susceptibility against MDA-MB-231 and MCF-7 cells. Furthermore, most of methyl-substituted JBs were classified into those clusters with higher selectivity to MDA-MB-231 than MCF-7 cells (II-subclusters 3 and 4, and cluster IV). Note that the variation of alkyl side chain also influenced the activity of 6,8-dimethylated chromanone or chromone JBs. The substitution of an alkyl side chain of 15 carbon atoms (S15 alkyl chain) was beneficial for improving inhibitory effect against MDA-MB-231 cells in 6,8-dimethyl-chromanones (<b>10</b>, <b>14</b><i>vs</i><b>2</b>, <b>6</b>). However, S17 alkyl substitution was suitable for increasing the activity against MDA-MB-231 cell in 6,8-dimethyl-chromones (<b>2a</b>, <b>6a</b><i>vs</i><b>10a</b>, <b>14a</b>). Again, the degree of unsaturation of alkyl chain could impact the anti-BC property of JBs. For instance, jamunone I (<b>10</b>) with a saturated S15 alkyl substituent presented a higher selectivity for MDA-MB-231 over MCF-7 cells than that of JM (<b>14</b>) with an unsaturated S15 alkyl chain. However, JM showed stronger cytotoxicity against BC cells than jamunone I. To summarize, the primary SAR information is illustrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Primary structure–activity relationships of JBs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cytotoxic Activity and Selectivity Index of JM</h3><div class="NLM_p">On the basis of the aforementioned analysis, JM exerted an optimal inhibitory effect on the proliferation of MDA-MB-231 (IC<sub>50</sub>: 6.79 μM) and MCF-7 (IC<sub>50</sub>: 17.47 μM) cell lines. To estimate the selective index (SI) of JM between cancer and normal cells,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> the cytotoxicities of JM against a panel of different cancer cells and two normal human cells (HEK293T and human umbilical vein endothelial cell (HUVEC)) were assayed (listed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Table S2</a>). As described in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, the inhibitory activities of JM against BC cells were markedly superior to those of other cancer cells. Simultaneously, JM displayed satisfying selectivity to BC cells (SI: 2.08–6.78), especially the TNBC cells, MDA-MB-231 (SI 293T/TNBC: 5.35; HUVEC/TNBC: 6.78). Remarkably, the SI values of JM were about 2–7 times of doxorubicin (DOX) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). These data demonstrated that JM could be a potential candidate drug for targeting BC, especially TNBC.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative bar graph illustrating the IC<sub>50</sub> and SI values. (A) IC<sub>50</sub> values of JM across a panel of cancer cell lines and two normal cell lines. (B) The SI values of JM and DOX (the ratio of IC<sub>50</sub> value of normal cells to BC cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In view of the above observations, two questions were easily raised. (1) Did JM induce cell death <i>via</i> inhibiting the cell cycle or stimulating the apoptosis? (2) Among all of analogues, why did JM specifically target to TNBC cells?</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Antiproliferative Activities of JM</h3><div class="NLM_p last">To reveal the inherent mechanisms, we initially determined the effects of JM on the growth of two BC cells by MTT assay. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S2</a>, JM suppressed the proliferation of BC cells in a time– and concentration–response curve. However, JM did not affect the viability of MDA-MB-231 and MCF-7 cells at concentrations of 5.0–0.56 and 15.0–1.67 μM, respectively, in 24 h. Therefore, these dosages of JM were selected for the following experiments.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> JM Induced Mitochondrial Apoptosis in BC Cells</h3><div class="NLM_p">To further validate these observations, we next determined if JM had the ability to induce the apoptosis of BC cells. By Hoechst 33342 staining, JM-treated cells exhibited the typical features of apoptosis with chromatin shrinkage, membrane blebbing, and the formation of apoptotic bodies (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S3A,B</a>). In addition, the flow cytometric analysis based on fluorescein isothiocyanate (FITC)-Annexin V/propidium iodide (PI) double staining showed that the total percentages of apoptotic cells (early and late apoptosis) in control groups were 3.5% (MDA-MB-231 cell) and 4.4% (MCF-7 cell), while the apoptosis ratios in JM-treated groups increased to 11.8 and 13.6%, respectively (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Both assays implied that JM could trigger BC cell death through an apoptotic pathway.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. JM-induced BC cell apoptosis. (A, C) Apoptotic BC cells were analyzed with Annexin V-FITC/PI double staining in JM-treated BC cells. (B, D) Quantitative analysis of apoptosis rates by flow cytometry. ***<i>p</i> < 0.001 <i>vs</i> control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The dysfunction of mitochondria has been reported to be responsible for apoptosis.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> During the course of mitochondrial apoptosis, the intracellular reactive oxygen species (ROS) is highly induced.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> The increasing levels of ROS can overoxidize cardiolipin in mitochondrial inner membrane, which promotes the decline of electron transfer chain function, leading to the variation of mitochondrial membrane potential (MMP) and cell apoptosis.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">To this end, we continued to inspect the production of ROS and levels of MMP in JM-treated BC cells. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S4A,B</a>, the intensity of green fluorescence was notably enhanced in JM-treated BC cells compared to that of controls. Similarly, the results of flow cytometry exhibited the accumulation of ROS in JM-treatment BC cells (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S4C–F</a>). Moreover, the MMP (ΔΨ<sub>m</sub>) was monitored by the fluorescent probe JC-1. As described in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, the intensity of green fluorescence was significantly increased and the intensity of red fluorescence was decreased in JM-treated BC cells. The results of flow cytometry disclosed a serious reduction of the ratio of red and green fluorescence in JM-treated groups (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). In the meantime, the MMP levels in MDA-MB-231 and MCF-7 cells drastically dropped to 62.2 and 68.7%, respectively, in JM-treated cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C,D). These observations indicated the involvement of mitochondrial apoptosis in JM-treated cells.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of JM on MMP. (A) Fluorescence distribution in JM-treated BC cells for 24 h was observed under a fluorescence microscope. (B) Quantitative analysis of the mitochondrial membrane potential of BC cells. ***<i>p</i> < 0.001 <i>vs</i> control. (C, D) Changes of MMP level in BC cells were detected by flow cytometry analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Effect of JM on Apoptosis-Related Proteins</h3><div class="NLM_p last">The mitochondria-dependent apoptotic pathway, also known as the intrinsic pathway, is primarily modulated by Bcl-2 family proteins.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> An elevated ratio of pro-apoptotic protein Bax and anti-apoptotic Bcl-2 can strengthen the permeability of mitochondrial membrane and facilitate the release of apoptosis-inducing factors, leading to the activation of caspases.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> As we know, caspase-9 and caspase-3 are critical for the cascade of apoptosis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Caspase-9 has the ability to activate caspase-3, which results in cleaving diverse protein substrates (<i>e.g</i>., poly(ADP-ribose) polymerase (PARP)) and participating in DNA fragmentation and reparation.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> To further elucidate the mechanism of JM on apoptosis, the protein expression of caspases was examined by western blotting assay. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S5A–D</a>, JM significantly increased the protein expression of Bax, and the production of cleaved caspase-9 and caspase-3 as well as decreased the level of Bcl-2 in a dose-dependent manner. Again, the cleaved protein level of poly(ADP-ribose) polymerase (PARP) was remarkably upregulated. On the basis of these observations, JM was found to induce cell death <i>via</i> the mitochondrial-dependent apoptotic pathway.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> JM-Caused BC Cell G0/G1 Phase Arrest</h3><div class="NLM_p">The disorder of cell cycle will result in the occurrence and development of tumor.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Currently, multiple regulators of cell cycle are used as the targets of cancer therapy.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> For these reasons, flow cytometry was carried out to determine the effects of JM on BC cells cycle. As depicted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A–D, a large amount of cell population accumulated in the G0/G1 phase after treatment with JM for 24 h. The percentage of MDA-MB-231 cell in the phase of G0/G1 increased from 45.2% (control group) to 62.4% (JM-treated group). A similar result was obtained in MCF-7 cell with an increase from 51.7 to 66.8% after treatment with JM. These results revealed that JM could block BC cells in the phase of G1/G0.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. JM-caused G0/G1 phase arrest of BC cells. (A, C) Cell cycle distribution was analyzed by flow cytometry in BC cells treated with or without JM. (B, D) Statistical analysis of the cell cycle distribution of BC cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Effect of JM on Cell Cycle-Related Proteins</h3><div class="NLM_p last">For regulating cell cycle, cyclins, cyclin-dependent kinases (CDK) and CDK inhibitors (CKIs) play an important role.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The expression of D-type cyclin (cyclin D) occurs in the early phase of cell cycle, which combines CDK4 and CDK6 to generate a ternary complex, leading to initiation of the activities of CDK4 and CDK6.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> In the late G1 stage, the complex of cyclin E and CDK2 will be formed to induce phase transition between G1 and S.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Besides, CKI p21 has the ability to negatively regulate the process of cell cycle by interacting with the cyclin E and CDK2.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In combination with these previous studies, western blots were performed to detect the expression of related regulators in JM-treated BC cells. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S6A,C</a>, the protein expressions of cyclin D1, cyclin D3, cyclin E1, CDK2, CDK4, and CDK6 were downregulated in JM-treated groups, whereas the expression level of p21 was upregulated in a dose-dependent manner. These results verified our hypothesis that JM could effectively arrest cell cycle of BC cells at the G0/G1 phase <i>via</i> reducing the protein expression of cyclins and CDKs and enhancing the protein expression of p21 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">Figure S6B,D</a>).</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> JM Decreased PTP1B Expression Level in BC Cells</h3><div class="NLM_p">Until now, the effects of JM on suppressing the BC cells had been found based on the above results. Nevertheless, it was still unclear that JM had a high selectivity toward TNBC cells relative to other jamunone-related analogues. Previously, our research had discovered that all of the tested jamunones had displayed a satisfying enzymatic inhibitory capacity of PTP1B,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> which were superior to that of ursolic acid (UA, a positive control), especially jamunone A (<b>1</b>, IC<sub>50</sub>: 0.45 μM) and jamunone E (<b>5</b>, IC<sub>50</sub>: 0.42 μM). Although the enzyme-inhibiting activity of JM (IC<sub>50</sub>: 1.80 μM) was lower than jamunones A and E, its activity of anti-BC was more efficacious than that of jamunones A and E. In consideration of these observations, the question was easily raised whether JM disturbed the expression of PTP1B in BC cells. For this purpose, the protein expression of PTP1B was determined by the western blotting assay in JM- or UA<b>-</b>treated BC cells. As expected, the protein level of PTP1B was significantly downregulated with increasing concentration of JM (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B). In contrast, UA had no effect on the expression of PTP1B. Hence, JM could exert anti-BC effects by specifically inhibiting the enzymatic activity and protein expression of PTP1B.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of JM and UA on the expression of PTP1B protein. (A, B) Analysis of expression levels and relative quantities of PTP1B protein in BC cells determined by western blotting. **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 <i>vs</i> control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Molecular Docking</h3><div class="NLM_p">To further validate the targeting specificity of JM and visualize its potential binding mode, the docking studies were performed based on the crystal structure of human PTP1B (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NNY">1NNY</a>). As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,D, although JM showed the similar binding cavity in p-loop domain to UA, the chromanone core of JM was posed into the deeper bottom of active site than UA. Compared with UA, JM could establish the conventional hydrogen bonds not only with Arg221 through 5-hydroxyl and 4-carbonyl groups but also with Lys116 <i>via</i> 7-OH (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B,E). The generation of a hydrogen bond between Lys116 and 7-OH further highlighted the significant contribution of free OH group at the C-7 position in anti-BC activity, which was in line with the analysis of SAR. Note that the residue Ala217 from the P-loop oriented toward 2-OH and 2′-CH<sub>2</sub> groups of JM to generate hydrogen-bond and hydrophobic interactions, respectively (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C,F). Moreover, the alkyl−π interaction occurred between the 6-Me group of JM and the aromatic ring of Trp179, which supported this inference of SAR that methyl substitution on chromanone skeleton influenced the selectivity of molecules toward BC cells. Intriguingly, the alkyl chain of JM could extend toward a side pocket to form a long and narrow hydrophobic channel by participating in the multiple hydrophobic interactions with residues Val49, Met258, and Ala27, which might endow JM with high potency and good specificity over PTP1B.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The results led us to assume that the length and flexibility of hydrophobic side chain had an important influence on the binding affinity of JM to PTP1B. Accordingly, the binding action of JM with PTP1B could provide precious information for a future lead optimization.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding mode of JM (A–C) and UA (D–F) to the active site of PTP1B. (A, D) Surface views of UA and JM with PTP1B. (B, E) Hydrogen-bond interactions of UA and JM with key amino acid residues. (C, F) Detailed interactions of UA and JM with key residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> JM Downregulated PI3K/Akt Signaling Pathway in BC Cells</h3><div class="NLM_p">The PI3K/Akt signaling pathway plays a central role in intracellular signal transduction, which participates in regulating various cell functions, including proliferation, survival, metastasis, metabolism, angiogenesis, <i>etc</i>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> More recently, the overexpression of oncogenic PTPs results in hyperactivating the PI3K pathway in some human cancers, leading to the promotion of tumor growth and development.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> For these reasons, western blot analysis was carried out to check if the inhibitory effect of JM on BC cells was mediated by the PTP1B/PI3K/Akt pathway. The protein expression of PI3K p85 and Akt in JM-treated BC cells were not altered compared to that of the control group, but the phosphorylation levels of PI3K and Akt were apparently inhibited in a concentration-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A–F). Consequently, our data suggested that JM might block cell proliferation and induce cell apoptosis by targeting PTP1B and deactivating the PI3K/Akt pathway.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of JM on PI3K/Akt signaling pathway. (A, D) Protein expressions of PI3K, p-PI3K, Akt, and p-Akt detected by western blotting in BC cells treated with various concentrations of JM. (B, C, E, F) Analysis of relative quantities of PI3K, p-PI3K, Akt, and p-Akt in BC cells. ***<i>p</i> < 0.001 <i>vs</i> Con.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> JM-Suppressed MDA-MB-231 Xenograft Growth <i>In Vivo</i></h3><div class="NLM_p">Following the excellent selectivity of JM for TNBC <i>in vitro</i>, we established an MDA-MB-231 xenograft mouse model to evaluate the inhibitory efficacy of JM on TNBC <i>in vivo</i>. As depicted in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A,B, the growth rate and tumor size in mice were substantially retarded with increasing the dosage of JM. Compared with the control group, the inhibiting values of tumor growth inhibition (TGI, %T/C) at 15 and 30 mg/kg dosage of JM for 20 days were up to 53.6 and 79.3%, respectively (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C). Notably, there were no significant changes in body weights among the three groups, which demonstrated no severe toxicity of JM in mice (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>D). Consistent with <i>in vitro</i> study, our <i>in vivo</i> study indicated that the expression levels of Bax, cleaved caspase-3, cleaved PARP, and p21 were dramatically upregulated, whereas cyclin D3, cyclin E1, and Bcl-2 expressions were downregulated in the JM-administered mice (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>E). Moreover, the PTP1B protein expression of tumor tissue obviously decreased in JM-administered groups. As a result, JM could target PTP1B and restrain the growth of MDA-MB-231 tumor xenograft <i>via</i> inducing apoptosis and cell cycle arrest.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antitumor activity of JM in mice bearing MDA-MB-231 xenograft. (A) Tumor volume of the mice was monitored during the experimental period. (B) Photographs of stripped tumors from each group. (C) Average tumor weights and inhibition rates measured after the mice were sacrificed. (D) Variation of mice body weight throughout the experiment. (E) Expression levels of PTP1B, Bcl-2, Bax, cleaved caspase-3, cleaved PARP, cyclin D3, cyclin E1, and p21 proteins in xenograft tumors analyzed by western blotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we elaborated the total synthesis of jamunones and deduced the primary SAR of anti-BC. The meaningful SARs can be drawn as follow: (i) hydroxyl group at the C-7 position is essential for activity; (ii) the length of alkyl side chain ranging from 11 to 19 carbon atoms is favorable for anti-BC activity; (iii) the 6,8-dimethyl substitution in chromanone or chromone scaffold benefits to improve the selectivity toward TNBC cell. JM was screened out as a highly selective candidate for treating TNBC. The in-depth biological investigations revealed distinct morphological changes, an excess ROS production, a downward ΔΨ<sub>m</sub>, apoptotic induction, and cell cycle blockage at the G0/G1 phase in JM-treated BC cells. The anti-BC feature of JM was found to target PTP1B, which resulted in deactivating PI3K/Akt pathway. Subsequently, the docking profile indicated that the formation of multiple hydrogen bonds and hydrophobic tunnel ensured the stable fit of JM in the catalytic domain of PTP1B, further elucidating the targeting ability of JM and some significant SARs. More importantly, JM dramatically inhibited tumor growth in the MDA-MB-231 tumor xenografts without obvious toxicity. All in all, these findings identified JM as an attractive drug candidate for PTP1B-targeted TNBC therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Methods</h3><div class="NLM_p last">All of the reagents and solvents were purchased from commercial suppliers and used without further purification unless otherwise indicated. Reactions were cooled using a cryocooler or external cooling baths (−78 °C or ice water 0 °C). Heating was achieved using a silicone oil bath with heating controlled by an electronic contact thermometer. Reaction courses were monitored by thin-layer chromatography (TLC) on silica gel-precoated F254 Merck plates. Purification of reaction mixtures was performed by column chromatography using silica gel (100–200 mesh, 200–300 mesh, Qingdao Marine Chemical Ltd., Qingdao, China). All of the intermediates and target compounds were fully analyzed and characterized by <sup>1</sup>H and <sup>13</sup>C NMR spectra, high-resolution mass spectra (HRESI-MS), ultraviolet (UV) spectra, and infrared (IR) spectra before biological screening. The following abbreviations were used to designate the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, m = multiplet, br = broad. All of the targeted compounds were analyzed by high-performance liquid chromatography (HPLC) with a UV–visible detector (2 μm, 50 mm × 2.0 mm, Agilent YMC-UltraHT Pro C18), eluted at 0.35 mL/min with MeOH/water + 5% MeCN + 0.1% formic acid (gradient: 85–95% in 25 min). The purities of compounds were confirmed as ≥95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Cell Culture and Cell Viability Assay</h3><div class="NLM_p last">All of the cell lines used in our study (obtained from the Chinese Academy of Science, Shanghai, China) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% <span class="smallcaps smallerCapital">l</span>-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere incubator (Thermo Fisher Scientific, Waltham, MA). The cytotoxicity and proliferation inhibition were quantified by the MTT assay. The results were represented as mean ± standard deviation (SD) from three independent experiments. The inhibition rate (%) = [<i>A</i><sub>570</sub> (control) – <i>A</i><sub>570</sub> (compound)]/<i>A</i><sub>570</sub> (control) × 100%. The IC<sub>50</sub> values were calculated by a nonlinear regression analysis using SPSS 13.0 (SPSS, Inc., Chicago, IL).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Cluster Analysis Assay</h3><div class="NLM_p last">Based on the Euclidean distance of the IC<sub>50</sub> values of test compounds against BC cells, cluster analysis was performed to characterize their anti-BC potency and structural features using the “ggplot2” package in the program R 4.0.2 (R Core Team, 2020).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Hoechst 33342 Staining</h3><div class="NLM_p last">Cells stained with Hoechst 33342 (Beyotime Biotechnology Co., Shanghai, China) were widely used to evaluate nuclear morphological changes. MDA-MB-231 and MCF-7 cells (6 × 10<sup>4</sup> cells/well) were seeded in 24-well plates and treated with different concentrations of JM (0 and 5.0 μM for MDA-MB-231; 0 and 15.0 μM for MCF-7) for 24 h. Subsequently, the cells were washed three times with phosphate-buffered saline (PBS) and stained with 1 mL suspension of Hoechst 33342 and PBS for 5 min in the dark at rt. The changes in nuclear morphology were evaluated and photographed by a fluorescence microscope (Leica, Wetzlar, HE, Germany).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cell Apoptosis Assay</h3><div class="NLM_p last">MDA-MB-231 and MCF-7 cells (3 × 10<sup>5</sup> cells/well) were seeded in six-well plates and exposed to compound JM (0 and 5.0 μM for MDA-MB-231; 0 and 15.0 μM for MCF-7) for 24 h. Afterward, the cells were collected, washed with cold PBS, and resuspended in 195 μL of binding buffer. Fluorescein isothiocyanate (FITC)-conjugated annexin-V reagent (1 μL) and PI (8 μL, BD, Franklin Lakes, NJ) were added to the samples and mixed gently. After 15 min incubation in the dark at room temperature, the samples were immediately run on an LSR-Fortessa flow cytometer and analyzed with the Annexin V-FITC/PI apoptosis method. Cytographs were performed using BD FACSDiva software (BD, Franklin Lakes, NJ). Each experiment was conducted three times.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Reactive Oxygen Species (ROS) Assay</h3><div class="NLM_p">The formation of intracellular ROS was assessed using a ROS Assay kit (Beyotime Biotechnology Co., Shanghai, China). MDA-MB-231 and MCF-7 cells (6 × 10<sup>4</sup> cells/well) were seeded in 24-well plates with 5.0 and 15.0 μM of M treatment for 24 h, respectively. After washing once with PBS, these cells were stained with 10 μM dichlorodihydrofluorescein diacetate (DCFH-DA) at 37 °C for 30 min in the dark, washed three times with serum-free medium, and then resuspended in serum-free medium. The alteration of fluorescence intensity was observed under a fluorescence microscope.</div><div class="NLM_p last">MDA-MB-231 and MCF-7 cells (3 × 10<sup>5</sup> cells/well) were seeded into six-well plates and treated with JM (0 and 5.0 μM for MDA-MB-231; 0 and 15.0 μM for MCF-7) for 24 h. The cells were washed once with PBS, incubated with 10 μM DCFH-DA at 37 °C for 30 min in the dark. Then, the cells were washed three times with serum-free medium, centrifuged (1000 rpm, 5 min), and collected. Finally, the cells were resuspended by the addition of 500 μL of PBS and loaded onto a flow cytometer.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Mitochondrial Membrane Potential (MMP) Assay</h3><div class="NLM_p">The mitochondrial membrane potential (ΔΨ<sub>m</sub>) was measured with an MMP assay kit with JC-1 (Beyotime Biotechnology Co., Shanghai, China). MDA-MB-231 and MCF-7 cells (6 × 10<sup>4</sup> cells/well) were seeded in 24-well plates. After 24 h incubation, the cells were treated with JM (0 and 5.0 μM for MDA-MB-231; 0 and 15.0 μM for MCF-7) for another 24 h. The cells were washed once with PBS. After that, 0.4 mL of the cell culture solution and 0.4 mL of JC-1 staining working solution were successively added, thoroughly mixed, and incubated at 37 °C for 20 min in the dark. The cells were washed twice with JC-1 staining buffer (1×) and resuspended in fresh culture medium. Finally, mitochondrial membrane potential was evaluated qualitatively under a fluorescence microscope.</div><div class="NLM_p last">MDA-MB-231 and MCF-7 cells (3 × 10<sup>5</sup> cells/well) were incubated with different concentrations of JM (0 and 5.0 μM for MDA-MB-231; 0 and 15.0 μM for MCF-7) in six-well plates. After treatment with 24 h, 1 mL of the cell culture media and 1 mL of JC-1 staining working solution was added, mixed well, and incubated at 37 °C for 20 min. Later, the cells were centrifuged (1000 rpm, 5 min) and washed twice by 1× JC-1 staining buffer. The collected cells were resuspended in 500 μL of JC-1 staining buffer and immediately analyzed by a flow cytometer.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell Cycle Assay</h3><div class="NLM_p last">MDA-MB-231 and MCF-7 cells (3 × 10<sup>5</sup> cells/well) were seeded in six-well plates and exposed to compound JM (0 and 5.0 μM for MDA-MB-231; 0 and 15.0 μM for MCF-7) for 24 h. The cells were then collected and fixed overnight in 75% ethanol at −20 °C. The next day, the cells were washed twice with cold PBS, gently resuspended in 500 μL of propidium iodide (PI) working fluid (Dingguo Changsheng Biotechnology Co. Ltd., Beijing, China), and incubated for 15 min in the dark at rt. Cell cycle analysis was performed using an LSR-Fortessa flow cytometer. The percentage of cells in each phase was analyzed using ModFit LT 4.1 software (Verity Software House, Topsham, ME). Each experiment was conducted three times.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>In Vivo</i> Xenograft Study</h3><div class="NLM_p last">A 150 μL MDA-MB-231 cell suspension (6 × 10<sup>6</sup> cells in PBS) was subcutaneously inoculated into the right back of 8-week-old female BALB/c nude mice (Changsheng Biotechnology Co., Ltd., Liaoning, China). When the average volume of the tumors reached about 60 mm<sup>3</sup>, the mice were randomized into three groups (<i>n</i> = 5/group). The control group (vehicle) and two JM treatment groups (15, 30 mg/kg) were intraperitoneally injected every other day for 10 treatments. Tumor volume and body weight were recorded every other day after drug treatment. After 20 days, all mice were sacrificed and the tumors were harvested for further study. The tumor size was calculated by the equation: <i>V</i> (tumor volume, mm<sup>3</sup>) = <i>L</i> (length, mm) × <i>W</i><sup>2</sup> (width, mm) × 0.5. The tumor growth inhibition (TGI) ratio was calculated with the following formula: TGI = (1 – TW<sub>t</sub>/TW<sub>c</sub>) × 100%, where TW<sub>t</sub> and TW<sub>c</sub> represent average tumor weight of JM-treated and control groups on day 20, respectively. All animal procedures were conducted in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) and were approved by the Animal Care and Use Committee of Northeastern University (Shenyang, China, 2016.04).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Molecular Modeling Study</h3><div class="NLM_p last">The available X-ray structure of PTP1B (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NNY">1NNY</a>)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> was downloaded from Protein Data Bank (<a href="http://www.rcsb.org/pdb" class="extLink">http://www.rcsb.org/pdb</a>). Docking study was conducted using Discovery Studio 3.5. The binding site was defined according to the reference ligand by a radius of 10.5 Å. The protein structure was processed by removing water molecules, adding hydrogen atoms, and applying Charmm forcefield. The ligands were prepared by adding hydrogen atoms and energy minimization. Gold score protocol was used as the score function, and the other parameters were set as default. The results were processed by PyMoL.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Western Blotting Analysis</h3><div class="NLM_p">The <i>in vitro</i> effect of JM on protein expression was examined in MDA-MB-231 and MCF-7 cells. MDA-MB-231 and MCF-7 cells were seeded in six-well plates with a density of 3 × 10<sup>5</sup> cells/well and treated with various concentrations of JM (0, 0.56, 1.67, and 5.0 μM for MDA-MB-231; 0, 1.67, 5.0, and 15.0 μM for MCF-7) for 24 h. The treated cells were washed with cold PBS and lysed with radioimmunoprecipitation assay (RIPA) lysis buffer (Beyotime Biotechnology Co., Shanghai, China) containing 2% protease inhibitor cocktail and 1% phosphatase inhibitor cocktail (Promega, Madison, WI). In <i>in vivo</i> experiment, tumor tissue homogenate was lysed for western blotting. Protein concentration was determined by a bicinchoninic acid (BCA) protein assay kit (Beyotime Biotechnology Co., Shanghai, China). Equal quantities of protein were separated by 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), electroblotted to poly(vinylidene difluoride) (PVDF) membranes (Millipore, Billerica, MA), and blocked with 5% nonfat milk for 60 min at rt. The membranes were incubated with specific primary antibodies (diluted 1: 3000 in 1× Tris-buffered saline) overnight at 4 °C.</div><div class="NLM_p last">After washing three times with TBST, the membranes were probed with the corresponding secondary antibodies (diluted 1:10 000 in 5% nonfat milk) for 60 min at rt. Then, protein bands were detected with ECL select western blot detection reagent (Millipore, Billerica, MA) by chemiluminescence (Tanon 5500, Shanghai, China). Each protein band was normalized to the respective anti-β-actin band. The GIS Gel Image System (Tanon, Shanghai, China) was used for the quantitative grayscale analysis of the bands. Again, the primary antibodies for Bax, Bcl-2, caspase-3, caspase-9, PARP, cyclin D1, cyclin D3, cyclin E1, CDK2, CDK4, CDK6, p21, Akt, phospho-Akt, PI3K, phospho-PI3K, β-actin, and horse-radish peroxidase (HRP)-conjugated secondary antibodies were purchased from Cell Signaling Technology (Dancers, MA), apart from the primary antibodies for PTP1B (Absin Bioscience, Inc., Shanghai, China).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00085" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00085?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00085</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic procedures, characterization data, and NMR spectra for all listed compounds; HPLC chromatogram of lead compounds; and some biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf">jm1c00085_si_001.pdf (20.29 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_002.csv">jm1c00085_si_002.csv (4.2 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NNY">1NNY</a> was used for modeling docking in PTP1B of JM. The authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.1c00085" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Han</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#690108070500290408000547070c1c470c0d1c470a07"><span class="__cf_email__" data-cfemail="92faf3fcfefbd2fff3fbfebcfcf7e7bcf7f6e7bcf1fc">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liya Li</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1894-9500" title="Orcid link">http://orcid.org/0000-0002-1894-9500</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dcb0a5b0b59cb1bdb5b0f2b2b9a9f2b9b8a9f2bfb2"><span class="__cf_email__" data-cfemail="d7bbaebbbe97bab6bebbf9b9b2a2f9b2b3a2f9b4b9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xueshi Huang</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1561-8108" title="Orcid link">http://orcid.org/0000-0002-1561-8108</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#305845515e574843705d51595c1e5e55451e5554451e535e"><span class="__cf_email__" data-cfemail="0f677a6e6168777c4f626e666321616a7a216a6b7a216c61">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caijuan Hu</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guoxun Li</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Mu</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenxi Wu</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bixuan Cao</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zixuan Wang</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hainan Yu</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peipei Guan</span> - <span class="hlFld-Affiliation affiliation">Institute of Microbial Pharmaceuticals,
College of Life and Health Sciences, Northeastern
University, Shenyang 110819, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e1662-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06473" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06473" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Dahong Yao from the School of Pharmaceutical Sciences, Shenzhen University, Shenzhen 518000, China, for the molecular docking assay. They are grateful for the financial support from the National Natural Science Foundation of China (no. 32072208).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">BC</td><td class="NLM_def"><p class="first last">breast cancer</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMP</td><td class="NLM_def"><p class="first last">Dess–Martin periodinane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">LAH</td><td class="NLM_def"><p class="first last">lithium aluminum hydride</p></td></tr><tr><td class="NLM_term">LDA</td><td class="NLM_def"><p class="first last">lithium diisopropylamide</p></td></tr><tr><td class="NLM_term">MOMBr</td><td class="NLM_def"><p class="first last">bromomethyl methyl ether</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-3,5-phenytetrazoliumromide</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PTP1B</td><td class="NLM_def"><p class="first last">protein-tyrosine phosphatase 1B</p></td></tr><tr><td class="NLM_term">SARs</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TBSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl chloride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeSantis, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lortet-Tieulent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">International variation in female breast cancer incidence and mortality rates</span>. <i>Cancer Epidemiol., Biomarkers Prev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1495</span>– <span class="NLM_lpage">1506</span>, <span class="refDoi"> DOI: 10.1158/1055-9965.EPI-15-0535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1158%2F1055-9965.EPI-15-0535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=26359465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BC283htFekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1495-1506&author=C.+E.+DeSantisauthor=F.+Brayauthor=J.+Ferlayauthor=J.+Lortet-Tieulentauthor=B.+O.+Andersonauthor=A.+Jemal&title=International+variation+in+female+breast+cancer+incidence+and+mortality+rates&doi=10.1158%2F1055-9965.EPI-15-0535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International Variation in Female Breast Cancer Incidence and Mortality Rates</span></div><div class="casAuthors">DeSantis Carol E; Lortet-Tieulent Joannie; Jemal Ahmedin; Bray Freddie; Ferlay Jacques; Anderson Benjamin O</div><div class="citationInfo"><span class="NLM_cas:title">Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1495-506</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death among women worldwide.  Herein, we examine global trends in female breast cancer rates using the most up-to-date data available.  METHODS:  Breast cancer incidence and mortality estimates were obtained from GLOBOCAN 2012 (globocan.iarc.fr).  We analyzed trends from 1993 onward using incidence data from 39 countries from the International Agency for Research on Cancer and mortality data from 57 countries from the World Health Organization.  RESULTS:  Of 32 countries with incidence and mortality data, rates in the recent period diverged-with incidence increasing and mortality decreasing-in nine countries mainly in Northern/Western Europe.  Both incidence and mortality decreased in France, Israel, Italy, Norway, and Spain.  In contrast, incidence and death rates both increased in Colombia, Ecuador, and Japan.  Death rates also increased in Brazil, Egypt, Guatemala, Kuwait, Mauritius, Mexico, and Moldova.  CONCLUSIONS:  Breast cancer mortality rates are decreasing in most high-income countries, despite increasing or stable incidence rates.  In contrast and of concern are the increasing incidence and mortality rates in a number of countries, particularly those undergoing rapid changes in human development.  Wide variations in breast cancer rates and trends reflect differences in patterns of risk factors and access to and availability of early detection and timely treatment.  IMPACT:  Increased awareness about breast cancer and the benefits of early detection and improved access to treatment must be prioritized to successfully implement breast cancer control programs, particularly in transitioning countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJEbxh97K6Vt6fW6udTcc2eYOI4Ce3hqXAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFekuw%253D%253D&md5=acbc8a0af01c7bf93e7af30991debbff</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F1055-9965.EPI-15-0535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1055-9965.EPI-15-0535%26sid%3Dliteratum%253Aachs%26aulast%3DDeSantis%26aufirst%3DC.%2BE.%26aulast%3DBray%26aufirst%3DF.%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DLortet-Tieulent%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DB.%2BO.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DInternational%2520variation%2520in%2520female%2520breast%2520cancer%2520incidence%2520and%2520mortality%2520rates%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2015%26volume%3D24%26spage%3D1495%26epage%3D1506%26doi%3D10.1158%2F1055-9965.EPI-15-0535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibshirani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisen, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matese, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonning, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borresen-Dale, A. L.</span></span> <span> </span><span class="NLM_article-title">Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10869</span>– <span class="NLM_lpage">10874</span>, <span class="refDoi"> DOI: 10.1073/pnas.191367098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1073%2Fpnas.191367098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=11553815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVGmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10869-10874&author=T.+Sorlieauthor=C.+M.+Perouauthor=R.+Tibshiraniauthor=T.+Aasauthor=S.+Geislerauthor=H.+Johnsenauthor=T.+Hastieauthor=M.+B.+Eisenauthor=M.+van+de%0ARijnauthor=S.+S.+Jeffreyauthor=T.+Thorsenauthor=H.+Quistauthor=J.+C.+Mateseauthor=P.+O.+Brownauthor=D.+Botsteinauthor=P.+E.+Lonningauthor=A.+L.+Borresen-Dale&title=Gene+expression+patterns+of+breast+carcinomas+distinguish+tumor+subclasses+with+clinical+implications&doi=10.1073%2Fpnas.191367098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications</span></div><div class="casAuthors">Sorlie, Therese; Perou, Charles M.; Tibshirani, Robert; Aas, Turid; Geisler, Stephanie; Johnsen, Hilde; Hastie, Trevor; Eisen, Michael B.; Van de Rijn, Matt; Jeffrey, Stefanie S.; Thorsen, Thor; Quist, Hanne; Matese, John C.; Brown, Patrick O.; Botstein, David; Lonning, Per Eystein; Borresen-Dale, Anne-Lise</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10869-10874</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The purpose of this study was to classify breast carcinomas based on variations in gene expression patterns derived from cDNA microarrays and to correlate tumor characteristics to clin. outcome.  A total of 85 cDNA microarray expts. representing 78 cancers, three fibroadenomas, and four normal breast tissues were analyzed by hierarchical clustering.  As reported previously, the cancers could be classified into a basal epithelial-like group, an ERBB2-overexpressing group and a normal breast-like group based on variations in gene expression.  A novel finding was that the previously characterized luminal epithelial/estrogen receptor-pos. group could be divided into at least two subgroups, each with a distinctive expression profile.  These subtypes proved to be reasonably robust by clustering using two different gene sets: first, a set of 456 cDNA clones previously selected to reflect intrinsic properties of the tumors and, second, a gene set that highly correlated with patient outcome.  Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-pos. groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFAw_CL6SrMrVg90H21EOLACvtfcHk0lhGZecx3nvFZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVGmsbo%253D&md5=5a54045e69bbc92a5294eb5e73934bd7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.191367098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.191367098%26sid%3Dliteratum%253Aachs%26aulast%3DSorlie%26aufirst%3DT.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DTibshirani%26aufirst%3DR.%26aulast%3DAas%26aufirst%3DT.%26aulast%3DGeisler%26aufirst%3DS.%26aulast%3DJohnsen%26aufirst%3DH.%26aulast%3DHastie%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DThorsen%26aufirst%3DT.%26aulast%3DQuist%26aufirst%3DH.%26aulast%3DMatese%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DBorresen-Dale%26aufirst%3DA.%2BL.%26atitle%3DGene%2520expression%2520patterns%2520of%2520breast%2520carcinomas%2520distinguish%2520tumor%2520subclasses%2520with%2520clinical%2520implications%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D10869%26epage%3D10874%26doi%3D10.1073%2Fpnas.191367098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisen, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akslen, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fluge, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergamenschikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lønning, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Børresen-Dale, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botstein, D.</span></span> <span> </span><span class="NLM_article-title">Molecular portraits of human breast tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1038/35021093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2F35021093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10963602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=747-752&author=C.+M.+Perouauthor=T.+Sorlieauthor=M.+B.+Eisenauthor=M.+van+de%0ARijnauthor=S.+S.+Jeffreyauthor=C.+A.+Reesauthor=J.+R.+Pollackauthor=D.+T.+Rossauthor=H.+Johnsenauthor=L.+A.+Akslenauthor=O.+Flugeauthor=A.+Pergamenschikovauthor=C.+Williamsauthor=S.+X.+Zhuauthor=P.+E.+L%C3%B8nningauthor=A.+L.+B%C3%B8rresen-Daleauthor=P.+O.+Brownauthor=D.+Botstein&title=Molecular+portraits+of+human+breast+tumours&doi=10.1038%2F35021093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular portraits of human breast tumors</span></div><div class="casAuthors">Perou, Charles M.; Serlie, Therese; Eisen, Michael B.; Van De Rijn, Matt; Jeffrey, Stefanie S.; Rees, Christian A.; Pollack, Jonathan R.; Rossi, Douglas T.; Johnsen, Hilde; Akslen, Lars A.; Fluge, Oystein; Pergamenschikov, Alexander; Williams, Cheryl; Zhu, Shirley X.; Lenning, Per E.; Berresen-Dale, Anne-Use; Brown, Patrick O.; Botstein, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6797</span>),
    <span class="NLM_cas:pages">747-752</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human breast tumors are diverse in their natural history and in their responsiveness to treatments.  Variation in transcriptional programs accounts for much of the biol. diversity of human cells and tumors.  In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome.  Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumors from 42 different individuals, using cDNA microarrays representing 8102 human genes.  These patterns provided a distinctive mol. portrait of each tumor.  Twenty of the tumors were sampled twice, before and after a 16-wk course of doxorubicin chemotherapy, and two tumors were paired with a lymph node metastasis from the same patient.  Gene expression patterns in two tumor samples from the same individual were almost always more similar to each other than either was to any other sample.  Sets of co-expressed genes were identified for which variation in mRNA levels could be related to specific features of physiol. variation.  The tumors could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorYsVvqq_EyLVg90H21EOLACvtfcHk0lhGZecx3nvFZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D&md5=f81e9b3e3d5e339ea463428b1c973f8d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F35021093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35021093%26sid%3Dliteratum%253Aachs%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DSorlie%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DRees%26aufirst%3DC.%2BA.%26aulast%3DPollack%26aufirst%3DJ.%2BR.%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DJohnsen%26aufirst%3DH.%26aulast%3DAkslen%26aufirst%3DL.%2BA.%26aulast%3DFluge%26aufirst%3DO.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DS.%2BX.%26aulast%3DL%25C3%25B8nning%26aufirst%3DP.%2BE.%26aulast%3DB%25C3%25B8rresen-Dale%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DBotstein%26aufirst%3DD.%26atitle%3DMolecular%2520portraits%2520of%2520human%2520breast%2520tumours%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D747%26epage%3D752%26doi%3D10.1038%2F35021093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polyak, K.</span></span> <span> </span><span class="NLM_article-title">Heterogeneity in breast cancer</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">3786</span>– <span class="NLM_lpage">3788</span>, <span class="refDoi"> DOI: 10.1172/JCI60534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1172%2FJCI60534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=21965334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12ht7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=3786-3788&author=K.+Polyak&title=Heterogeneity+in+breast+cancer&doi=10.1172%2FJCI60534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneity in breast cancer</span></div><div class="casAuthors">Polyak, Kornelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3786-3788</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Breast cancer is a heterogeneous disease.  There is a high degree of diversity between and within tumors as well as among cancer-bearing individuals, and all of these factors together det. the risk of disease progression and therapeutic resistance.  Advances in technologies such as whole-genome sequencing and functional viability screens now allow us to analyze tumors at unprecedented depths.  However, translating this increasing knowledge into clin. practice remains a challenge in part due to tumor evolution driven by the diversity of cancer cell populations and their microenvironment.  The articles in this Review series discuss recent advances in our understanding of breast tumor heterogeneity, therapies tailored based on this knowledge, and future ways of assessing and treating heterogeneous tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtmFGt9inzXrVg90H21EOLACvtfcHk0lhGZecx3nvFZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12ht7vP&md5=df8082e7d6dda725d6c23569da5ea065</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1172%2FJCI60534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI60534%26sid%3Dliteratum%253Aachs%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DHeterogeneity%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D3786%26epage%3D3788%26doi%3D10.1172%2FJCI60534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, R. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradishar, W. J.</span></span> <span> </span><span class="NLM_article-title">Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1007/s10549-018-4697-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1007%2Fs10549-018-4697-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29417298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVygsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2018&pages=397-406&author=R.+L.+B.+Costaauthor=H.+S.+Hanauthor=W.+J.+Gradishar&title=Targeting+the+PI3K%2FAKT%2FmTOR+pathway+in+triple-negative+breast+cancer%3A+a+review&doi=10.1007%2Fs10549-018-4697-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review</span></div><div class="casAuthors">Costa, Ricardo L. B.; Han, Hyo Sook; Gradishar, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Triple-neg. breast cancer (TNBC) accounts for approx. 20% of breast cancer cases.  Although there have been advances in the treatment of hormone receptor-pos. and human epidermal growth factor receptor 2-pos. breast cancers, targeted therapies for TNBC remain unavailable.  In this narrative review, we summarize recent discoveries related to the underlying biol. of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) pathway in TNBC, examine clin. progress to date, and suggest rational future approaches for investigational therapies in TNBC.  Results: As with other subtypes of breast cancer, aberrations in the PI3K/AKT/mTOR pathway are common in TNBC.  Preclin. data support the notion that these aberrations predict TNBC inhibition by targeted agents.  In a recently published phase 2 clin. trial, an AKT inhibitor (ipatasertib) improved outcomes in a subset of patients with metastatic TNBC when combined with paclitaxel in the first-line setting.  In addn., new compds. with distinct specificity and potency targeting different PI3K/AKT/mTOR components and cognate mols. (e.g., mitogen-activated protein kinase) are being developed.  These agents present a wide range of toxicity profiles and early efficacy signals, which must be considered prior to the advancement of new agents in later-phase clin. trials.  Conclusions: The development of drugs targeting the PI3K/AKT/mTOR pathway for the treatment of TNBC is an evolving field that should take into account the efficacies and toxicities of new agents in addn. to their interactions with different cancer pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_aSITy3SaC7Vg90H21EOLACvtfcHk0lj6IA71_nsVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVygsL8%253D&md5=2b79ebda8f1037d8aab960b9a8dafff6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs10549-018-4697-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-018-4697-y%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DR.%2BL.%2BB.%26aulast%3DHan%26aufirst%3DH.%2BS.%26aulast%3DGradishar%26aufirst%3DW.%2BJ.%26atitle%3DTargeting%2520the%2520PI3K%252FAKT%252FmTOR%2520pathway%2520in%2520triple-negative%2520breast%2520cancer%253A%2520a%2520review%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2018%26volume%3D169%26spage%3D397%26epage%3D406%26doi%3D10.1007%2Fs10549-018-4697-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarthy, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyr, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietenpol, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">2750</span>– <span class="NLM_lpage">2767</span>, <span class="refDoi"> DOI: 10.1172/JCI45014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1172%2FJCI45014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=21633166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=2750-2767&author=B.+D.+Lehmannauthor=J.+A.+Bauerauthor=X.+Chenauthor=M.+E.+Sandersauthor=A.+B.+Chakravarthyauthor=Y.+Shyrauthor=J.+A.+Pietenpol&title=Identification+of+human+triple-negative+breast+cancer+subtypes+and+preclinical+models+for+selection+of+targeted+therapies&doi=10.1172%2FJCI45014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies</span></div><div class="casAuthors">Lehmann, Brian D.; Bauer, Joshua A.; Chen, Xi; Sanders, Melinda E.; Chakravarthy, A. Bapsi; Shyr, Yu; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2750-2767</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a highly diverse group of cancers, and subtyping is necessary to better identify mol.-based therapies.  In this study, we analyzed gene expression (GE) profiles from 21 breast cancer data sets and identified 587 TNBC cases.  Cluster anal. identified 6 TNBC subtypes displaying unique GE and ontologies, including 2 basal-like (BL1 and BL2), an immunomodulatory (IM), a mesenchymal (M), a mesenchymal stem-like (MSL), and a luminal androgen receptor (LAR) subtype.  Further, GE anal. allowed us to identify TNBC cell line models representative of these subtypes.  Predicted "driver" signaling pathways were pharmacol. targeted in these cell line models as proof of concept that anal. of distinct GE signatures can inform therapy selection.  BL1 and BL2 subtypes had higher expression of cell cycle and DNA damage response genes, and representative cell lines preferentially responded to cisplatin.  M and MSL subtypes were enriched in GE for epithelial-mesenchymal transition, and growth factor pathways and cell models responded to NVP-BEZ235 (a PI3K/mTOR inhibitor) and dasatinib (an abl/src inhibitor).  The LAR subtype includes patients with decreased relapse-free survival and was characterized by androgen receptor (AR) signaling.  LAR cell lines were uniquely sensitive to bicalutamide (an AR antagonist).  These data may be useful in biomarker selection, drug discovery, and clin. trial design that will enable alignment of TNBC patients to appropriate targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbhoQQUFogW7Vg90H21EOLACvtfcHk0lj6IA71_nsVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D&md5=c3681c79e0b972f16f6d5a5ecdc99fec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI45014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45014%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DBauer%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DChakravarthy%26aufirst%3DA.%2BB.%26aulast%3DShyr%26aufirst%3DY.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520human%2520triple-negative%2520breast%2520cancer%2520subtypes%2520and%2520preclinical%2520models%2520for%2520selection%2520of%2520targeted%2520therapies%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D2750%26epage%3D2767%26doi%3D10.1172%2FJCI45014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anders, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, L. A.</span></span> <span> </span><span class="NLM_article-title">Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer</span>. <i>Clin. Breast Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">S73</span>– <span class="NLM_lpage">S81</span>, <span class="refDoi"> DOI: 10.3816/CBC.2009.s.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.3816%2FCBC.2009.s.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19596646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlWgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=S73-S81&author=C.+K.+Andersauthor=L.+A.+Carey&title=Biology%2C+metastatic+patterns%2C+and+treatment+of+patients+with+triple-negative+breast+cancer&doi=10.3816%2FCBC.2009.s.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer</span></div><div class="casAuthors">Anders, Carey K.; Carey, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Breast Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S73-S81</span>CODEN:
                <span class="NLM_cas:coden">CBCLB7</span>;
        ISSN:<span class="NLM_cas:issn">1526-8209</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group, LP</span>)
        </div><div class="casAbstract">A review.  Of the estd. 1 million cases of breast cancer diagnosed annually worldwide, it is estd. that over 170,000 will harbor the triple-neg. (estrogen receptor/progesterone receptor/HER2-neg.) phenotype.  Most, though not all, triple-neg. breast cancers will be basal-like on gene expression microarrays.  The basal-like mol. subtype exhibits a unique mol. profile and set of risk factors, aggressive and early pattern of metastasis, limited treatment options, and poor prognosis.  Large population-based studies have identified a higher proportion of triple-neg. breast tumors among premenopausal African American women, and a suggestion that increased parity, younger age at first-term pregnancy, shorter duration of breast feeding, and elevated hip-to-waist ratio might be particular risk factors.  When BRCA1 mutation carriers develop breast cancer, it is usually basal-like; given the central role of BRCA1 in DNA repair, this could have profound therapeutic implications.  When diagnosed, triple-neg. breast cancers illustrate preferential relapse in visceral organs, including the central nervous system.  Although initial response to chemotherapy might be more profound, relapse is early and common among triple-neg. breast cancers compared with luminal breast cancers.  The armamentarium of "targeted therapeutics" for triple-neg. breast cancer is evolving and includes strategies to inhibit angiogenesis, epidermal growth factor receptor, and other kinases.  Finally, the pos. assocn. between triple-neg. breast cancer and BRCA mutations makes inhibition of poly(ADP-ribose) polymerase-1 an attractive therapeutic strategy that is in active study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbA5DSLInPtLVg90H21EOLACvtfcHk0lj6IA71_nsVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlWgt7w%253D&md5=2e95f61ee46bd7b3fb6cc27c66299cd7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3816%2FCBC.2009.s.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCBC.2009.s.008%26sid%3Dliteratum%253Aachs%26aulast%3DAnders%26aufirst%3DC.%2BK.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26atitle%3DBiology%252C%2520metastatic%2520patterns%252C%2520and%2520treatment%2520of%2520patients%2520with%2520triple-negative%2520breast%2520cancer%26jtitle%3DClin.%2520Breast%2520Cancer%26date%3D2009%26volume%3D9%26spage%3DS73%26epage%3DS81%26doi%3D10.3816%2FCBC.2009.s.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garimella, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowitz, S.</span></span> <span> </span><span class="NLM_article-title">Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer</span>. <i>Breast Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/BD-2010-0307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.3233%2FBD-2010-0307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=35-48&author=K.+J.+Chavezauthor=S.+V.+Garimellaauthor=S.+Lipkowitz&title=Triple+negative+breast+cancer+cell+lines%3A+one+tool+in+the+search+for+better+treatment+of+triple+negative+breast+cancer&doi=10.3233%2FBD-2010-0307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3233%2FBD-2010-0307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FBD-2010-0307%26sid%3Dliteratum%253Aachs%26aulast%3DChavez%26aufirst%3DK.%2BJ.%26aulast%3DGarimella%26aufirst%3DS.%2BV.%26aulast%3DLipkowitz%26aufirst%3DS.%26atitle%3DTriple%2520negative%2520breast%2520cancer%2520cell%2520lines%253A%2520one%2520tool%2520in%2520the%2520search%2520for%2520better%2520treatment%2520of%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DBreast%2520Dis.%26date%3D2011%26volume%3D32%26spage%3D35%26epage%3D48%26doi%3D10.3233%2FBD-2010-0307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. W.</span></span> <span> </span><span class="NLM_article-title">Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2018.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.intimp.2018.09.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=30342344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFCgsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2018&pages=279-283&author=W.+H.+Wangauthor=H.+Y.+Xuauthor=Z.+M.+Zhaoauthor=G.+M.+Zhangauthor=F.+W.+Lin&title=Dynamic+and+significant+changes+of+T-cell+subgroups+in+breast+cancer+patients+during+surgery+and+chemotherapy&doi=10.1016%2Fj.intimp.2018.09.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy</span></div><div class="casAuthors">Wang, Wen-Hui; Xu, Hong-Yan; Zhao, Zhong-Min; Zhang, Guang-Mei; Lin, Feng-Wu</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-283</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer and its surgical treatment and chemotherapy have great impact on the immune system.  This study aimed to monitor the various T cells in breast cancer patients and evaluate the immune functions.  The percentages of the CD3+, CD4+, CD8+, CD45RA+, and CD45RO+ T cells were measured using flow cytometry.  Another 200 healthy women were used as control.  The percentages of CD45RO+ T cells and CD4+CD25+ (Treg) cells were significantly higher in stage II/III malignancies vs. stage I, and was significantly higher in stage I malignancies vs. the normal control (P < 0.05).  The preoperative percentages of CD3+ and CD4+ T cells were significantly reduced after 3 cycles and after 6 cycles of chemotherapy (P < 0.05).  In patients with stage II/III malignancies, there was a higher percentage of CD45RO+ T cells than CD45RA+ T cells, which was reversed after surgery.  After 6 chemotherapy cycles, the percentage of Treg cells was significantly reduced in comparison with that before the chemotherapy in the patients with stage II/III malignancies.  Patients with breast cancer had significantly suppressed immune functions.  Surgical removal of the tumor may improve the immune functions.  Chemotherapy significantly reduced the percentages of CD3+ and CD4+ T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTCUWE3IxqFrVg90H21EOLACvtfcHk0liSs1gCxvnxcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFCgsrjN&md5=42a37c189558e12fe64a1b4e640723c8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2018.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2018.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BH.%26aulast%3DXu%26aufirst%3DH.%2BY.%26aulast%3DZhao%26aufirst%3DZ.%2BM.%26aulast%3DZhang%26aufirst%3DG.%2BM.%26aulast%3DLin%26aufirst%3DF.%2BW.%26atitle%3DDynamic%2520and%2520significant%2520changes%2520of%2520T-cell%2520subgroups%2520in%2520breast%2520cancer%2520patients%2520during%2520surgery%2520and%2520chemotherapy%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2018%26volume%3D65%26spage%3D279%26epage%3D283%26doi%3D10.1016%2Fj.intimp.2018.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balko, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2016.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fnrclinonc.2016.66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=27184417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=674-690&author=G.+Bianchiniauthor=J.+M.+Balkoauthor=I.+A.+Mayerauthor=M.+E.+Sandersauthor=L.+Gianni&title=Triple-negative+breast+cancer%3A+challenges+and+opportunities+of+a+heterogeneous+disease&doi=10.1038%2Fnrclinonc.2016.66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span></div><div class="casAuthors">Bianchini, Giampaolo; Balko, Justin M.; Mayer, Ingrid A.; Sanders, Melinda E.; Gianni, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">674-690</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy is the primary established systemic treatment for patients with triple-neg. breast cancer (TNBC) in both the early and advanced-stages of the disease.  The lack of targeted therapies and the poor prognosis of patients with TNBC have fostered a major effort to discover actionable mol. targets to treat patients with these tumors.  Massively parallel sequencing and other 'omics' technologies have revealed an unexpected level of heterogeneity of TNBCs and have led to the identification of potentially actionable mol. features in some TNBCs, such as germline BRCA1/2 mutations or 'BRCAness', the presence of the androgen receptor, and several rare genomic alterations.  Whether these alterations are mol. 'drivers', however, has not been clearly established.  A subgroup of TNBCs shows a high degree of tumor-infiltrating lymphocytes that also correlates with a lower risk of disease relapse and a higher likelihood of benefit from chemotherapy.  Proof-of-principle studies with immune-checkpoint inhibitors in advanced-stage TNBC have yielded promising results, indicating the potential benefit of immunotherapy for patients with TNBC.  In this Review, we discuss the most relevant mol. findings in TNBC from the past decade and the most promising therapeutic opportunities derived from these data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHF3dPbmmkIbVg90H21EOLACvtfcHk0liSs1gCxvnxcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D&md5=1844e2d72f6321238d275cddc745ba1c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.66%26sid%3Dliteratum%253Aachs%26aulast%3DBianchini%26aufirst%3DG.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DGianni%26aufirst%3DL.%26atitle%3DTriple-negative%2520breast%2520cancer%253A%2520challenges%2520and%2520opportunities%2520of%2520a%2520heterogeneous%2520disease%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D13%26spage%3D674%26epage%3D690%26doi%3D10.1038%2Fnrclinonc.2016.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nurgali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagoe, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abalo, R.</span></span> <span> </span><span class="NLM_article-title">Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">245</span> <span class="refDoi"> DOI: 10.3389/fphar.2018.00245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.3389%2Ffphar.2018.00245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29623040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKnsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=K.+Nurgaliauthor=R.+T.+Jagoeauthor=R.+Abalo&title=Editorial%3A+adverse+effects+of+cancer+chemotherapy%3A+anything+new+to+improve+tolerance+and+reduce+sequelae%3F&doi=10.3389%2Ffphar.2018.00245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?</span></div><div class="casAuthors">Nurgali, Kulmira; Jagoe, R. Thomas; Abalo, Raquel</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245/1-245/3</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review discussing longer-term toxicity from cancer chemotherapy.  It also discusses impact of cancer chemotherapy on sensory functioning such as hearing, approaches to maintain fertility during and after treatment and the broad long-term impact of systemic anti-cancer treatment on health and aging in cancer survivor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHaOY45xlot7Vg90H21EOLACvtfcHk0liSs1gCxvnxcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKnsr7O&md5=960717fc0c56e29e1bbadd4c931f80f7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00245%26sid%3Dliteratum%253Aachs%26aulast%3DNurgali%26aufirst%3DK.%26aulast%3DJagoe%26aufirst%3DR.%2BT.%26aulast%3DAbalo%26aufirst%3DR.%26atitle%3DEditorial%253A%2520adverse%2520effects%2520of%2520cancer%2520chemotherapy%253A%2520anything%2520new%2520to%2520improve%2520tolerance%2520and%2520reduce%2520sequelae%253F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26doi%3D10.3389%2Ffphar.2018.00245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turchi, J. J.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy induced DNA damage response: convergence of drugs and pathways</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.4161/cbt.23761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.4161%2Fcbt.23761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=23380594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvFOrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=379-389&author=D.+Woodsauthor=J.+J.+Turchi&title=Chemotherapy+induced+DNA+damage+response%3A+convergence+of+drugs+and+pathways&doi=10.4161%2Fcbt.23761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy induced DNA damage response: convergence of drugs and pathways</span></div><div class="casAuthors">Woods, Derek; Turchi, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-389</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics target rapidly dividing cancer cells by directly or indirectly inducing DNA damage.  Upon recognizing DNA damage, cells initiate a variety of signaling pathways collectively referred to as the DNA damage response (DDR).  Interestingly, the pathways used to elicit this response are as varied as the types of DNA damage induced.  However, the activation of these various pathways has similar results including DNA repair, suppression of global general translation, cell cycle arrest and, ultimately, either cell survival or cell death.  This review will focus on a series of chemotherapy-induced DNA lesions and highlight recent advances in our understanding of the DDR, the DNA repair pathways it activates and the cellular consequences of these converging pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBzViNyUg_FrVg90H21EOLACvtfcHk0lgNerM2YyrXqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvFOrtr8%253D&md5=2e8747c1e59190e291bd3d3d3f63f82d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4161%2Fcbt.23761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.23761%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DD.%26aulast%3DTurchi%26aufirst%3DJ.%2BJ.%26atitle%3DChemotherapy%2520induced%2520DNA%2520damage%2520response%253A%2520convergence%2520of%2520drugs%2520and%2520pathways%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2013%26volume%3D14%26spage%3D379%26epage%3D389%26doi%3D10.4161%2Fcbt.23761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teles, R. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moralles, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, M. R.</span></span> <span> </span><span class="NLM_article-title">Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2321</span>– <span class="NLM_lpage">2336</span>, <span class="refDoi"> DOI: 10.2147/IJN.S164355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.2147%2FIJN.S164355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29713164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOrt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2321-2336&author=R.+H.+G.+Telesauthor=H.+F.+Morallesauthor=M.+R.+Cominetti&title=Global+trends+in+nanomedicine+research+on+triple+negative+breast+cancer%3A+a+bibliometric+analysis&doi=10.2147%2FIJN.S164355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis</span></div><div class="casAuthors">Teles, Ramon Handerson Gomes; Moralles, Herick Fernando; Cominetti, Marcia Regina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2321-2336</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Nanotechnol. has emerged as a promising tool in the clinic to combat several difficult-to-manage diseases, such as cancer, which is the second leading cause of death worldwide.  Chemotherapeutic drugs present several limitations such as undesired side effects, low specificity, resistance, and high relapse rates.  Triple neg. breast cancer (TNBC) is caused by cells that lack specific receptors in their membrane, such as estrogen (ER+) and progesterone (PR+) receptors, or by cells that do not express the amplification of human epidermal growth factor receptor-2 (HER-2+).  This cancer type has poor prognosis, high relapse rates, and no targeted therapies.  Thus, this study aimed to investigate the trends of nanotechnol. research in TNBC and compare the contribution of research from different regions, institutions, and authors.  A search of the studies published between 2012 and 2017, related to nanotechnol. and TNBC, with different keyword combinations, was performed in the Scopus database.  The keywords found in this search were grouped into four clusters, in which "breast cancer" was the most mentioned (1,133 times) and the word "MCF-7 cell line" is one of the latest hotspots that appeared in the year 2016.  A total of 1,932 articles, which were cited 26,450 times, were identified.  The USA accounted for 28.36% of the articles and 27.61% of the citations; however, none of its centers appeared in the list of 10 most productive ones in terms of publications.  The journals Biomaterials and International Journal of Nanomedicine had the highest no. of publications.  The USA and China had the highest no. of articles produced and cited; however, the highest av. citation per article was from Singapore.  The studies focused on the research of antineoplastic agents in animal models and cell culture, and these were the most used topics in research with nanotechnol. and TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3yO0UsGSuP7Vg90H21EOLACvtfcHk0lgNerM2YyrXqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOrt7vP&md5=fc9c65a395a977eb03a6d2c93a0f3df1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2147%2FIJN.S164355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S164355%26sid%3Dliteratum%253Aachs%26aulast%3DTeles%26aufirst%3DR.%2BH.%2BG.%26aulast%3DMoralles%26aufirst%3DH.%2BF.%26aulast%3DCominetti%26aufirst%3DM.%2BR.%26atitle%3DGlobal%2520trends%2520in%2520nanomedicine%2520research%2520on%2520triple%2520negative%2520breast%2520cancer%253A%2520a%2520bibliometric%2520analysis%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2018%26volume%3D13%26spage%3D2321%26epage%3D2336%26doi%3D10.2147%2FIJN.S164355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesar, J. M.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of breast cancer</span>. <i>Am. J. Health-Syst. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2228</span>, <span class="refDoi"> DOI: 10.2146/ajhp070663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.2146%2Fajhp070663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19020189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFChs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=2221-2228&author=A.+Thomsenauthor=J.+M.+Kolesar&title=Chemoprevention+of+breast+cancer&doi=10.2146%2Fajhp070663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of breast cancer</span></div><div class="casAuthors">Thomsen, Annelise; Kolesar, Jill M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2221-2228</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  Purpose: The risk factors for and risk assessment of breast cancer, recommendations for risk redn., and roles of tamoxifen and raloxifene in the prevention of breast cancer are discussed.  Summary: Breast cancer either may be a familial syndrome or develop sporadically.  In familial syndromes, cancer occurs in multiple family members and the risk factors are primarily genetic.  The majority of breast cancers are sporadic, and risk factors are primarily related to estrogen exposure.  Recommendation strategies for reducing breast cancer risk include engaging in a healthy lifestyle by decreasing alc. consumption, following a low-fat diet enriched with fruits and vegetables, exercising, and reducing wt. if obese.  Breast self-examns., clin. breast examns., and screening mammogs. are strategies for the early detection of breast cancer.  Recommendations for the use of tamoxifen for risk redn. are intended only for women who are at an increased risk for the development of breast cancer as assessed by the Gail model.  One study found a significantly increased risk of cardiovascular events and hypertriglyceridemia in the tamoxifen group compared to placebo.  Raloxifene is also intended for women at high risk for breast cancer.  During clin. trials, hot flashes, influenzalike syndromes, peripheral edema, and leg cramps were reported more frequently in patients receiving raloxifene when compared with patients receiving placebo, and the risk of thromboembolic disease was 3.1 times higher in the raloxifene group compared with the placebo.  Conclusion: Tamoxifen and raloxifene are both indicated for and equally effective in the prevention of breast cancer in women at high risk for development of the disease.  Raloxifene may have a more favorable adverse-effect profile, with fewer thromboembolic events and less uterine hyperplasia when compared with tamoxifen.  Despite being at high risk, many women decide against breast cancer chemoprevention with either tamoxifen or raloxifene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYQDR9F7L5XLVg90H21EOLACvtfcHk0lgNerM2YyrXqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFChs7zO&md5=376d467a0d6eba04c176b7db98afc0dc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2146%2Fajhp070663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp070663%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DA.%26aulast%3DKolesar%26aufirst%3DJ.%2BM.%26atitle%3DChemoprevention%2520of%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2008%26volume%3D65%26spage%3D2221%26epage%3D2228%26doi%3D10.2146%2Fajhp070663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90405-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2F0092-8674%2895%2990405-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=7834742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaK2MXjtlGnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=225-236&author=T.+Hunter&title=Protein+kinases+and+phosphatases%3A+the+yin+and+yang+of+protein+phosphorylation+and+signaling&doi=10.1016%2F0092-8674%2895%2990405-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling</span></div><div class="casAuthors">Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-36</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 127 refs.  Protein phosphorylation plays a cardinal role in regulating many cellular processes in eukaryotes.  In particular, protein phosphorylation is a major factor in signal transduction pathways.  Processes that are reversibly controlled by protein phosphorylation require not only a protein kinase but also a protein phosphatase.  Target proteins are phosphorylated at specific sites by one or more protein kinases, and these phosphates are removed by specific protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw8tLm7EuSmbVg90H21EOLACvtfcHk0lh_564iJfDung"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtlGnsrs%253D&md5=5262cb6e7a5175a97a11c8d87d8993c0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990405-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990405-0%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DProtein%2520kinases%2520and%2520phosphatases%253A%2520the%2520yin%2520and%2520yang%2520of%2520protein%2520phosphorylation%2520and%2520signaling%26jtitle%3DCell%26date%3D1995%26volume%3D80%26spage%3D225%26epage%3D236%26doi%3D10.1016%2F0092-8674%2895%2990405-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenner, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anyanwu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olefsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusari, J.</span></span> <span> </span><span class="NLM_article-title">Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">19810</span>– <span class="NLM_lpage">19816</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.33.19810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1074%2Fjbc.271.33.19810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=8702689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaK28XltVKrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=19810-19816&author=K.+A.+Kennerauthor=E.+Anyanwuauthor=J.+M.+Olefskyauthor=J.+Kusari&title=Protein-tyrosine+phosphatase+1B+is+a+negative+regulator+of+insulin-+and+insulin-like+growth+factor-I-stimulated+signaling&doi=10.1074%2Fjbc.271.33.19810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling</span></div><div class="casAuthors">Kenner, Kathleen A.; Anyanwu, Ezenta; Olefsky, Jerrold M.; Kusari, Jyotirmoy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">19810-19816</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">To understand the physiol. role of protein-tyrosine phosphatase 1B (PTPase 1B) in insulin and insulin-like factor-I (IGF-I) signaling, we established clonal cell lines overexpressing wild type or inactive mutant (C215S) PTPase 1B in cells overexpressing insulin (Hirc) or IGF-I (CICFR) receptors.  PTPase 1B overexpression in transfected cells was verified by immunoblot anal. with a monoclonal PTPase 1B antibody.  Subfractionation of parental cells demonstrated that greater than 90% of PTPase activity was localized in the Triton X-100-sol. particulate (P1) (P1) cell fraction.  PTPase activity in the P1 fraction of cells overexpressing wild type PTPase 1B was 3-6-fold higher than parental cells but was unaltered in all fractions from C215S PTPase 1B-contg. cells.  The overexpression of wild type and C215S PTPase 1B had no effects on intrinsic receptor kinase activity, growth rate, or general cell morphol.  The effects of PTPase 1B overexpression on cellular protein tyrosine phosphorylation were examd. by anti-phosphotyrosine immunoblot anal.  No differences were apparent under basal conditions, but hormone-stimulated receptor autophosphorylation and/or insulin receptor substrate tyrosine phosphorylation were inhibited in cells overexpressing wild type PTPase 1B and increased in cells expressing mutant PTPase 1B, in comparison with parental cells.  Metabolic signaling, assessed by ligand-stimulated [14C]glucose incorporation into glycogen, was also inhibited in cells overexpressing active PTPase 1B and enhanced in cells contg. C215S PTPase 1B and enhanced in cells contg. C215S PTPase 1B.  These data strongly suggest that PTPase 1B acts as a neg. regulator of insulin and IGF-I signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorJdPrqCOpkLVg90H21EOLACvtfcHk0lh_564iJfDung"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVKrsrg%253D&md5=042402074a5006449c23f5e00d80a810</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.33.19810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.33.19810%26sid%3Dliteratum%253Aachs%26aulast%3DKenner%26aufirst%3DK.%2BA.%26aulast%3DAnyanwu%26aufirst%3DE.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DKusari%26aufirst%3DJ.%26atitle%3DProtein-tyrosine%2520phosphatase%25201B%2520is%2520a%2520negative%2520regulator%2520of%2520insulin-%2520and%2520insulin-like%2520growth%2520factor-I-stimulated%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D19810%26epage%3D19816%26doi%3D10.1074%2Fjbc.271.33.19810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ping, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, X. W.</span></span> <span> </span><span class="NLM_article-title">PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT</span>. <i>Tumour Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">13479</span>– <span class="NLM_lpage">13487</span>, <span class="refDoi"> DOI: 10.1007/s13277-016-5245-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1007%2Fs13277-016-5245-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=27465552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ltV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=13479-13487&author=X.+Liuauthor=Q.+Chenauthor=X.+G.+Huauthor=X.+C.+Zhangauthor=T.+W.+Fuauthor=Q.+Liuauthor=Y.+Liangauthor=X.+L.+Zhaoauthor=X.+Zhangauthor=Y.+F.+Pingauthor=X.+W.+Bian&title=PTP1B+promotes+aggressiveness+of+breast+cancer+cells+by+regulating+PTEN+but+not+EMT&doi=10.1007%2Fs13277-016-5245-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT</span></div><div class="casAuthors">Liu Xue; Chen Qian; Hu Xu-Gang; Zhang Xian-Chao; Fu Ti-Wei; Liu Qing; Liang Yan; Zhao Xi-Long; Zhang Xia; Ping Yi-Fang; Bian Xiu-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">13479-13487</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metastasis is a complicated, multistep process and remains the major cause of cancer-related mortality.  Exploring the molecular mechanisms underlying tumor metastasis is crucial for development of new strategies for cancer prevention and treatment.  In this study, we found that protein tyrosine phosphatase 1B (PTP1B) promoted breast cancer metastasis by regulating phosphatase and tensin homolog (PTEN) but not epithelial-mesenchymal transition (EMT).  By detecting PTP1B expression of the specimens from 128 breast cancer cases, we found that the level of PTP1B was higher in breast cancer tissues than the corresponding adjacent normal tissues.  Notably, PTP1B was positively associated with lymph node metastasis (LNM) and estrogen receptor (ER) status.  In vitro, disturbing PTP1B expression obviously attenuated cell migration and invasion.  On the contrary, PTP1B overexpression significantly increased migration and invasion of breast cancer cells.  Mechanistically, PTP1B knockdown upregulated PTEN, accompanied with an abatement of AKT phosphorylation and the expression of matrix metalloproteinase 2 (MMP2) and MMP7.  Conversely, forced expression of PTP1B reduced PTEN and increased AKT phosphorylation as well as the expression of MMP2 and MMP7.  Notably, neither EMT nor stemness of breast cancer cells was regulated by PTP1B.  We also found that PTP1B acted as an independent prognostic factor and predicted poor prognosis in ER-positive breast cancer patients.  Taken together, our findings provide advantageous evidence for the development of PTP1B as a potential therapeutic target for breast cancer, especially for ER-positive breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGjCxvJ807GIJKJbLTgsvCfW6udTcc2eau2Xp3cMb4i7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ltV2mtQ%253D%253D&md5=27c3509a84eff5d4e73a0fd936688c3c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs13277-016-5245-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-016-5245-1%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DX.%2BG.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DFu%26aufirst%3DT.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPing%26aufirst%3DY.%2BF.%26aulast%3DBian%26aufirst%3DX.%2BW.%26atitle%3DPTP1B%2520promotes%2520aggressiveness%2520of%2520breast%2520cancer%2520cells%2520by%2520regulating%2520PTEN%2520but%2520not%2520EMT%26jtitle%3DTumour%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D13479%26epage%3D13487%26doi%3D10.1007%2Fs13277-016-5245-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206</span>. <i>Cancer Cell Int.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>, <span class="NLM_elocation-id">275</span> <span class="refDoi"> DOI: 10.1186/s12935-019-0958-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1186%2Fs12935-019-0958-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=31695578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BB3MjmtVekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&author=Y.+Liauthor=Q.+Zengauthor=J.+Qiuauthor=T.+Pangauthor=J.+Xianauthor=X.+Zhang&title=Long+non-coding+RNA+UCA1+promotes+breast+cancer+by+upregulating+PTP1B+expression+via+inhibiting+miR-206&doi=10.1186%2Fs12935-019-0958-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206</span></div><div class="casAuthors">Li Yi; Zeng Qingan; Qiu Jiliang; Pang Ting; Xian Jianzhong; Zhang Xuexia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer cell international</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275</span>
        ISSN:<span class="NLM_cas:issn">1475-2867</span>.
    </div><div class="casAbstract">Background:  The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) is involved in various cancers and often functions through microRNAs.  The pro-survival protein PTP1B is known to play important roles in cancer development.  However, the connection between UCA1 and PTP1B in breast cancer is not well studied.  Methods:  In this study, we first evaluated the correlation between UCA1 level and PTP1B expression in breast tissues, which showed the expression of PTP1B were much higher in the breast tumor tissues than in the peritumor normal tissues.  The UCA1 level was positively associated with PTP1B expression in breast tumor tissues.  Results:  We observed that UCA1 could up-regulate PTP1B expression in breast cancer cells.  We also found that miR-206 could inhibit the expression of PTP1B by directly binding to the 3'-UTR of its mRNA.  Interestingly, UCA1 could increase the expression of PTP1B through sequestering miR-206 at post-transcriptional level.  The results also suggested that UCA1-induced PTP1B expression facilitated the proliferation of breast cancer cells.  Conclusions:  We conclude that UCA1 can up-regulates PTP1B to enhance cell proliferation through sequestering miR-206 in breast cancer.  Our finding provides new insights into the mechanism of breast cancer regulation by UCA1, which could be a potential target for breast cancer treatment.Trial registration 2012N5hSYSU48573.  Registered at Oct 12, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCYqLxS6eNXLZpSb_XWfMrfW6udTcc2eY7j2uSRfo3Nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjmtVekug%253D%253D&md5=ce715c25b9b7a38c39ad60d05474e4df</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs12935-019-0958-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12935-019-0958-z%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DT.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DLong%2520non-coding%2520RNA%2520UCA1%2520promotes%2520breast%2520cancer%2520by%2520upregulating%2520PTP1B%2520expression%2520via%2520inhibiting%2520miR-206%26jtitle%3DCancer%2520Cell%2520Int.%26date%3D2019%26volume%3D19%26doi%3D10.1186%2Fs12935-019-0958-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">1136</span>– <span class="NLM_lpage">1153</span>, <span class="refDoi"> DOI: 10.1111/febs.14724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1111%2Ffebs.14724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=30548198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFymsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2019&pages=1136-1153&author=M.+Yuauthor=Z.+Liuauthor=Y.+Liuauthor=X.+Zhouauthor=F.+Sunauthor=Y.+Liuauthor=L.+Liauthor=S.+Huaauthor=Y.+Zhaoauthor=H.+Gaoauthor=Z.+Zhuauthor=M.+Naauthor=Q.+Zhangauthor=R.+Yangauthor=J.+Zhangauthor=Y.+Yaoauthor=X.+Chen&title=PTP1B+markedly+promotes+breast+cancer+progression+and+is+regulated+by+miR-193a-3p&doi=10.1111%2Ffebs.14724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p</span></div><div class="casAuthors">Yu, Mengchao; Liu, Zhijian; Liu, Yuan; Zhou, Xinyan; Sun, Feng; Liu, Yanqing; Li, Liuyi; Hua, Shiyu; Zhao, Yi; Gao, Haidong; Zhu, Zhouting; Na, Muhan; Zhang, Qipeng; Yang, Rong; Zhang, Jianguo; Yao, Yongzhong; Chen, Xi</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1136-1153</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase PTP1B, which is encoded by PTPN1, is a ubiquitously expressed nonreceptor protein tyrosine phosphatase.  PTP1B has long been known to neg. regulate insulin and leptin receptor signaling.  Recently, it was reported to be aberrantly expressed in cancer cells and to function as an important oncogene.  In this study, we found that PTP1B protein levels are dramatically increased in breast cancer (BC) tissues and that PTP1B promotes the proliferation, and suppresses the apoptosis, of both HER2-pos. and triple-neg. BC cell lines.  Bioinformatics anal. identified that the miRNA, miR-193a-3p, might potentially target PTP1B.  We demonstrate that miR-193a-3p regulates PTP1B in BC cells and that it regulates the proliferation and apoptosis of BC cells by targeting PTP1B, both in vitro and in vivo.  In conclusion, this study confirms that PTP1B acts as an oncogene in BC and demonstrates that miR-193a-3p can serve as a tumor suppressor gene in BC by targeting PTP1B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAN9o5Mp_5mLVg90H21EOLACvtfcHk0lhTSJ_VdQqp5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFymsLnP&md5=e5baf3e61c576dd40f5477f45a3fcc7d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14724%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DNa%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DPTP1B%2520markedly%2520promotes%2520breast%2520cancer%2520progression%2520and%2520is%2520regulated%2520by%2520miR-193a-3p%26jtitle%3DFEBS%2520J.%26date%3D2019%26volume%3D286%26spage%3D1136%26epage%3D1153%26doi%3D10.1111%2Ffebs.14724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilmarsdottir, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldorsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kricker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingthorsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsdottir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maelandsmo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudjonsson, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PTP1B disrupts cell-cell adhesion and induces anoikis in breast epithelial cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e2769</span> <span class="refDoi"> DOI: 10.1038/cddis.2017.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fcddis.2017.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=28492548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=B.+Hilmarsdottirauthor=E.+Briemauthor=S.+Halldorssonauthor=J.+Krickerauthor=S.+Ingthorssonauthor=S.+Gustafsdottirauthor=G.+M.+Maelandsmoauthor=M.+K.+Magnussonauthor=T.+Gudjonsson&title=Inhibition+of+PTP1B+disrupts+cell-cell+adhesion+and+induces+anoikis+in+breast+epithelial+cells&doi=10.1038%2Fcddis.2017.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PTP1B disrupts cell-cell adhesion and induces anoikis in breast epithelial cells</span></div><div class="casAuthors">Hilmarsdottir, Bylgja; Briem, Eirikur; Halldorsson, Skarphedinn; Kricker, Jennifer; Ingthorsson, Saevar; Gustafsdottir, Sigrun; Maelandsmo, Gunhild M.; Magnusson, Magnus K.; Gudjonsson, Thorarinn</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2769</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is a well-known inhibitor of insulin signaling pathways and inhibitors against PTP1B are being developed as promising drug candidates for treatment of obesity.  PTP1B has also been linked to breast cancer both as a tumor suppressor and as an oncogene.  Furthermore, PTP1B has been shown to be a regulator of cell adhesion and migration in normal and cancer cells.  In this study, we analyzed the PTP1B expression in normal breast tissue, primary breast cells and the breast epithelial cell line D492.  In normal breast tissue and primary breast cells, PTP1B is widely expressed in both epithelial and stromal cells, with highest expression in myoepithelial cells and fibroblasts.  PTP1B is widely expressed in branching structures generated by D492 when cultured in 3D reconstituted basement membrane (3D rBM).  Inhibition of PTP1B in D492 and another mammary epithelial cell line HMLE resulted in reduced cell proliferation and induction of anoikis.  These changes were seen when cells were cultured both in monolayer and in 3D rBM.  PTP1B inhibition affected cell attachment, expression of cell adhesion proteins and actin polymn.  Moreover, epithelial to mesenchymal transition (EMT) sensitized cells to PTP1B inhibition.  A mesenchymal sublines of D492 and HMLE (D492M and HMLEmes) were more sensitive to PTP1B inhibition than D492 and HMLE.  Reversion of D492M to an epithelial state using miR-200c-141 restored resistance to detachment induced by PTP1B inhibition.  In conclusion, we have shown that PTP1B is widely expressed in the human breast gland with highest expression in myoepithelial cells and fibroblasts.  Inhibition of PTP1B in D492 and HMLE affects cell-cell adhesion and induces anoikis-like effects.  Finally, cells with an EMT phenotype are more sensitive to PTP1B inhibitors making PTP1B a potential candidate for further studies as a target for drug development in cancer involving the EMT phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4YxdYzIsprVg90H21EOLACvtfcHk0lhTSJ_VdQqp5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1KisLg%253D&md5=f1a676e78a2454cb868e01cf056a8ac8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.177%26sid%3Dliteratum%253Aachs%26aulast%3DHilmarsdottir%26aufirst%3DB.%26aulast%3DBriem%26aufirst%3DE.%26aulast%3DHalldorsson%26aufirst%3DS.%26aulast%3DKricker%26aufirst%3DJ.%26aulast%3DIngthorsson%26aufirst%3DS.%26aulast%3DGustafsdottir%26aufirst%3DS.%26aulast%3DMaelandsmo%26aufirst%3DG.%2BM.%26aulast%3DMagnusson%26aufirst%3DM.%2BK.%26aulast%3DGudjonsson%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520PTP1B%2520disrupts%2520cell-cell%2520adhesion%2520and%2520induces%2520anoikis%2520in%2520breast%2520epithelial%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fcddis.2017.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soysal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermann, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oertli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillanders, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viehl, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muenst, S.</span></span> <span> </span><span class="NLM_article-title">PTP1B expression is an independent positive prognostic factor in human breast cancer</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1007/s10549-012-2373-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1007%2Fs10549-012-2373-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=23242616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=637-644&author=S.+Soysalauthor=E.+C.+Obermannauthor=F.+Gaoauthor=D.+Oertliauthor=W.+E.+Gillandersauthor=C.+T.+Viehlauthor=S.+Muenst&title=PTP1B+expression+is+an+independent+positive+prognostic+factor+in+human+breast+cancer&doi=10.1007%2Fs10549-012-2373-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">PTP1B expression is an independent positive prognostic factor in human breast cancer</span></div><div class="casAuthors">Soysal, S.; Obermann, E. C.; Gao, F.; Oertli, D.; Gillanders, W. E.; Viehl, C. T.; Muenst, S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">637-644</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is a non-transmembrane protein tyrosine phosphatase that has come into focus as a crit. regulator of multiple signaling pathways.  The role of PTP1B in breast cancer remains unclear with evidence suggesting that PTP1B can exert both tumor-suppressing and tumor-promoting effects.  To better define the role of PTP1B in human breast cancer, and its relationship with HER2, we performed immunohistochem. studies on a large cohort of functionally annotated primary breast cancer specimens. 683 of 1,402 (49 %) evaluable primary breast cancers are pos. for PTP1B.  There is no statistically significant assocn. between PTP1B expression and age, tumor size, T stage, histol. grade, lymph node status, or histol. subtype.  Of note, there is no significant assocn. between PTP1B expression and HER2 expression (PTP1B expression 53.1 % in HER2+ cancers vs. 47.5 % in HER2- cancers, p = 0.0985).  However, PTP1B expression is significantly assocd. with estrogen receptor expression (PTP1B expression 50.7 % in ER+ cancers vs. 43.1 % in ER- cancers, p = 0.0137) and intrinsic mol. subtype (PTP1B expression 53.9 % in the luminal B HER2+ subtype and 37.9 % in the basal-like subtype).  Of note, multivariate analyses demonstrate that PTP1B is an independent predictor of improved survival in breast cancer (HR 0.779, p = 0.006).  Taken together, we demonstrate in the largest study to date that (1) PTP1B is commonly expressed in breast cancer, (2) there is no assocn. or functional impact of PTP1B expression in HER2+ breast cancer, and (3) PTP1B expression in breast cancer is assocd. with significantly improved clin. outcome.  Until addnl. studies are performed, caution should be exercised in using PTP1B inhibitors in human breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopQ5L2QnqK1LVg90H21EOLACvtfcHk0li7DmswQpOkcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVCjsA%253D%253D&md5=23be07e6bb2ccb35939880b728b7626f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10549-012-2373-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-012-2373-1%26sid%3Dliteratum%253Aachs%26aulast%3DSoysal%26aufirst%3DS.%26aulast%3DObermann%26aufirst%3DE.%2BC.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DOertli%26aufirst%3DD.%26aulast%3DGillanders%26aufirst%3DW.%2BE.%26aulast%3DViehl%26aufirst%3DC.%2BT.%26aulast%3DMuenst%26aufirst%3DS.%26atitle%3DPTP1B%2520expression%2520is%2520an%2520independent%2520positive%2520prognostic%2520factor%2520in%2520human%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2013%26volume%3D137%26spage%3D637%26epage%3D644%26doi%3D10.1007%2Fs10549-012-2373-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiener, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglehart, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berchuck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, R. C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1093/jnci/86.5.372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1093%2Fjnci%2F86.5.372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=7905928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADyaK2c7ktF2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1994&pages=372-378&author=J.+R.+Wienerauthor=B.+J.+Kernsauthor=E.+L.+Harveyauthor=M.+R.+Conawayauthor=J.+D.+Iglehartauthor=A.+Berchuckauthor=R.+C.+Bast&title=Overexpression+of+the+protein+tyrosine+phosphatase+PTP1B+in+human+breast+cancer%3A+association+with+p185c-erbB-2+protein+expression&doi=10.1093%2Fjnci%2F86.5.372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression</span></div><div class="casAuthors">Wiener J R; Kerns B J; Harvey E L; Conaway M R; Iglehart J D; Berchuck A; Bast R C Jr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-8</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">BACKGROUND:  The p185c-erbB-2 growth factor receptor protein tyrosine kinase (PTK) is overexpressed in one third of human breast cancer patients and indicates a poor prognosis in these patients.  Protein tyrosine phosphatases (PTPs) may balance PTK activity as part of normal growth-regulation pathways.  PTP1B is an intracellular PTP that is involved in linkage between signal transduction pathways and may interface with inappropriate PTK activity in transformed cells.  PURPOSE:  The aim of this study was to determine if PTP1B is overexpressed in human mammary tumors and to determine if such overexpression is associated with the overexpression of the p185c-erbB-2 receptor PTK.  METHODS:  Our samples were frozen sections from 29 human mammary tumors (19 pure infiltrating, two pure intraductal, and eight combined intraductal and infiltrating) and nine sections from normal breast tissue.  The sections were immunohistochemically stained for PTP1B and p185c-erbB-2, and the results were analyzed statistically for association between overexpression of the two proteins.  Northern blot analysis was used to assess if PTP1B overexpression was coincident with increased transcription of the PTP1B gene.  RESULTS:  Overexpression of the PTP1B protein was observed in 72.4% of the tumor sections compared with normal epithelium, with maximal expression occurring in 37.9% of the tumors.  All of the tumor subtypes, including the pure intraductal lesions, overexpressed PTP1B.  Statistical analyses demonstrated a significant association between PTP1B overexpression and breast cancer (P < .038) and between the overexpression of PTP1B and the overexpression of p185c-erbB-2 (P < .006).  PTP1B messenger RNA steady-state transcription was consistently increased in tumors versus normal tissues.  CONCLUSIONS:  PTP1B overexpression is a common phenotypic manifestation in human breast cancers and is associated with over-expression of p185c-erbB-2.  Steady-state PTP1B transcription is increased in tumor tissue.  IMPLICATIONS:  Further studies are needed to determine if PTP1B overexpression balances or augments PTK activity.  PTP1B overexpression might also be evaluated as a clinical prognostic factor in human breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQ1ypzMAcFxbjnyZkbE8yXfW6udTcc2ebKsjI17PAWV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7ktF2ltA%253D%253D&md5=ed821ac6ef3ef6014ceb83c7746fe9a2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F86.5.372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F86.5.372%26sid%3Dliteratum%253Aachs%26aulast%3DWiener%26aufirst%3DJ.%2BR.%26aulast%3DKerns%26aufirst%3DB.%2BJ.%26aulast%3DHarvey%26aufirst%3DE.%2BL.%26aulast%3DConaway%26aufirst%3DM.%2BR.%26aulast%3DIglehart%26aufirst%3DJ.%2BD.%26aulast%3DBerchuck%26aufirst%3DA.%26aulast%3DBast%26aufirst%3DR.%2BC.%26atitle%3DOverexpression%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520PTP1B%2520in%2520human%2520breast%2520cancer%253A%2520association%2520with%2520p185c-erbB-2%2520protein%2520expression%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1994%26volume%3D86%26spage%3D372%26epage%3D378%26doi%3D10.1093%2Fjnci%2F86.5.372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arias-Romero, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villamar-Cruz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernoff, J.</span></span> <span> </span><span class="NLM_article-title">Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">4582</span>– <span class="NLM_lpage">4588</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1158%2F0008-5472.CAN-08-4001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19435911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=4582-4588&author=L.+E.+Arias-Romeroauthor=S.+Sahaauthor=O.+Villamar-Cruzauthor=S.+C.+Yipauthor=S.+P.+Ethierauthor=Z.+Y.+Zhangauthor=J.+Chernoff&title=Activation+of+Src+by+protein+tyrosine+phosphatase+1B+is+required+for+ErbB2+transformation+of+human+breast+epithelial+cells&doi=10.1158%2F0008-5472.CAN-08-4001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells</span></div><div class="casAuthors">Arias-Romero, Luis E.; Saha, Sayanti; Villamar-Cruz, Olga; Yip, Shu-Chin; Ethier, Stephen P.; Zhang, Zhong-Yin; Chernoff, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4582-4588</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase (PTP) 1B plays a major role in inhibiting signaling from the insulin and leptin receptors.  Recently, PTP1B was found to have an unexpected pos. role in ErbB2 signaling in a mouse model of breast cancer, but the mechanism underlying this effect has been unclear.  Using human breast epithelial cells grown in a three-dimensional matrix, we found that PTP1B, but not the closely related enzyme T-cell PTP, is required for ErbB2 transformation in vitro.  Activation of ErbB2, but not ErbB1, increases PTP1B expression, and increased expression of PTP1B activates Src and induces a Src-dependent transformed phenotype.  These findings identify a mol. mechanism by which PTP1B links an important oncogenic receptor tyrosine kinase to signaling pathways that promote aberrant cell division and survival in human breast epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpesj7LqeWTrVg90H21EOLACvtfcHk0li7DmswQpOkcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFGltLc%253D&md5=d396f049f65eae14e41be5b1cb9c0870</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4001%26sid%3Dliteratum%253Aachs%26aulast%3DArias-Romero%26aufirst%3DL.%2BE.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DVillamar-Cruz%26aufirst%3DO.%26aulast%3DYip%26aufirst%3DS.%2BC.%26aulast%3DEthier%26aufirst%3DS.%2BP.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DChernoff%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520Src%2520by%2520protein%2520tyrosine%2520phosphatase%25201B%2520is%2520required%2520for%2520ErbB2%2520transformation%2520of%2520human%2520breast%2520epithelial%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D4582%26epage%3D4588%26doi%3D10.1158%2F0008-5472.CAN-08-4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julien, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. L.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1038/ng1963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fng1963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=17259984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=338-346&author=S.+G.+Julienauthor=N.+Dubeauthor=M.+Readauthor=J.+Penneyauthor=M.+Paquetauthor=Y.+Hanauthor=B.+P.+Kennedyauthor=W.+J.+Mullerauthor=M.+L.+Tremblay&title=Protein+tyrosine+phosphatase+1B+deficiency+or+inhibition+delays+ErbB2-induced+mammary+tumorigenesis+and+protects+from+lung+metastasis&doi=10.1038%2Fng1963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis</span></div><div class="casAuthors">Julien, Sofi G.; Dube, Nadia; Read, Michelle; Penney, Janice; Paquet, Marilene; Han, Yongxin; Kennedy, Brian P.; Muller, William J.; Tremblay, Michel L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We investigated the role of protein tyrosine phosphatase 1B (PTP1B) in mammary tumorigenesis using both genetic and pharmacol. approaches.  It has been previously shown that transgenic mice with a deletion mutation in the region of Erbb2 encoding its extracellular domain (referred to as NDL2 mice, for 'Neu deletion in extracellular domain 2') develop mammary tumors that progress to lung metastasis.  However, deletion of PTP1B activity in the NDL2 transgenic mice either by breeding with Ptpn1-deficient mice or by treatment with a specific PTP1B inhibitor results in significant mammary tumor latency and resistance to lung metastasis.  In contrast, specific overexpression of PTP1B in the mammary gland leads to spontaneous breast cancer development.  The regulation of ErbB2-induced mammary tumorigenesis by PTB1B occurs through the attenuation of both the MAP kinase (MAPK) and Akt pathways.  This report provides a rationale for the development of PTP1B as a new therapeutic target in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqihGXIv6TTrVg90H21EOLACvtfcHk0liGkEWRV8B0Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOksbk%253D&md5=a682a67da810c4c1692eb657cd267709</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fng1963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1963%26sid%3Dliteratum%253Aachs%26aulast%3DJulien%26aufirst%3DS.%2BG.%26aulast%3DDube%26aufirst%3DN.%26aulast%3DRead%26aufirst%3DM.%26aulast%3DPenney%26aufirst%3DJ.%26aulast%3DPaquet%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DKennedy%26aufirst%3DB.%2BP.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26aulast%3DTremblay%26aufirst%3DM.%2BL.%26atitle%3DProtein%2520tyrosine%2520phosphatase%25201B%2520deficiency%2520or%2520inhibition%2520delays%2520ErbB2-induced%2520mammary%2520tumorigenesis%2520and%2520protects%2520from%2520lung%2520metastasis%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D338%26epage%3D346%26doi%3D10.1038%2Fng1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span> <span> </span><span class="NLM_article-title">Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1002/med.20079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1002%2Fmed.20079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=17039461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1GjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=553-573&author=S.+Leeauthor=Q.+Wang&title=Recent+development+of+small+molecular+specific+inhibitor+of+protein+tyrosine+phosphatase+1B&doi=10.1002%2Fmed.20079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B</span></div><div class="casAuthors">Lee, Seokjoon; Wang, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">553-573</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs), a large family of signaling enzymes, play essential roles in intracellular signal transduction by regulating the cellular level of tyrosine phosphorylation to control cell growth and differentiation, metab., cell migration, gene transcription, ion-channel activity, immune response, cell apoptosis, and bone development.  Among all PTPs, protein tyrosine phosphatase 1B (PTP1B) plays a seminal role in cellular signaling and in many human diseases, including cancer, diabetes, and obesity.  Therefore, small mol. inhibitors of PTP1B can be promising drug candidates.  Because of the structural homologies in many families of PTPs, it is a challenging task to find inhibitors specific to each PTP.  Recent studies suggested that secondary binding pockets or peripheral binding sites around the conserved active site should be exploited to design novel potent and selective PTP1B inhibitors.  In this review, we discuss the structural and biol. features of small mol. PTP1B-specific inhibitors, with particular emphasis on small mol. inhibitors targeting PTP1B over the other PTPs that have been synthesized in the past 4 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46I4_bW5HFrVg90H21EOLACvtfcHk0liGkEWRV8B0Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1GjsLs%253D&md5=e2d9fe426fc11f39ef9341e6b2227de1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fmed.20079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20079%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DRecent%2520development%2520of%2520small%2520molecular%2520specific%2520inhibitor%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2007%26volume%3D27%26spage%3D553%26epage%3D573%26doi%3D10.1002%2Fmed.20079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koveal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akshinthala, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kragelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackledge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthuswamy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fnchembio.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=24845231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=558-566&author=N.+Krishnanauthor=D.+Kovealauthor=D.+H.+Millerauthor=B.+Xueauthor=S.+D.+Akshinthalaauthor=J.+Krageljauthor=M.+R.+Jensenauthor=C.+M.+Gaussauthor=R.+Pageauthor=M.+Blackledgeauthor=S.+K.+Muthuswamyauthor=W.+Petiauthor=N.+K.+Tonks&title=Targeting+the+disordered+C+terminus+of+PTP1B+with+an+allosteric+inhibitor&doi=10.1038%2Fnchembio.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span></div><div class="casAuthors">Krishnan, Navasona; Koveal, Dorothy; Miller, Daniel H.; Xue, Bin; Akshinthala, Sai Dipikaa; Kragelj, Jaka; Jensen, Malene Ringkjoebing; Gauss, Carla-Maria; Page, Rebecca; Blackledge, Martin; Muthuswamy, Senthil K.; Peti, Wolfgang; Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">PTP1B, a validated therapeutic target for diabetes and obesity, has a crit. pos. role in HER2 signaling in breast tumorigenesis.  Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chem. properties of the active site.  We define a new mechanism of allosteric inhibition that targets the C-terminal, noncatalytic segment of PTP1B.  We present what is to our knowledge the first ensemble structure of PTP1B contg. this intrinsically disordered segment, within which we identified a binding site for the small-mol. inhibitor MSI-1436.  We demonstrate binding to a second site close to the catalytic domain, with cooperative effects between the two sites locking PTP1B in an inactive state.  MSI-1436 antagonized HER2 signaling, inhibited tumorigenesis in xenografts and abrogated metastasis in the NDL2 mouse model of breast cancer, validating inhibition of PTP1B as a therapeutic strategy in breast cancer.  This new approach to inhibition of PTP1B emphasizes the potential of disordered segments of proteins as specific binding sites for therapeutic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo526if7ja9XbVg90H21EOLACvtfcHk0liGkEWRV8B0Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D&md5=10a460f3a5deafb9f7c206246d67a29b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1528%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DKoveal%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DAkshinthala%26aufirst%3DS.%2BD.%26aulast%3DKragelj%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DBlackledge%26aufirst%3DM.%26aulast%3DMuthuswamy%26aufirst%3DS.%2BK.%26aulast%3DPeti%26aufirst%3DW.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DTargeting%2520the%2520disordered%2520C%2520terminus%2520of%2520PTP1B%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fnchembio.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeram, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Phloroglucinol derivatives with protein tyrosine phosphatase 1B inhibitory activities from eugenia <i>jambolana</i> seeds</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b01073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b01073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Ois7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=544-550&author=F.+Liuauthor=T.+Yuanauthor=W.+Liuauthor=H.+Maauthor=N.+P.+Seeramauthor=Y.+Liauthor=L.+Xuauthor=Y.+Muauthor=X.+Huangauthor=L.+Li&title=Phloroglucinol+derivatives+with+protein+tyrosine+phosphatase+1B+inhibitory+activities+from+eugenia+jambolana+seeds&doi=10.1021%2Facs.jnatprod.6b01073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phloroglucinol Derivatives with Protein Tyrosine Phosphatase 1B Inhibitory Activities from Eugenia jambolana Seeds</span></div><div class="casAuthors">Liu, Feifei; Yuan, Tao; Liu, Wei; Ma, Hang; Seeram, Navindra P.; Li, Yuanyuan; Xu, Li; Mu, Yu; Huang, Xueshi; Li, Liya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">544-550</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Fifteen new phloroglucinol derivs., jamunones A-O (I, 2-8 and 10-16, resp.), along with one known analog spiralisone C (9), were isolated from Eugenia jambolana seeds.  Their structures were elucidated by detailed NMR and mass spectrometry spectroscopic data interpretation.  Compds. I-9, 11, 12, and 14-16 inhibited protein tyrosine phosphatase 1B activity with IC50 values ranging from 0.42 to 3.2 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjn3JjzTywjLVg90H21EOLACvtfcHk0liE9IuYIy5LzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Ois7c%253D&md5=8513f4b26908157e58b339b4dab6c22b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b01073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b01073%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DYuan%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DSeeram%26aufirst%3DN.%2BP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DPhloroglucinol%2520derivatives%2520with%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitory%2520activities%2520from%2520eugenia%2520jambolana%2520seeds%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D544%26epage%3D550%26doi%3D10.1021%2Facs.jnatprod.6b01073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span> <span> </span><span class="NLM_article-title">New phloroglucinol derivatives from the fruit tree <i>Syzygium jambos</i> and their cytotoxic and antioxidant activities</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">10257</span>– <span class="NLM_lpage">10262</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.5b04293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.5b04293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2htrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=10257-10262&author=G.+Q.+Liauthor=Y.+B.+Zhangauthor=P.+Wuauthor=N.+H.+Chenauthor=Z.+N.+Wuauthor=L.+Yangauthor=R.+X.+Qiuauthor=G.+C.+Wangauthor=Y.+L.+Li&title=New+phloroglucinol+derivatives+from+the+fruit+tree+Syzygium+jambos+and+their+cytotoxic+and+antioxidant+activities&doi=10.1021%2Facs.jafc.5b04293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">New Phloroglucinol Derivatives from the Fruit Tree Syzygium jambos and Their Cytotoxic and Antioxidant Activities</span></div><div class="casAuthors">Li, Guo-Qiang; Zhang, Yu-Bo; Wu, Peng; Chen, Neng-Hua; Wu, Zhong-Nan; Yang, Li; Qiu, Rui-Xia; Wang, Guo-Cai; Li, Yao-Lan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10257-10262</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Seven new phloroglucinol derivs. (1-7) were isolated from the fruit tree Syzygium jambos together with four known triterpenoids (8-11) and two known flavones (12 and 13).  According to the spectroscopic analyses (IR, electrospray ionization mass spectrometry (ESIMS), high-resoln. ESIMS, 1D and 2D NMR), the structures of compds. 1-7 were elucidated as jambone A (1), jambone B (2), jambone C (3), jambone D (4), jambone E (5), jambone F (6), and jambone G (7).  All the isolates were detd. for their cytotoxic activities on melanoma cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, and compds. 10 and 11 showed potent activities.  Moreover, compds. 1, 2, 4-7, 12, and 13 exhibited weak antioxidant activities under ferric-reducing antioxidant power and 2,2-diphenyl-1-picryhydrazyl radical-scavenging assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqFTIBX4PySbVg90H21EOLACvtfcHk0liE9IuYIy5LzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2htrfL&md5=b2d25f37b5f934df2f44cb8da3e42a80</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.5b04293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.5b04293%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%2BB.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DN.%2BH.%26aulast%3DWu%26aufirst%3DZ.%2BN.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DR.%2BX.%26aulast%3DWang%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BL.%26atitle%3DNew%2520phloroglucinol%2520derivatives%2520from%2520the%2520fruit%2520tree%2520Syzygium%2520jambos%2520and%2520their%2520cytotoxic%2520and%2520antioxidant%2520activities%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2015%26volume%3D63%26spage%3D10257%26epage%3D10262%26doi%3D10.1021%2Facs.jafc.5b04293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Acylphloroglucinol derivatives from the leaves of <i>Syzygium samarangense</i> and their cytotoxic activities</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2018.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.fitote.2018.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29879460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWqsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2018&pages=1-6&author=J.+Yangauthor=J.+C.+Suauthor=X.+P.+Leiauthor=X.+J.+Huangauthor=D.+M.+Zhangauthor=W.+C.+Yeauthor=Y.+Wang&title=Acylphloroglucinol+derivatives+from+the+leaves+of+Syzygium+samarangense+and+their+cytotoxic+activities&doi=10.1016%2Fj.fitote.2018.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Acylphloroglucinol derivatives from the leaves of Syzygium samarangense and their cytotoxic activities</span></div><div class="casAuthors">Yang, Jiao; Su, Jun-Cheng; Lei, Xue-Ping; Huang, Xiao-Jun; Zhang, Dong-Mei; Ye, Wen-Cai; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Samarones A-D (1-4), four new acylphloroglucinol derivs. bearing a C17 alkyl side chain, along with five known analogs (5-9), were isolated from the leaves of Syzygium samarangense.  Their structures were characterized on the basis of extensive spectroscopic methods including HR-ESI-MS/MS anal.  The cytotoxic activities of compds. 1-3 and 5-9 against HepG2 and MDA-MB-231 cells were also evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBCyLzNcT8urVg90H21EOLACvtfcHk0liE9IuYIy5LzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWqsL7I&md5=866f36b3d25c239b5556fdd8d396dd0f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2018.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DJ.%2BC.%26aulast%3DLei%26aufirst%3DX.%2BP.%26aulast%3DHuang%26aufirst%3DX.%2BJ.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DYe%26aufirst%3DW.%2BC.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DAcylphloroglucinol%2520derivatives%2520from%2520the%2520leaves%2520of%2520Syzygium%2520samarangense%2520and%2520their%2520cytotoxic%2520activities%26jtitle%3DFitoterapia%26date%3D2018%26volume%3D129%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.fitote.2018.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tringali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piatelli, M.</span></span> <span> </span><span class="NLM_article-title">Two chrome derivatives from the brown alga <i>Zonaria tournefortii</i></span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1512</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)87145-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2FS0040-4039%2800%2987145-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaL38XksFamsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1982&pages=1509-1512&author=C.+Tringaliauthor=M.+Piatelli&title=Two+chrome+derivatives+from+the+brown+alga+Zonaria+tournefortii&doi=10.1016%2FS0040-4039%2800%2987145-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Two chromone derivatives from the brown alga Zonaria tournefortii</span></div><div class="casAuthors">Tringali, Corrado; Piattelli, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1509-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Two minor lipid components of Z. tournefortii were identified as the chromones I [R = (all-Z)-(CH:CHCH2)5Me; (CH2)11Me] by spectroscopic and chem. means.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9xlX_B0cYrVg90H21EOLACvtfcHk0lhHb9VrOhY2iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XksFamsr0%253D&md5=90b87cbbc7f732200a2712858cb7407c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2987145-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252987145-2%26sid%3Dliteratum%253Aachs%26aulast%3DTringali%26aufirst%3DC.%26aulast%3DPiatelli%26aufirst%3DM.%26atitle%3DTwo%2520chrome%2520derivatives%2520from%2520the%2520brown%2520alga%2520Zonaria%2520tournefortii%26jtitle%3DTetrahedron%2520Lett.%26date%3D1982%26volume%3D23%26spage%3D1509%26epage%3D1512%26doi%3D10.1016%2FS0040-4039%2800%2987145-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Derivatives of natural product agrimophol as disruptors of intrabacterial pH homeostasis in mycobacterium tuberculosis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1104</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFOltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1087-1104&author=J.+Wuauthor=R.+Muauthor=M.+Sunauthor=N.+Zhaoauthor=M.+Panauthor=H.+Liauthor=Y.+Dongauthor=Z.+Sunauthor=J.+Baiauthor=M.+Huauthor=C.+F.+Nathanauthor=B.+Javidauthor=G.+Liu&title=Derivatives+of+natural+product+agrimophol+as+disruptors+of+intrabacterial+pH+homeostasis+in+mycobacterium+tuberculosis&doi=10.1021%2Facsinfecdis.8b00325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives of Natural Product Agrimophol as Disruptors of Intrabacterial pH Homeostasis in Mycobacterium tuberculosis</span></div><div class="casAuthors">Wu, Jie; Mu, Ran; Sun, Mingna; Zhao, Nan; Pan, Miaomiao; Li, Hongshuang; Dong, Yi; Sun, Zhaogang; Bai, Jie; Hu, Minwan; Nathan, Carl F.; Javid, Babak; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1087-1104</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This article reports the rational medicinal chem. of a natural product, agrimophol (1), as a new disruptor of intrabacterial pH (pHIB) homeostasis in Mycobacterium tuberculosis (Mtb).  Through the systematic investigation of the structure-activity relationship of 1, scaffold-hopping of the diphenylmethane scaffold, pharmacophore displacement strategies, and studies of the structure-metab. relationship, a new deriv. 5a was achieved.  Compd. 5a showed 100-fold increased potency in the ability to reduce pHIB to pH 6.0 and similarly improved mycobactericidal activity compared with 1 against both Mycobacterium bovis-BCG and Mtb.  Compd. 5a possessed improved metabolic stability in human liver microsomes and hepatocytes, lower cytotoxicity, higher selectivity index, and similar pKa value to natural 1.  This study introduces a novel scaffold to an old drug, resulting in improved mycobactericidal activity through decreasing pHIB, and may contribute to the crit. search for new agents to overcome drug resistance and persistence in the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplR-adMUe3cLVg90H21EOLACvtfcHk0lhHb9VrOhY2iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFOltLk%253D&md5=24c31d1257e6d7b313f8e7a71e53caff</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00325%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26aulast%3DJavid%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DDerivatives%2520of%2520natural%2520product%2520agrimophol%2520as%2520disruptors%2520of%2520intrabacterial%2520pH%2520homeostasis%2520in%2520mycobacterium%2520tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1087%26epage%3D1104%26doi%3D10.1021%2Facsinfecdis.8b00325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adlington, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. L.</span></span> <span> </span><span class="NLM_article-title">A short biomimetic synthesis of the meroterpenoids guajadial and psidial A</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1021/ol100138k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100138k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlahs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1676-1679&author=A.+L.+Lawrenceauthor=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=V.+Leeauthor=J.+A.+Kershawauthor=A.+L.+Thompson&title=A+short+biomimetic+synthesis+of+the+meroterpenoids+guajadial+and+psidial+A&doi=10.1021%2Fol100138k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Short Biomimetic Synthesis of the Meroterpenoids Guajadial and Psidial A</span></div><div class="casAuthors">Lawrence, Andrew L.; Adlington, Robert M.; Baldwin, Jack E.; Lee, Victor; Kershaw, Jessica A.; Thompson, Amber L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1676-1679</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The biosynthesis of the meroterpenoid guajadial was previously hypothesized to occur via a hetero-Diels-Alder reaction between caryophyllene and an o-quinone methide.  This hypothesis has been verified via the biomimetic synthesis of guajadial (I) and psidial A (II) in an aq. three-component coupling reaction, between caryophyllene, benzaldehyde, and diformylphloroglucinol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHkMpvGvrHybVg90H21EOLACvtfcHk0lhHb9VrOhY2iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlahs7k%253D&md5=67e8b0e6e0b2a85ed8514aa293346020</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol100138k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100138k%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DA.%2BL.%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DV.%26aulast%3DKershaw%26aufirst%3DJ.%2BA.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26atitle%3DA%2520short%2520biomimetic%2520synthesis%2520of%2520the%2520meroterpenoids%2520guajadial%2520and%2520psidial%2520A%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1676%26epage%3D1679%26doi%3D10.1021%2Fol100138k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. X.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis of rottlerin and its two subunits</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1856</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2016.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.tetlet.2016.03.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Ghu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1856-1859&author=Y.+F.+Liauthor=B.+Yuauthor=R.+X.+Wang&title=Efficient+synthesis+of+rottlerin+and+its+two+subunits&doi=10.1016%2Fj.tetlet.2016.03.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of rottlerin and its two subunits</span></div><div class="casAuthors">Li, Yangfeng; Yu, Biao; Wang, Renxiao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1856-1859</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Rottlerin (I), a natural product isolated from Mallotus philippensis, is assocd. with a range of biol. activities.  Its chem. structure features two different substituted phloroglucinol units linked by a methylene group.  In this study, we accomplished a total synthesis of rottlerin using phenol-aldehyde condensation as the key reaction.  By our method, gram-scale prepn. of the two structural subunits was achieved, and rottlerin was obtained in a longest eight linear step with 20% overall yield.  Our study provides a practical soln. for obtaining the sample of rottlerin in an efficient way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO85P_zYKm2rVg90H21EOLACvtfcHk0ljis5HRqE-4GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Ghu7s%253D&md5=3c5dd2ecd04661b995a7ac28e5c2f39b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2016.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2016.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DR.%2BX.%26atitle%3DEfficient%2520synthesis%2520of%2520rottlerin%2520and%2520its%2520two%2520subunits%26jtitle%3DTetrahedron%2520Lett.%26date%3D2016%26volume%3D57%26spage%3D1856%26epage%3D1859%26doi%3D10.1016%2Fj.tetlet.2016.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkhalifa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qusa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyprian, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Sayed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Moustafa, A.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>187</i></span>, <span class="NLM_elocation-id">111954</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.ejmech.2019.111954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=31838326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVajsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2020&author=D.+Elkhalifaauthor=A.+B.+Siddiqueauthor=M.+Qusaauthor=F.+S.+Cyprianauthor=K.+El+Sayedauthor=F.+Alaliauthor=A.-E.+Al+Moustafaauthor=A.+Khalil&title=Design%2C+synthesis%2C+and+validation+of+novel+nitrogen-based+chalcone+analogs+against+triple+negative+breast+cancer&doi=10.1016%2Fj.ejmech.2019.111954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer</span></div><div class="casAuthors">Elkhalifa, Dana; Siddique, Abu Bakar; Qusa, Mohammed; Cyprian, Farhan S.; El Sayed, Khalid; Alali, Feras; Al Moustafa, Ala-Eddin; Khalil, Ashraf</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111954</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Great strides have been made in triple neg. breast cancer (TNBC) treatment, which represents 20% of total predicted annual US breast cancer (BC) cases.  Despite the development of several therapeutics, TNBC patients have poor overall survival rate, compared to other BC patients, justifying the urgent need to discover new entities for use to control TNBC.  Chalcones are important natural products with diverse bioactivities including anticancer effects.  This study aimed to design, synthesize and validate novel chalcone leads as potential therapies for TNBC.  Fourteen novel chalcone analogs were designed and synthesized comprising alicyclic amines (pyrrolidine, morpholine and piperidine) or nitrogen mustard (Bis-(2-chloroethyl) amine) substituents.  Among them, compd. I, ((E)-3-(4-(Bis(2-chloroethyl) amino) phenyl)-1-(3-methoxyphenyl) prop-2-en-1-one) was identified as the most effective against TNBC and other BC phenotypes, with anti-proliferative IC50 values ranging between 3.94 and 9.22μM against the TNBC cell lines MDA-MB-231 and MDA-MB-468, as well as against the estrogen pos. MCF-7 cell line.  Chalcone I effectively suppressed the colony formation capacity of MDA-MB-231, MDA-MB-468, and MCF-7 cell lines at 5 and 10μM treatment concns.  Furthermore, compd. I has significantly inhibited cell invasion and migration of MDA-MB-231 and MCF-7 BC cell lines.  Addnl., compd. I had significantly promoted apoptosis by upregulating BAX and downregulating Bcl-2 proteins.  Compd. I induced significant cell cycle arrest of TNBC cells at the G2/M phase.  It also induced a reversal of Epithelial Mesenchymal Transition (EMT) by upregulating the epithelial markers E-cadherin and Pan-cadherin and downregulating FAK.  Furthermore, it had dramatically diminished new vessel formation (vasculogenesis) in chick chorioallantoic membrane (CAM) model by 60.20 ± 8.47%.  Chalcone I inhibited 46.41 ± 0.71% of the TNBC MAD-MB-231 cells growth in a nude mouse orthotopic xenograft model in comparison with vehicle control treated animals.  Collectively, this study results propose chalcone I as a promising lead mol. for the control of TNBC as well as other breast cancer phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo80wRmt8RwLrVg90H21EOLACvtfcHk0ljis5HRqE-4GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVajsrjE&md5=0318b763a58511302de96b6a2553864f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111954%26sid%3Dliteratum%253Aachs%26aulast%3DElkhalifa%26aufirst%3DD.%26aulast%3DSiddique%26aufirst%3DA.%2BB.%26aulast%3DQusa%26aufirst%3DM.%26aulast%3DCyprian%26aufirst%3DF.%2BS.%26aulast%3DEl%2BSayed%26aufirst%3DK.%26aulast%3DAlali%26aufirst%3DF.%26aulast%3DAl%2BMoustafa%26aufirst%3DA.-E.%26aulast%3DKhalil%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520validation%2520of%2520novel%2520nitrogen-based%2520chalcone%2520analogs%2520against%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D187%26doi%3D10.1016%2Fj.ejmech.2019.111954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Organometallic Gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3478</span>– <span class="NLM_lpage">3490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3478-3490&author=K.+B.+Huangauthor=F.+Y.+Wangauthor=X.+M.+Tangauthor=H.+W.+Fengauthor=Z.+F.+Chenauthor=Y.+C.+Liuauthor=Y.+N.+Liuauthor=H.+Liang&title=Organometallic+Gold%28III%29+complexes+similar+to+tetrahydroisoquinoline+induce+ER-stress-mediated+apoptosis+and+pro-death+autophagy+in+A549+cancer+cells&doi=10.1021%2Facs.jmedchem.7b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span></div><div class="casAuthors">Huang, Ke-Bin; Wang, Feng-Yang; Tang, Xiao-Ming; Feng, Hai-Wen; Chen, Zhen-Feng; Liu, Yan-Cheng; Liu, You-Nian; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3478-3490</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gold(III) cyclometalated benzeneethanamine chelate complexes exhibit high cytotoxic activity towards lung cancer cells, causing ER-controlled apoptosis and autophagy, exhibiting less toxicity compared to cisplatin.  Agents inducing both apoptosis and autophagic death can be effective chemotherapeutic drugs.  In our present work, we synthesized two organometallic gold(III) complexes harboring C-N ligands that structurally resemble tetrahydroisoquinoline (THIQ): Cyc-Au-1 (AuL1Cl2, HL1 = 3,4-dimethoxyphenethylamine) and Cyc-Au-2 (AuL2Cl2, HL2 = 1,3-benzodioxole-5-ethanamine).  In screening their in vitro activity, we found both gold complexes exhibited lower toxicity, lower resistance factors, and better anticancer activity than those of cisplatin.  The organometallic gold(III) complexes accumulate in mitochondria and induce elevated ROS and an ER stress response through mitochondrial dysfunction.  These effects ultimately result in simultaneous apoptosis and autophagy.  Importantly, compared to cisplatin, Cyc-Au-2 exhibits lower toxicity and better anticancer activity in a murine tumor model.  To the best of our knowledge, Cyc-Au-2 is the first organometallic Au(III) compd. that induces apoptosis and autophagic death.  On the basis of our results, we believe Cyc-Au-2 to be a promising anticancer agent or lead compd. for further anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIcN1K09UUe7Vg90H21EOLACvtfcHk0ljis5HRqE-4GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D&md5=08921b2a076c3cf07260611ab629fe93</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01694%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BB.%26aulast%3DWang%26aufirst%3DF.%2BY.%26aulast%3DTang%26aufirst%3DX.%2BM.%26aulast%3DFeng%26aufirst%3DH.%2BW.%26aulast%3DChen%26aufirst%3DZ.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DOrganometallic%2520Gold%2528III%2529%2520complexes%2520similar%2520to%2520tetrahydroisoquinoline%2520induce%2520ER-stress-mediated%2520apoptosis%2520and%2520pro-death%2520autophagy%2520in%2520A549%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3478%26epage%3D3490%26doi%3D10.1021%2Facs.jmedchem.7b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial membrane permeabilization in cell death</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1152/physrev.00013.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1152%2Fphysrev.00013.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=17237344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVahu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=99-163&author=G.+Kroemerauthor=L.+Galluzziauthor=C.+Brenner&title=Mitochondrial+membrane+permeabilization+in+cell+death&doi=10.1152%2Fphysrev.00013.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial membrane permeabilization in cell death</span></div><div class="casAuthors">Kroemer, Guido; Galluzzi, Lorenzo; Brenner, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-163</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Irresp. of the morphol. features of end-stage cell death (that may be apoptotic, necrotic, autophagic, or mitotic), mitochondrial membrane permeabilization (MMP) is frequently the decisive event that delimits the frontier between survival and death.  Thus mitochondrial membranes constitute the battleground on which opposing signals combat to seal the cell's fate.  Local players that det. the propensity to MMP include the pro- and antiapoptotic members of the Bcl-2 family, proteins from the mitochondrial permeability transition pore complex, as well as a plethora of interacting partners including mitochondrial lipids.  Intermediate metabolites, redox processes, sphingolipids, ion gradients, transcription factors, as well as kinases and phosphatases link lethal and vital signals emanating from distinct subcellular compartments to mitochondria.  Thus mitochondria integrate a variety of proapoptotic signals.  Once MMP has been induced, it causes the release of catabolic hydrolases and activators of such enzymes (including those of caspases) from mitochondria.  These catabolic enzymes as well as the cessation of the bioenergetic and redox functions of mitochondria finally lead to cell death, meaning that mitochondria coordinate the late stage of cellular demise.  Pathol. cell death induced by ischemia/reperfusion, intoxication with xenobiotics, neurodegenerative diseases, or viral infection also relies on MMP as a crit. event.  The inhibition of MMP constitutes an important strategy for the pharmaceutical prevention of unwarranted cell death.  Conversely, induction of MMP in tumor cells constitutes the goal of anticancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0e6l_KkfcfrVg90H21EOLACvtfcHk0lgnvl7ENbVrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVahu7k%253D&md5=ad216e4f60d7a70fb946534242c07e5b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00013.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00013.2006%26sid%3Dliteratum%253Aachs%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DMitochondrial%2520membrane%2520permeabilization%2520in%2520cell%2520death%26jtitle%3DPhysiol.%2520Rev.%26date%3D2007%26volume%3D87%26spage%3D99%26epage%3D163%26doi%3D10.1152%2Fphysrev.00013.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnoletto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bononi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missiroli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patergnani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimessi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieckowski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-ros crosstalk in the control of cell death and aging</span>. <i>J. Signal Transduction</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>, <span class="NLM_elocation-id">329635</span> <span class="refDoi"> DOI: 10.1155/2012/329635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1155%2F2012%2F329635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=22175013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FnvFSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&author=S.+Marchiauthor=C.+Giorgiauthor=J.+M.+Suskiauthor=C.+Agnolettoauthor=A.+Bononiauthor=M.+Bonoraauthor=E.+De+Marchiauthor=S.+Missiroliauthor=S.+Patergnaniauthor=F.+Polettiauthor=A.+Rimessiauthor=J.+Duszynskiauthor=M.+R.+Wieckowskiauthor=P.+Pinton&title=Mitochondria-ros+crosstalk+in+the+control+of+cell+death+and+aging&doi=10.1155%2F2012%2F329635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-ros crosstalk in the control of cell death and aging</span></div><div class="casAuthors">Marchi Saverio; Giorgi Carlotta; Suski Jan M; Agnoletto Chiara; Bononi Angela; Bonora Massimo; De Marchi Elena; Missiroli Sonia; Patergnani Simone; Poletti Federica; Rimessi Alessandro; Duszynski Jerzy; Wieckowski Mariusz R; Pinton Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of signal transduction</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">329635</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are highly reactive molecules, mainly generated inside mitochondria that can oxidize DNA, proteins, and lipids.  At physiological levels, ROS function as "redox messengers" in intracellular signalling and regulation, whereas excess ROS induce cell death by promoting the intrinsic apoptotic pathway.  Recent work has pointed to a further role of ROS in activation of autophagy and their importance in the regulation of aging.  This review will focus on mitochondria as producers and targets of ROS and will summarize different proteins that modulate the redox state of the cell.  Moreover, the involvement of ROS and mitochondria in different molecular pathways controlling lifespan will be reported, pointing out the role of ROS as a "balance of power," directing the cell towards life or death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRL6rNrbwOxBcjl5L8hwNX0fW6udTcc2eZ_HUkYfGnx_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FnvFSmsA%253D%253D&md5=4c45343fd1c1cd9c5ee543f4c2524618</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1155%2F2012%2F329635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F329635%26sid%3Dliteratum%253Aachs%26aulast%3DMarchi%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DC.%26aulast%3DSuski%26aufirst%3DJ.%2BM.%26aulast%3DAgnoletto%26aufirst%3DC.%26aulast%3DBononi%26aufirst%3DA.%26aulast%3DBonora%26aufirst%3DM.%26aulast%3DDe%2BMarchi%26aufirst%3DE.%26aulast%3DMissiroli%26aufirst%3DS.%26aulast%3DPatergnani%26aufirst%3DS.%26aulast%3DPoletti%26aufirst%3DF.%26aulast%3DRimessi%26aufirst%3DA.%26aulast%3DDuszynski%26aufirst%3DJ.%26aulast%3DWieckowski%26aufirst%3DM.%2BR.%26aulast%3DPinton%26aufirst%3DP.%26atitle%3DMitochondria-ros%2520crosstalk%2520in%2520the%2520control%2520of%2520cell%2520death%2520and%2520aging%26jtitle%3DJ.%2520Signal%2520Transduction%26date%3D2012%26volume%3D2012%26doi%3D10.1155%2F2012%2F329635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span> <span> </span><span class="NLM_article-title">Alteronol induces cell cycle arrest and apoptosis via increased reactive oxygen species production in human breast cancer T47D cells</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1111/jphp.12879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1111%2Fjphp.12879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29411391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=516-524&author=B.+Renauthor=D.+Liauthor=L.+Siauthor=Y.+Dingauthor=J.+Hanauthor=X.+Chenauthor=Q.+Zheng&title=Alteronol+induces+cell+cycle+arrest+and+apoptosis+via+increased+reactive+oxygen+species+production+in+human+breast+cancer+T47D+cells&doi=10.1111%2Fjphp.12879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Alteronol induces cell cycle arrest and apoptosis via increased reactive oxygen species production in human breast cancer T47D cells</span></div><div class="casAuthors">Ren, Boxue; Li, Defang; Si, Lingling; Ding, Yangfang; Han, Jichun; Chen, Xiaoyu; Zheng, Qiusheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">516-524</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objective : Emerging evidence showed that alteronol has a potential antitumor effect in several tumor cells.  However, the antitumor effect of alteronol on breast cancer has not been reported.  This study investigated the mechanisms of alteronol-induced cell proliferation inhibition in human breast cancer T47D cells.  Methods : After treatment with alteronol, T47D cell proliferation was examd. by MTT assay.  The cell cycle distribution, cell apoptosis, reactive oxygen species level and mitochondrial membrane potential were evaluated via flow cytometry.  Next, the protein levels of cyclin B1, cdc2, p21, p-cyclin B1, p-cdc2, p53, Bax, Bcl-2 and cytochrome c were analyzed using Western blot anal.  Meanwhile, the mRNA levels of cyclin B1, cdc2, p21 and p53 were examd. by qRT-PCR.  Key findings : Our data showed that alteronol inhibited the proliferation of T47D cells via inducing G2-phase arrest and cell apoptosis.  Compared with control group, alteronol significantly increased ROS level and triggered mitochondrial dysfunction in alteronol-treated T47D cells.  Further studies showed that the mRNA and protein levels of cdc2 and cyclin B1 were downregulated, while the mRNA and protein levels of p21, p53, p-cyclin B1, p-cdc2 and cytochrome c were upregulated.  In addn., the expression level of Bax was increased, and the expression level of Bcl-2 was decreased.  Conclusions : Alteronol induced T47D cell cycle arrest and cell apoptosis through increasing ROS prodn. and triggering mitochondrial dysfunction, and subsequently inhibiting T47D cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryp_p0gkYoIrVg90H21EOLACvtfcHk0lgnvl7ENbVrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2nuro%253D&md5=ad3950fe23bfc673b21e841833c7bd52</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12879%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DSi%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DQ.%26atitle%3DAlteronol%2520induces%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520via%2520increased%2520reactive%2520oxygen%2520species%2520production%2520in%2520human%2520breast%2520cancer%2520T47D%2520cells%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2018%26volume%3D70%26spage%3D516%26epage%3D524%26doi%3D10.1111%2Fjphp.12879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span> <span> </span><span class="NLM_article-title">The course of uncarinic acid E-induced apoptosis of HepG2 cells from damage to DNA and p53 activation to mitochondrial release of cytochrome c</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1644</span>, <span class="refDoi"> DOI: 10.1248/bpb.29.1639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1248%2Fbpb.29.1639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=16880619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWgsrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=1639-1644&author=M.+Zhaoauthor=T.+Guoauthor=M.+Wangauthor=Q.+Zhaoauthor=Y.+Liuauthor=X.+Sunauthor=H.+Wangauthor=Y.+Hou&title=The+course+of+uncarinic+acid+E-induced+apoptosis+of+HepG2+cells+from+damage+to+DNA+and+p53+activation+to+mitochondrial+release+of+cytochrome+c&doi=10.1248%2Fbpb.29.1639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The course of uncarinic acid E-induced apoptosis of HepG2 cells from damage to DNA and p53 activation to mitochondrial release of cytochrome c</span></div><div class="casAuthors">Zhao, Minghong; Guo, Tao; Wang, Minwei; Zhao, Qingchun; Liu, Yanxia; Sun, Xuehui; Wang, Huailiang; Hou, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1639-1644</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Uncarinic acid E, an active component isolated from Gelsemium elegans BENTH, has been reported to exhibit antitumor effects, but little is known about its mol. mechanisms of action.  In this study, the growth inhibitory activity of uncarinic acid E for HepG2 cells is in time- and dose-dependent manner.  HepG2 cells treated with uncarinic acid E exhibited several typical characteristics of apoptosis through photomicroscopical observation, DNA agarose gel electrophoresis.  The inhibitory effect of uncarinic acid E on HepG2 cells was partially reversed by the inhibitors of pan-caspase, caspase-3 and caspase-6.  The protein expression ratio of Bcl-xL/Bax and Bcl-2/Bax was down-regulated and uncarinic acid E-induced apoptosis involves the initial phase mediated by the balance among Bcl-xL, Bcl-2 and Bax proteins, resulting in cytochrome c release from the mitochondria.  Uncarinic acid E significantly increased the expression of p53 proteins indicates that p53 plays a pivotal role in the initiation phase of uncarinic acid E-induced HepG2 cell apoptosis.  The phosphatidylinositol 3-kinase (PI3-K) family inhibitor wortmanin and the MEK inhibitor (PD98059) rescued the viability loss induced by uncarinic acid E through the expression of p53.  Taken together, uncarinic acid E induces apoptosis in HepG2 cells via accumulation of p53, alters the Bax/Bcl-2 ratio, and activates caspases, resulting in cytochrome c release from the mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAdCBZq--aOLVg90H21EOLACvtfcHk0ljFFkguvXvjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWgsrrM&md5=cba7a7c85e8093ca694b168695c86815</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1248%2Fbpb.29.1639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.29.1639%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DY.%26atitle%3DThe%2520course%2520of%2520uncarinic%2520acid%2520E-induced%2520apoptosis%2520of%2520HepG2%2520cells%2520from%2520damage%2520to%2520DNA%2520and%2520p53%2520activation%2520to%2520mitochondrial%2520release%2520of%2520cytochrome%2520c%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2006%26volume%3D29%26spage%3D1639%26epage%3D1644%26doi%3D10.1248%2Fbpb.29.1639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriwacki, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of apoptosis induction by inhibition of the anti-apoptotic Bcl-2 proteins</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">20327</span>– <span class="NLM_lpage">20332</span>, <span class="refDoi"> DOI: 10.1073/pnas.0808036105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1073%2Fpnas.0808036105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19074266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=20327-20332&author=J.+E.+Chipukauthor=J.+C.+Fisherauthor=C.+P.+Dillonauthor=R.+W.+Kriwackiauthor=T.+Kuwanaauthor=D.+R.+Green&title=Mechanism+of+apoptosis+induction+by+inhibition+of+the+anti-apoptotic+Bcl-2+proteins&doi=10.1073%2Fpnas.0808036105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins</span></div><div class="casAuthors">Chipuk, Jerry E.; Fisher, John C.; Dillon, Christopher P.; Wriwacki, Richard W.; Kuwana, Tomomi; Green, Douglas R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">20327-20332</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Normal cellular lifespan is contingent upon preserving outer mitochondrial membrane (OMM) integrity, as permeabilization promotes apoptosis.  BCL-2 family proteins control mitochondrial outer membrane permeabilization (MOMP) by regulating the activation of the pro-apoptotic BCL-2 effector mols., BAX and BAK.  Sustainable cellular stress induces proteins (e.g., BID, BIM, and cytosolic p53) capable of directly activating BAX and/or BAK, but these direct activators are sequestered by the anti-apoptotic BCL-2 proteins (e.g., BCL-2, BCL-xL, and MCL-1).  In the event of accumulated or marked cellular stress, a coordinated effort between previously sequestered and nascent BH3-only proteins inhibits the anti-apoptotic BCL-2 repertoire to promote direct activator protein-mediated MOMP.  We examd. the effect of ABT-737, a BCL-2 antagonist, and PUMA, a BH3-only protein that inhibits the entire anti-apoptotic BCL-2 repertoire, with cells and mitochondria that sequestered direct activator proteins.  ABT-737 and PUMA cooperated with sequestered direct activator proteins to promote MOMP and apoptosis, which in the absence of ABT-737 or PUMA did not influence OMM integrity or cellular survival.  Our data show that the induction of apoptosis by inhibition of the anti-apoptotic BCL-2 repertoire requires "covert" levels of direct activators of BAX and BAK at the OMM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgZPMXKLAR_7Vg90H21EOLACvtfcHk0ljFFkguvXvjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWlsA%253D%253D&md5=88312b9fdcaeaeea4a13cc0846650536</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0808036105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0808036105%26sid%3Dliteratum%253Aachs%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DFisher%26aufirst%3DJ.%2BC.%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DKriwacki%26aufirst%3DR.%2BW.%26aulast%3DKuwana%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DMechanism%2520of%2520apoptosis%2520induction%2520by%2520inhibition%2520of%2520the%2520anti-apoptotic%2520Bcl-2%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D20327%26epage%3D20332%26doi%3D10.1073%2Fpnas.0808036105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuzil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. J.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of ’mitocan’-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>580</i></span>,  <span class="NLM_fpage">5125</span>– <span class="NLM_lpage">5129</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2006.05.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.febslet.2006.05.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=16979626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=5125-5129&author=J.+Neuzilauthor=X.+F.+Wangauthor=L.+F.+Dongauthor=P.+Lowauthor=S.+J.+Ralph&title=Molecular+mechanism+of+%E2%80%99mitocan%E2%80%99-induced+apoptosis+in+cancer+cells+epitomizes+the+multiple+roles+of+reactive+oxygen+species+and+Bcl-2+family+proteins&doi=10.1016%2Fj.febslet.2006.05.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins</span></div><div class="casAuthors">Neuzil, Jiri; Wang, Xiu-Fang; Dong, Lan-Feng; Low, Pauline; Ralph, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">580</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5125-5129</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mitochondria have emerged recently as effective targets for novel anti-cancer drugs referred to as 'mitocans'.  We propose that the mol. mechanism of induction of apoptosis by mitocans, as exemplified by the drug α-tocopheryl succinate, involves generation of reactive oxygen species (ROS).  ROS then mediate the formation of disufide bridges between cytosolic Bax monomers, resulting in the formation of mitochondrial outer membrane channels.  ROS also cause oxidn. of cardiolipin, triggering the release of cytochrome c and its translocation via the activated Bax channels.  This model may provide a general mechanism for the action of inducers of apoptosis and anticancer drugs, mitocans, targeting mitochondria via ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dJ4e6bOuoLVg90H21EOLACvtfcHk0ljFFkguvXvjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGntr8%253D&md5=c34a58ee8e0683e057712c3d74b497a8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2006.05.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2006.05.072%26sid%3Dliteratum%253Aachs%26aulast%3DNeuzil%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DDong%26aufirst%3DL.%2BF.%26aulast%3DLow%26aufirst%3DP.%26aulast%3DRalph%26aufirst%3DS.%2BJ.%26atitle%3DMolecular%2520mechanism%2520of%2520%25E2%2580%2599mitocan%25E2%2580%2599-induced%2520apoptosis%2520in%2520cancer%2520cells%2520epitomizes%2520the%2520multiple%2520roles%2520of%2520reactive%2520oxygen%2520species%2520and%2520Bcl-2%2520family%2520proteins%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D5125%26epage%3D5129%26doi%3D10.1016%2Fj.febslet.2006.05.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span> <span> </span><span class="NLM_article-title">Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">11748</span>– <span class="NLM_lpage">11756</span>, <span class="refDoi"> DOI: 10.1021/ja505212y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja505212y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=11748-11756&author=P.+Huangauthor=D.+Wangauthor=Y.+Suauthor=W.+Huangauthor=Y.+Zhouauthor=D.+Cuiauthor=X.+Zhuauthor=D.+Yan&title=Combination+of+small+molecule+prodrug+and+nanodrug+delivery%3A+amphiphilic+drug-drug+conjugate+for+cancer+therapy&doi=10.1021%2Fja505212y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug-Drug Conjugate for Cancer Therapy</span></div><div class="casAuthors">Huang, Ping; Wang, Dali; Su, Yue; Huang, Wei; Zhou, Yongfeng; Cui, Daxiang; Zhu, Xinyuan; Yan, Deyue</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11748-11756</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">All drugs for cancer therapy face several transportation barriers on their tortuous journey to the action sites.  To overcome these barriers, an effective drug delivery system for cancer therapy is imperative.  Here, we develop a drug self-delivery system for cancer therapy, in which anticancer drugs can be delivered by themselves without any carriers.  To demonstrate this unique approach, an amphiphilic drug-drug conjugate (ADDC) has been synthesized from the hydrophilic anticancer drug irinotecan (Ir) and the hydrophobic anticancer drug chlorambucil (Cb) via a hydrolyzable ester linkage.  The amphiphilic Ir-Cb conjugate self-assembles into nanoparticles in water and exhibits longer blood retention half-life compared with the free drugs, which facilitates the accumulation of drugs in tumor tissues and promotes their cellular uptake.  A benefit of the nanoscale characteristics of the Ir-Cb ADDC nanoparticles is that the multidrug resistance (MDR) of tumor cells can be overcome efficiently.  After cellular internalization, the ester bond between hydrophilic and hydrophobic drugs undergoes hydrolysis to release free Ir and Cb, resulting in an excellent anticancer activity in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre8pgZaWvbY7Vg90H21EOLACvtfcHk0lhWEIlCMhw12A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git73M&md5=48fd2f3715825ffa9bbfb32f06b5626c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja505212y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja505212y%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DD.%26atitle%3DCombination%2520of%2520small%2520molecule%2520prodrug%2520and%2520nanodrug%2520delivery%253A%2520amphiphilic%2520drug-drug%2520conjugate%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D11748%26epage%3D11756%26doi%3D10.1021%2Fja505212y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänicke, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Osthoff, K.</span></span> <span> </span><span class="NLM_article-title">Many cuts to ruin: a comprehensive update of caspase substrates</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fsj.cdd.4401160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=12655297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12murs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=76-100&author=U.+Fischerauthor=R.+U.+J%C3%A4nickeauthor=K.+Schulze-Osthoff&title=Many+cuts+to+ruin%3A+a+comprehensive+update+of+caspase+substrates&doi=10.1038%2Fsj.cdd.4401160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Many cuts to ruin: a comprehensive update of caspase substrates</span></div><div class="casAuthors">Fischer, U.; Jaenicke, R. U.; Schulze-Osthoff, K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-100</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Apoptotic cell death is executed by the caspase-mediated cleavage of various vital proteins.  Elucidating the consequences of this endoproteolytic cleavage is crucial for an understanding of cell death and other biol. processes.  Many caspase substrates are just cleaved as bystanders, because they happen to contain a caspase cleavage site in their sequence.  Several targets, however, have a discrete function in propagation of the cell death process.  Many structural and regulatory proteins are inactivated by caspases, whereas other substrates can be activated.  In most cases, the consequences of this gain-of-function are poorly understood.  Caspase substrates can regulate the key morphol. changes in apoptosis.  Several caspase substrates also act as transducers and amplifiers that det. the apoptotic threshold and cell fate.  This review summarizes the known caspase substrates comprising a bewildering list of >280 different proteins.  The authors highlight some recent aspects inferred by the cleavage of certain proteins in apoptosis.  The authors also discuss emerging themes of caspase cleavage in other forms of cell death and, in particular, in apparently unrelated processes, such as cell cycle regulation and cellular differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO-3y3NL036bVg90H21EOLACvtfcHk0lhWEIlCMhw12A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12murs%253D&md5=40058cba0ab6217667ed4c8011ba1ddf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401160%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DU.%26aulast%3DJ%25C3%25A4nicke%26aufirst%3DR.%2BU.%26aulast%3DSchulze-Osthoff%26aufirst%3DK.%26atitle%3DMany%2520cuts%2520to%2520ruin%253A%2520a%2520comprehensive%2520update%2520of%2520caspase%2520substrates%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D76%26epage%3D100%26doi%3D10.1038%2Fsj.cdd.4401160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez
de Castro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárcer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malumbres, M.</span></span> <span> </span><span class="NLM_article-title">A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">912</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgm019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1093%2Fcarcin%2Fbgm019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=899-912&author=I.+Perez%0Ade+Castroauthor=G.+C%C3%A1rcerauthor=M.+Malumbres&title=A+census+of+mitotic+cancer+genes%3A+new+insights+into+tumor+cell+biology+and+cancer+therapy&doi=10.1093%2Fcarcin%2Fbgm019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgm019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgm019%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%2Bde%2BCastro%26aufirst%3DI.%26aulast%3DC%25C3%25A1rcer%26aufirst%3DG.%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DA%2520census%2520of%2520mitotic%2520cancer%2520genes%253A%2520new%2520insights%2520into%2520tumor%2520cell%2520biology%2520and%2520cancer%2520therapy%26jtitle%3DCarcinogenesis%26date%3D2006%26volume%3D28%26spage%3D899%26epage%3D912%26doi%3D10.1093%2Fcarcin%2Fbgm019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartwell, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span> <span> </span><span class="NLM_article-title">Cell cycle control and cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1126/science.7997877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1126%2Fscience.7997877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=7997877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaK2MXislCjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1994&pages=1821-1828&author=L.+H.+Hartwellauthor=M.+B.+Kastan&title=Cell+cycle+control+and+cancer&doi=10.1126%2Fscience.7997877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle control and cancer</span></div><div class="casAuthors">Hartwell, Leland H.; Kastan, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">5192</span>),
    <span class="NLM_cas:pages">1821-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 102 refs.  Multiple genetic changes occur during the evolution of normal cells into cancer cells.  This evolution is facilitated in cancer cells by loss of fidelity in the processes that replicate, repair, and segregate the genome.  Recent advances in our understanding of the cell cycle reveal how fidelity is normally achieved by the coordinated activity of cyclin-dependent kinases, checkpoint controls, and repair pathways and how this fidelity can be abrogated by sp. genetic changes.  These insights suggest mol. mechanisms for cellular transformation and may help to identify potential targets for improved cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNraoG5m-ETrVg90H21EOLACvtfcHk0lhWEIlCMhw12A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislCjsr8%253D&md5=8d6833068841c075f52a77a6d0f08c17</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.7997877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7997877%26sid%3Dliteratum%253Aachs%26aulast%3DHartwell%26aufirst%3DL.%2BH.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DCell%2520cycle%2520control%2520and%2520cancer%26jtitle%3DScience%26date%3D1994%26volume%3D266%26spage%3D1821%26epage%3D1828%26doi%3D10.1126%2Fscience.7997877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, K. B.</span></span> <span> </span><span class="NLM_article-title">Pattern of cellular quiescence over the hibernation cycle in liver of thirteen-lined ground squirrels</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1726</span>, <span class="refDoi"> DOI: 10.4161/cc.19799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.4161%2Fcc.19799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=22510572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFemtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1714-1726&author=C.+W.+Wuauthor=K.+B.+Storey&title=Pattern+of+cellular+quiescence+over+the+hibernation+cycle+in+liver+of+thirteen-lined+ground+squirrels&doi=10.4161%2Fcc.19799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern of cellular quiescence over the hibernation cycle in liver of thirteen-lined ground squirrels</span></div><div class="casAuthors">Wu, Cheng-Wei; Storey, Kenneth B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1714-1726</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">We analyze the status of the cell cycle during hibernation in liver of thirteen-lined ground squirrels (Ictidomys tridecemlineatus) and examines the expression levels of cell cycle regulators over 6 stages of the torpor-arousal cycle.  Immunoblot anal. showed that the protein expression levels of cyclin D1 and cyclin E were reduced in liver (by 31% and 48%, resp.) during long-term torpor; however, during arousal from torpor, PCR anal. showed an upregulation of cyclin D1 transcript levels of ∼1.5-fold.  Protein expression of cyclin A and cyclin B1 were also elevated (1.57-fold and 2.44-fold, resp.) during early arousal from torpor, and in addn., cyclin A2 transcript levels increased by ∼1.8-fold during arousal.  Protein levels of 2 CKIs, p15INK4b and p21CIP1, each increased by ∼1.4-fold during torpor and transcript levels of p15INK4b also rose by 1.7-2.1 fold during torpor, whereas p21CIP1 transcripts increased by 1.5-1.7-fold.  A redn. in cyclin D and E protein expression coupled with upregulation of p15INK4b and p21CIP1 inhibitors during torpor reflects markers of cell cycle arrest during hibernation.  Elevated expression of cyclin A and B protein expression during arousal stages of torpor suggests cell cycle progression is reversibly arrested during torpor and is reinitiated upon return to euthermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKmZ-Uu23_y7Vg90H21EOLACvtfcHk0liLcTnDE1g1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFemtb0%253D&md5=cc8c0498777929a862d4b548fa2f90e6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.4161%2Fcc.19799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.19799%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3DStorey%26aufirst%3DK.%2BB.%26atitle%3DPattern%2520of%2520cellular%2520quiescence%2520over%2520the%2520hibernation%2520cycle%2520in%2520liver%2520of%2520thirteen-lined%2520ground%2520squirrels%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26spage%3D1714%26epage%3D1726%26doi%3D10.4161%2Fcc.19799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiskanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laiho, M.</span></span> <span> </span><span class="NLM_article-title">Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5888</span>– <span class="NLM_lpage">5896</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1204745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fsj.onc.1204745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=11593394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlSgt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5888-5896&author=F.+Zhangauthor=M.+Taipaleauthor=A.+Heiskanenauthor=M.+Laiho&title=Ectopic+expression+of+Cdk6+circumvents+transforming+growth+factor-beta+mediated+growth+inhibition&doi=10.1038%2Fsj.onc.1204745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ectopic expression of Cdk6 circumvents transforming growth factor-β mediated growth inhibition</span></div><div class="casAuthors">Zhang, Fan; Taipale, Minna; Heiskanen, Annamari; Laiho, Marikki</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">5888-5896</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transforming growth factor-β (TGF-β) induced growth arrest of cells involves regulation of the activities of both D- and E-type cyclin kinase complexes thought to be mediated primarily by the regulation of p15InK4b and p27Kip1 cyclin kinase inhibitors.  We show here that TGF-β downregulates Cdk6 and that transient and stable expression of Cdk6 in Mv1Lu mink epithelial cells overrides TGF-β mediated arrest.  The main effect of the ectopic Cdk6 expression was to sequester TGF-β induced p15InK4b and to maintain more p27Kip1 in cyclin D-complexes preventing the complete shift of p27Kip1 to Cdk2 invoked by TGF-β.  This led to the presence of an active cyclin D-Cdk6-p27Kip1 complex and partially active cyclin E-Cdk2 complex and resulted in the failure of TGF-β to fully arrest Mv1Lu cell growth.  Though dominant neg. Cdk6, expressed similarly in the cells, sequestered both p15InK4b and p27Kip1, it lacks kinase activity and was unable to override the TGF-β arrest.  The results demonstrate that downregulation of Cdk6 kinase is required for the enforcement of the G1-phase arrest by TGF-β and results in changes in assocn. of the p15InK4b and p27Kip1 inhibitors with D- and E-type cyclin kinase complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uv_8st2rnLVg90H21EOLACvtfcHk0liLcTnDE1g1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlSgt7o%253D&md5=4ed340e36c53cee4b589cf2dcf84ea73</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1204745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1204745%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DHeiskanen%26aufirst%3DA.%26aulast%3DLaiho%26aufirst%3DM.%26atitle%3DEctopic%2520expression%2520of%2520Cdk6%2520circumvents%2520transforming%2520growth%2520factor-beta%2520mediated%2520growth%2520inhibition%26jtitle%3DOncogene%26date%3D2001%26volume%3D20%26spage%3D5888%26epage%3D5896%26doi%3D10.1038%2Fsj.onc.1204745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyomarsi, K.</span></span> <span> </span><span class="NLM_article-title">Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.4161/cbt.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.4161%2Fcbt.201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=37-46&author=S.+Akliauthor=K.+Keyomarsi&title=Cyclin+E+and+its+low+molecular+weight+forms+in+human+cancer+and+as+targets+for+cancer+therapy&doi=10.4161%2Fcbt.201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.4161%2Fcbt.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.201%26sid%3Dliteratum%253Aachs%26aulast%3DAkli%26aufirst%3DS.%26aulast%3DKeyomarsi%26aufirst%3DK.%26atitle%3DCyclin%2520E%2520and%2520its%2520low%2520molecular%2520weight%2520forms%2520in%2520human%2520cancer%2520and%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D37%26epage%3D46%26doi%3D10.4161%2Fcbt.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciemerych, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebel, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigematsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagozdzon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicinska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicinski, P.</span></span> <span> </span><span class="NLM_article-title">Mouse development and cell proliferation in the absence of D-cyclins</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.cell.2004.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=15315760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=477-491&author=K.+Kozarauthor=M.+A.+Ciemerychauthor=V.+I.+Rebelauthor=H.+Shigematsuauthor=A.+Zagozdzonauthor=E.+Sicinskaauthor=Y.+Gengauthor=Q.+Yuauthor=S.+Bhattacharyaauthor=R.+T.+Bronsonauthor=K.+Akashiauthor=P.+Sicinski&title=Mouse+development+and+cell+proliferation+in+the+absence+of+D-cyclins&doi=10.1016%2Fj.cell.2004.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse development and cell proliferation in the absence of D-cyclins</span></div><div class="casAuthors">Kozar, Katarzyna; Ciemerych, Maria A.; Rebel, Vivienne I.; Shigematsu, Hirokazu; Zagozdzon, Agnieszka; Sicinska, Ewa; Geng, Yan; Yu, Qunyan; Bhattacharya, Shoumo; Bronson, Roderick T.; Akashi, Koichi; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-491</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">D-type cyclins (cyclins D1, D2, and D3) are regarded as essential links between cell environment and the core cell cycle machinery.  We tested the requirement for D-cyclins in mouse development and in proliferation by generating mice lacking all D-cyclins.  We found that these cyclin D1-/-D2-/-D3-/- mice develop until mid/late gestation and die due to heart abnormalities combined with a severe anemia.  Our analyses revealed that the D-cyclins are critically required for the expansion of hematopoietic stem cells.  In contrast, cyclin D-deficient fibroblasts proliferate nearly normally but show increased requirement for mitogenic stimulation in cell cycle re-entry.  We found that the proliferation of cyclin D1-/-D2-/-D3-/- cells is resistant to the inhibition by p16INK4a, but it critically depends on CDK2.  Lastly, we found that cells lacking D-cyclins display reduced susceptibility to the oncogenic transformation.  Our results reveal the presence of alternative mechanisms that allow cell cycle progression in a cyclin D-independent fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCN6XBf-BR7Vg90H21EOLACvtfcHk0liLcTnDE1g1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlCmu7Y%253D&md5=ccdd86f0826fb0a9d064aa3bb064033c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DKozar%26aufirst%3DK.%26aulast%3DCiemerych%26aufirst%3DM.%2BA.%26aulast%3DRebel%26aufirst%3DV.%2BI.%26aulast%3DShigematsu%26aufirst%3DH.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DAkashi%26aufirst%3DK.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DMouse%2520development%2520and%2520cell%2520proliferation%2520in%2520the%2520absence%2520of%2520D-cyclins%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D477%26epage%3D491%26doi%3D10.1016%2Fj.cell.2004.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agami, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernards, R.</span></span> <span> </span><span class="NLM_article-title">Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00010-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2FS0092-8674%2800%2900010-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10929713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=55-66&author=R.+Agamiauthor=R.+Bernards&title=Distinct+initiation+and+maintenance+mechanisms+cooperate+to+induce+G1+cell+cycle+arrest+in+response+to+DNA+damage&doi=10.1016%2FS0092-8674%2800%2900010-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage</span></div><div class="casAuthors">Agami, Reuven; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-66</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">DNA damage causes stabilization of p53, leading to G1 arrest through induction of p21cip1.  As this process requires transcription, several hours are needed to exert this response.  We show that DNA damage causes an immediate and p53-independent G1 arrest, caused by rapid proteolysis of cyclin D1.  Degrdn. is mediated through a previously unrecognized destruction box in cyclin D1 and leads to a release of p21cip1 from CDK4 to inhibit CDK2.  Interference with cyclin D1 degrdn. prevents initiation of G1 arrest and renders cells more susceptible to DNA damage, indicating that cyclin D1 degrdn. is an essential component of the cellular response to genotoxic stress.  Thus, induction of G1 arrest in response to DNA damage is minimally a two step process: a fast p53-independent initiation of G1 arrest mediated by cyclin D1 proteolysis and a slower maintenance of arrest resulting from increased p53 stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrujLpuNeU2z7Vg90H21EOLACvtfcHk0ljICCfDM5j5yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr8%253D&md5=949036323a3674e4a92bd2062d8c4b94</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900010-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900010-6%26sid%3Dliteratum%253Aachs%26aulast%3DAgami%26aufirst%3DR.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DDistinct%2520initiation%2520and%2520maintenance%2520mechanisms%2520cooperate%2520to%2520induce%2520G1%2520cell%2520cycle%2520arrest%2520in%2520response%2520to%2520DNA%2520damage%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D55%26epage%3D66%26doi%3D10.1016%2FS0092-8674%2800%2900010-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span> <span> </span><span class="NLM_article-title">The design strategy of selective PTP1B inhibitors over TCPTP</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3343</span>– <span class="NLM_lpage">3352</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.bmc.2016.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=27353889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3343-3352&author=X.+Liauthor=L.+Wangauthor=D.+Shi&title=The+design+strategy+of+selective+PTP1B+inhibitors+over+TCPTP&doi=10.1016%2Fj.bmc.2016.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The design strategy of selective PTP1B inhibitors over TCPTP</span></div><div class="casAuthors">Li, XiangQian; Wang, LiJun; Shi, DaYong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3343-3352</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) has already been well studied as a highly validated therapeutic target for diabetes and obesity.  However, the lack of selectivity limited further studies and clin. applications of PTP1B inhibitors, esp. over T-cell protein tyrosine phosphatase (TCPTP).  In this review, we enumerate the published specific inhibitors of PTP1B, discuss the structure-activity relationships by anal. of their X-ray structures or docking results, and summarize the characteristic of selectivity related residues and groups.  Furthermore, the design strategy of selective PTP1B inhibitors over TCPTP is also proposed.  We hope our work could provide an effective way to gain specific PTP1B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru3UMERwaHirVg90H21EOLACvtfcHk0ljICCfDM5j5yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnt7nI&md5=d980fa1e807b115676652a702a2792c0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DD.%26atitle%3DThe%2520design%2520strategy%2520of%2520selective%2520PTP1B%2520inhibitors%2520over%2520TCPTP%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3343%26epage%3D3352%26doi%3D10.1016%2Fj.bmc.2016.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer</span>. <i>Oral Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.oraloncology.2018.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.oraloncology.2018.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29496059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=56-63&author=M.+W.+Hanauthor=I.+S.+Ryuauthor=J.+C.+Leeauthor=S.+H.+Kimauthor=H.+W.+Changauthor=Y.+S.+Leeauthor=S.+Leeauthor=S.+W.+Kimauthor=S.+Y.+Kim&title=Phosphorylation+of+PI3K+regulatory+subunit+p85+contributes+to+resistance+against+PI3K+inhibitors+in+radioresistant+head+and+neck+cancer&doi=10.1016%2Fj.oraloncology.2018.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer</span></div><div class="casAuthors">Han, Myung Woul; Ryu, In Sun; Lee, Jong Cheol; Kim, Song Hee; Chang, Hyo Won; Lee, Yoon Sun; Lee, Seulkina; Kim, Seong Who; Kim, Sang Yoon</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Objectives: PI3K/Akt/mTOR pathway is commonly activated in most cancers and is correlated with resistance to anticancer therapies such as radiotherapy.  Therefore, PI3K is an attractive target for treating PI3K-assocd. cancers.  Material and Methods: We investigated the basal expression and the expression after treatment of PI3K inhibitor or Src inhibitor of PI3K/Akt pathway-related proteins in AMC-HN3, AMC-HN3R, HN30 and HN31 cells by performing immunoblotting anal.  The sensitivity to PI3K inhibitors or Src inhibitor was analyzed by MTT assay and clonogenic assay.  To det. the antitumoral activity of combination treatment with PI3K inhibitor and Src inhibitor, we used using xenograft mouse model.  Results: We found that PI3K regulatory subunit p85 was predominantly phosphorylated in radioresistant head and neck cancer cell line (HN31), which showed resistance to PI3K inhibitors.  Next, we investigated mechanism through which PI3K p85 phosphorylation modulated response to PI3K inhibitors.  Of note, constitutive activation of Src was found in HN31 cells and upon PI3K inhibitor treatment, restoration of p-Src was occurred.  Src inhibitor improved the efficacy of PI3K inhibitor treatment and suppressed the reactivation of both Src and PI3K p85 in HN31 cells.  Furthermore, downregulation of PI3K p85 expression by using a specific siRNA suppressed Src phosphorylation.  Conclusions: Together, our results imply the novel role of the PI3K regulatory subunit p85 in the development of resistance to PI3K inhibitors and suggest the presence of a regulatory loop between PI3K p85 and Src in radioresistant head and neck cancers with constitutively active PI3K/Akt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA8G__vi1cCbVg90H21EOLACvtfcHk0ljICCfDM5j5yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKju70%253D&md5=2d6cbc76681230cd71830f67f3db7516</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2018.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DM.%2BW.%26aulast%3DRyu%26aufirst%3DI.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DChang%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BY.%26atitle%3DPhosphorylation%2520of%2520PI3K%2520regulatory%2520subunit%2520p85%2520contributes%2520to%2520resistance%2520against%2520PI3K%2520inhibitors%2520in%2520radioresistant%2520head%2520and%2520neck%2520cancer%26jtitle%3DOral%2520Oncol.%26date%3D2018%26volume%3D78%26spage%3D56%26epage%3D63%26doi%3D10.1016%2Fj.oraloncology.2018.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollu, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazumdar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. H.</span></span> <span> </span><span class="NLM_article-title">Molecular pathways: targeting protein tyrosine phosphatases in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2136</span>– <span class="NLM_lpage">2142</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-0934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1158%2F1078-0432.CCR-16-0934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=28087641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFegtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=2136-2142&author=L.+R.+Bolluauthor=A.+Mazumdarauthor=M.+I.+Savageauthor=P.+H.+Brown&title=Molecular+pathways%3A+targeting+protein+tyrosine+phosphatases+in+cancer&doi=10.1158%2F1078-0432.CCR-16-0934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer</span></div><div class="casAuthors">Bollu, Lakshmi Reddy; Mazumdar, Abhijit; Savage, Michelle I.; Brown, Powel H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2136-2142</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The aberrant activation of oncogenic signaling pathways is a universal phenomenon in cancer and drives tumorigenesis and malignant transformation.  This abnormal activation of signaling pathways in cancer is due to the altered expression of protein kinases and phosphatases.  In response to extracellular signals, protein kinases activate downstream signaling pathways through a series of protein phosphorylation events, ultimately producing a signal response.  Protein tyrosine phosphatases (PTP) are a family of enzymes that hydrolytically remove phosphate groups from proteins.  Initially, PTPs were shown to act as tumor suppressor genes by terminating signal responses through the dephosphorylation of oncogenic kinases.  More recently, it has become clear that several PTPs overexpressed in human cancers do not suppress tumor growth; instead, they pos. regulate signaling pathways and promote tumor development and progression.  In this review, we discuss both types of PTPs: those that have tumor suppressor activities as well as those that act as oncogenes.  We also discuss the potential of PTP inhibitors for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHYatwDwEqM7Vg90H21EOLACvtfcHk0lgb62bteACh0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFegtLY%253D&md5=d35515e2f4934c3deb3255f14af59576</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-0934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-0934%26sid%3Dliteratum%253Aachs%26aulast%3DBollu%26aufirst%3DL.%2BR.%26aulast%3DMazumdar%26aufirst%3DA.%26aulast%3DSavage%26aufirst%3DM.%2BI.%26aulast%3DBrown%26aufirst%3DP.%2BH.%26atitle%3DMolecular%2520pathways%253A%2520targeting%2520protein%2520tyrosine%2520phosphatases%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D2136%26epage%3D2142%26doi%3D10.1158%2F1078-0432.CCR-16-0934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szczepankiewicz, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubben, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirousek, M. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">4087</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1021/ja0296733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0296733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=4087-4096&author=B.+G.+Szczepankiewiczauthor=G.+Liuauthor=P.+J.+Hajdukauthor=C.+Abad-Zapateroauthor=Z.+Peiauthor=Z.+Xinauthor=T.+H.+Lubbenauthor=J.+M.+Trevillyanauthor=M.+A.+Stashkoauthor=S.+J.+Ballaronauthor=H.+Liangauthor=F.+Huangauthor=C.+W.+Hutchinsauthor=S.+W.+Fesikauthor=M.+R.+Jirousek&title=Discovery+of+a+potent%2C+selective+protein+tyrosine+phosphatase+1B+inhibitor+using+a+linked-fragment+strategy&doi=10.1021%2Fja0296733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy</span></div><div class="casAuthors">Szczepankiewicz, Bruce G.; Liu, Gang; Hajduk, Philip J.; Abad-Zapatero, Cele; Pei, Zhonghua; Xin, Zhili; Lubben, Thomas H.; Trevillyan, James M.; Stashko, Michael A.; Ballaron, Stephen J.; Liang, Heng; Huang, Flora; Hutchins, Charles W.; Fesik, Stephen W.; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4087-4096</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is an enzyme that downregulates the insulin receptor.  Inhibition of PTP1B is expected to improve insulin action, and the design of small mol. PTP1B inhibitors to treat type II diabetes has received considerable attention.  In this work, NMR-based screening identified a nonselective competitive inhibitor of PTP1B.  A second site ligand was also identified by NMR-based screening and then linked to the catalytic site ligand by rational design. X-ray data confirmed that the inhibitor bound with the catalytic site in the native, "open" conformation.  The final compd. displayed excellent potency and good selectivity over many other phosphatases.  The modular approach to drug design described in this work should be applicable for the design of potent and selective inhibitors of other therapeutically relevant protein tyrosine phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAUdjzxyGdkrVg90H21EOLACvtfcHk0lgb62bteACh0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D&md5=ff294c94485d4aa4c7a890b018218c84</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja0296733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0296733%26sid%3Dliteratum%253Aachs%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DLubben%26aufirst%3DT.%2BH.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitor%2520using%2520a%2520linked-fragment%2520strategy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D4087%26epage%3D4096%26doi%3D10.1021%2Fja0296733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>205</i></span>, <span class="NLM_elocation-id">112648</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.ejmech.2020.112648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=32791401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsF2qtLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2020&author=D.+Yaoauthor=C.+Liauthor=J.+Jiangauthor=J.+Huangauthor=J.+Wangauthor=Z.+Heauthor=J.+Zhang&title=Design%2C+synthesis+and+biological+evaluation+of+novel+HDAC+inhibitors+with+improved+pharmacokinetic+profile+in+breast+cancer&doi=10.1016%2Fj.ejmech.2020.112648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer</span></div><div class="casAuthors">Yao, Dahong; Li, Chenyang; Jiang, Jin; Huang, Jian; Wang, Jinhui; He, Zhendan; Zhang, Jin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112648</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The dysfunction of histone deacetylase (HDACs) is closely related to tumorigenesis and development, which has been emerged as an attractive drug design target for cancer therapy.  In the present study, a series of novel HDAC inhibitors using a substituted quinazoline as the capping group and attaching 3,5-dimethylbenyl as a potential metabolic site protector have been designed and synthesized.  Compds. I and II demonstrated potent HDAC inhibitory activities and anti-proliferative effects against MDA-MB-231 cells.  In addn., I and II both could significantly increase the acetylation level of intracellular proteins, esp. in α-Tubulin and HSP90.  Compds. I and II displayed a slight different anti-tumor mechanism, I mainly induced apoptosis while II induced obviously ER-Stress.  Furthermore, I and II both induced autophagy and migration inhibition.  In pharmacokinetics assay, I showed a significant improvement of pharmacokinetic profile for oral administration.  Addnl., I presented more potent anti-proliferation and anti-migration activity than SAHA in zebrafish MDA-MB-231 cell line-derived xenograft model.  Together, these results demonstrate that I is a novel oral HDAC inhibitor with a potential capacity of treating breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpumrKnEFMqmbVg90H21EOLACvtfcHk0lgb62bteACh0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsF2qtLzM&md5=277eeeb1f89c2ccc459770cf99106d68</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112648%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520HDAC%2520inhibitors%2520with%2520improved%2520pharmacokinetic%2520profile%2520in%2520breast%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D205%26doi%3D10.1016%2Fj.ejmech.2020.112648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and retrosynthetic analysis of jamunones <b>1</b>–<b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Completion of Syntheses of Jamunones (<b>1</b>, <b>5</b>, <b>9</b>, <b>13</b>) and JBs (<b>1a</b>–<b>c</b>, <b>5a</b>–<b>c</b>, <b>9a</b>–<b>f</b>, <b>13a</b>–<b>c</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (I) Ac<sub>2</sub>O, BF<sub>3</sub>-OEt<sub>2</sub>, AcOH, 100 °C, 6 h; (II) NaH, TBSCl/bromomethyl methyl ether (MOMBr), THF, 0 °C, 3 h; (III) lithium aluminum hydride (LAH), THF, 0 °C, 3 h; (IV) Dess–Martin periodinane (DMP), dichloromethane (DCM), 0 °C, 3 h; (V) LDA, THF, −78 °C, 12 h; (VI) TBAF, THF, room temperature (rt), 1 h; (VII) HCl/MeOH, 65 °C, 12 h; (VIII) TFA, DCM, 0 °C, 3 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Completion of Syntheses of Jamunones (<b>2</b>–<b>4</b>, <b>6–8</b>, <b>10</b>–<b>12</b>, <b>14–16</b>) and JBs (<b>2a</b> to <b>4a</b>, <b>2b</b> to <b>4b</b>, <b>6a</b> to <b>8a</b>, <b>6b</b> to <b>8b</b>, <b>10a</b> to <b>12a</b>, <b>10b</b> to <b>12b</b>, <b>14a</b> to <b>16a</b>, <b>14b</b> to <b>16b</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (I) POCl<sub>3</sub>, <i>N</i>,<i>N</i>-dimethylformamide (DMF), 1,4-dioxane, 0 to 25 °C, 3 h; (II) NaBH<sub>3</sub>CN, HCl, THF, 0 to 25 °C, 12 h; (III) Ac<sub>2</sub>O, BF<sub>3</sub>-OEt<sub>2</sub>, AcOH, 100 °C, 3 h; (IV) NaH, TBSCl, THF, 0 °C, 2 h; (V) LAH, THF, 0 °C, 3 h; (VI) DMP, DCM, 0 °C, 3 h; (VII) LDA, THF, −78 °C, 12 h; (VIII) TBAF, THF, 0 °C, 1 h; (IX) TFA, DCM, 0 °C, 3 h; (X) HCl/MeOH, 65 °C, 12 h.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Primary structure–activity relationships of JBs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative bar graph illustrating the IC<sub>50</sub> and SI values. (A) IC<sub>50</sub> values of JM across a panel of cancer cell lines and two normal cell lines. (B) The SI values of JM and DOX (the ratio of IC<sub>50</sub> value of normal cells to BC cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. JM-induced BC cell apoptosis. (A, C) Apoptotic BC cells were analyzed with Annexin V-FITC/PI double staining in JM-treated BC cells. (B, D) Quantitative analysis of apoptosis rates by flow cytometry. ***<i>p</i> < 0.001 <i>vs</i> control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of JM on MMP. (A) Fluorescence distribution in JM-treated BC cells for 24 h was observed under a fluorescence microscope. (B) Quantitative analysis of the mitochondrial membrane potential of BC cells. ***<i>p</i> < 0.001 <i>vs</i> control. (C, D) Changes of MMP level in BC cells were detected by flow cytometry analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. JM-caused G0/G1 phase arrest of BC cells. (A, C) Cell cycle distribution was analyzed by flow cytometry in BC cells treated with or without JM. (B, D) Statistical analysis of the cell cycle distribution of BC cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of JM and UA on the expression of PTP1B protein. (A, B) Analysis of expression levels and relative quantities of PTP1B protein in BC cells determined by western blotting. **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 <i>vs</i> control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding mode of JM (A–C) and UA (D–F) to the active site of PTP1B. (A, D) Surface views of UA and JM with PTP1B. (B, E) Hydrogen-bond interactions of UA and JM with key amino acid residues. (C, F) Detailed interactions of UA and JM with key residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of JM on PI3K/Akt signaling pathway. (A, D) Protein expressions of PI3K, p-PI3K, Akt, and p-Akt detected by western blotting in BC cells treated with various concentrations of JM. (B, C, E, F) Analysis of relative quantities of PI3K, p-PI3K, Akt, and p-Akt in BC cells. ***<i>p</i> < 0.001 <i>vs</i> Con.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/medium/jm1c00085_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antitumor activity of JM in mice bearing MDA-MB-231 xenograft. (A) Tumor volume of the mice was monitored during the experimental period. (B) Photographs of stripped tumors from each group. (C) Average tumor weights and inhibition rates measured after the mice were sacrificed. (D) Variation of mice body weight throughout the experiment. (E) Expression levels of PTP1B, Bcl-2, Bax, cleaved caspase-3, cleaved PARP, cyclin D3, cyclin E1, and p21 proteins in xenograft tumors analyzed by western blotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00085/20210506/images/large/jm1c00085_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00085&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeSantis, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lortet-Tieulent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">International variation in female breast cancer incidence and mortality rates</span>. <i>Cancer Epidemiol., Biomarkers Prev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1495</span>– <span class="NLM_lpage">1506</span>, <span class="refDoi"> DOI: 10.1158/1055-9965.EPI-15-0535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1158%2F1055-9965.EPI-15-0535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=26359465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BC283htFekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1495-1506&author=C.+E.+DeSantisauthor=F.+Brayauthor=J.+Ferlayauthor=J.+Lortet-Tieulentauthor=B.+O.+Andersonauthor=A.+Jemal&title=International+variation+in+female+breast+cancer+incidence+and+mortality+rates&doi=10.1158%2F1055-9965.EPI-15-0535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International Variation in Female Breast Cancer Incidence and Mortality Rates</span></div><div class="casAuthors">DeSantis Carol E; Lortet-Tieulent Joannie; Jemal Ahmedin; Bray Freddie; Ferlay Jacques; Anderson Benjamin O</div><div class="citationInfo"><span class="NLM_cas:title">Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1495-506</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death among women worldwide.  Herein, we examine global trends in female breast cancer rates using the most up-to-date data available.  METHODS:  Breast cancer incidence and mortality estimates were obtained from GLOBOCAN 2012 (globocan.iarc.fr).  We analyzed trends from 1993 onward using incidence data from 39 countries from the International Agency for Research on Cancer and mortality data from 57 countries from the World Health Organization.  RESULTS:  Of 32 countries with incidence and mortality data, rates in the recent period diverged-with incidence increasing and mortality decreasing-in nine countries mainly in Northern/Western Europe.  Both incidence and mortality decreased in France, Israel, Italy, Norway, and Spain.  In contrast, incidence and death rates both increased in Colombia, Ecuador, and Japan.  Death rates also increased in Brazil, Egypt, Guatemala, Kuwait, Mauritius, Mexico, and Moldova.  CONCLUSIONS:  Breast cancer mortality rates are decreasing in most high-income countries, despite increasing or stable incidence rates.  In contrast and of concern are the increasing incidence and mortality rates in a number of countries, particularly those undergoing rapid changes in human development.  Wide variations in breast cancer rates and trends reflect differences in patterns of risk factors and access to and availability of early detection and timely treatment.  IMPACT:  Increased awareness about breast cancer and the benefits of early detection and improved access to treatment must be prioritized to successfully implement breast cancer control programs, particularly in transitioning countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJEbxh97K6Vt6fW6udTcc2ebnRuEamQipqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFekuw%253D%253D&md5=acbc8a0af01c7bf93e7af30991debbff</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1158%2F1055-9965.EPI-15-0535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1055-9965.EPI-15-0535%26sid%3Dliteratum%253Aachs%26aulast%3DDeSantis%26aufirst%3DC.%2BE.%26aulast%3DBray%26aufirst%3DF.%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DLortet-Tieulent%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DB.%2BO.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DInternational%2520variation%2520in%2520female%2520breast%2520cancer%2520incidence%2520and%2520mortality%2520rates%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2015%26volume%3D24%26spage%3D1495%26epage%3D1506%26doi%3D10.1158%2F1055-9965.EPI-15-0535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibshirani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisen, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matese, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonning, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borresen-Dale, A. L.</span></span> <span> </span><span class="NLM_article-title">Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10869</span>– <span class="NLM_lpage">10874</span>, <span class="refDoi"> DOI: 10.1073/pnas.191367098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1073%2Fpnas.191367098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=11553815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVGmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10869-10874&author=T.+Sorlieauthor=C.+M.+Perouauthor=R.+Tibshiraniauthor=T.+Aasauthor=S.+Geislerauthor=H.+Johnsenauthor=T.+Hastieauthor=M.+B.+Eisenauthor=M.+van+de%0ARijnauthor=S.+S.+Jeffreyauthor=T.+Thorsenauthor=H.+Quistauthor=J.+C.+Mateseauthor=P.+O.+Brownauthor=D.+Botsteinauthor=P.+E.+Lonningauthor=A.+L.+Borresen-Dale&title=Gene+expression+patterns+of+breast+carcinomas+distinguish+tumor+subclasses+with+clinical+implications&doi=10.1073%2Fpnas.191367098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications</span></div><div class="casAuthors">Sorlie, Therese; Perou, Charles M.; Tibshirani, Robert; Aas, Turid; Geisler, Stephanie; Johnsen, Hilde; Hastie, Trevor; Eisen, Michael B.; Van de Rijn, Matt; Jeffrey, Stefanie S.; Thorsen, Thor; Quist, Hanne; Matese, John C.; Brown, Patrick O.; Botstein, David; Lonning, Per Eystein; Borresen-Dale, Anne-Lise</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10869-10874</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The purpose of this study was to classify breast carcinomas based on variations in gene expression patterns derived from cDNA microarrays and to correlate tumor characteristics to clin. outcome.  A total of 85 cDNA microarray expts. representing 78 cancers, three fibroadenomas, and four normal breast tissues were analyzed by hierarchical clustering.  As reported previously, the cancers could be classified into a basal epithelial-like group, an ERBB2-overexpressing group and a normal breast-like group based on variations in gene expression.  A novel finding was that the previously characterized luminal epithelial/estrogen receptor-pos. group could be divided into at least two subgroups, each with a distinctive expression profile.  These subtypes proved to be reasonably robust by clustering using two different gene sets: first, a set of 456 cDNA clones previously selected to reflect intrinsic properties of the tumors and, second, a gene set that highly correlated with patient outcome.  Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-pos. groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFAw_CL6SrMrVg90H21EOLACvtfcHk0livFgusPUuxvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVGmsbo%253D&md5=5a54045e69bbc92a5294eb5e73934bd7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.191367098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.191367098%26sid%3Dliteratum%253Aachs%26aulast%3DSorlie%26aufirst%3DT.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DTibshirani%26aufirst%3DR.%26aulast%3DAas%26aufirst%3DT.%26aulast%3DGeisler%26aufirst%3DS.%26aulast%3DJohnsen%26aufirst%3DH.%26aulast%3DHastie%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DThorsen%26aufirst%3DT.%26aulast%3DQuist%26aufirst%3DH.%26aulast%3DMatese%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DLonning%26aufirst%3DP.%2BE.%26aulast%3DBorresen-Dale%26aufirst%3DA.%2BL.%26atitle%3DGene%2520expression%2520patterns%2520of%2520breast%2520carcinomas%2520distinguish%2520tumor%2520subclasses%2520with%2520clinical%2520implications%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D10869%26epage%3D10874%26doi%3D10.1073%2Fpnas.191367098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisen, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akslen, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fluge, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergamenschikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lønning, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Børresen-Dale, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botstein, D.</span></span> <span> </span><span class="NLM_article-title">Molecular portraits of human breast tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1038/35021093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2F35021093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10963602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=747-752&author=C.+M.+Perouauthor=T.+Sorlieauthor=M.+B.+Eisenauthor=M.+van+de%0ARijnauthor=S.+S.+Jeffreyauthor=C.+A.+Reesauthor=J.+R.+Pollackauthor=D.+T.+Rossauthor=H.+Johnsenauthor=L.+A.+Akslenauthor=O.+Flugeauthor=A.+Pergamenschikovauthor=C.+Williamsauthor=S.+X.+Zhuauthor=P.+E.+L%C3%B8nningauthor=A.+L.+B%C3%B8rresen-Daleauthor=P.+O.+Brownauthor=D.+Botstein&title=Molecular+portraits+of+human+breast+tumours&doi=10.1038%2F35021093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular portraits of human breast tumors</span></div><div class="casAuthors">Perou, Charles M.; Serlie, Therese; Eisen, Michael B.; Van De Rijn, Matt; Jeffrey, Stefanie S.; Rees, Christian A.; Pollack, Jonathan R.; Rossi, Douglas T.; Johnsen, Hilde; Akslen, Lars A.; Fluge, Oystein; Pergamenschikov, Alexander; Williams, Cheryl; Zhu, Shirley X.; Lenning, Per E.; Berresen-Dale, Anne-Use; Brown, Patrick O.; Botstein, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6797</span>),
    <span class="NLM_cas:pages">747-752</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human breast tumors are diverse in their natural history and in their responsiveness to treatments.  Variation in transcriptional programs accounts for much of the biol. diversity of human cells and tumors.  In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome.  Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumors from 42 different individuals, using cDNA microarrays representing 8102 human genes.  These patterns provided a distinctive mol. portrait of each tumor.  Twenty of the tumors were sampled twice, before and after a 16-wk course of doxorubicin chemotherapy, and two tumors were paired with a lymph node metastasis from the same patient.  Gene expression patterns in two tumor samples from the same individual were almost always more similar to each other than either was to any other sample.  Sets of co-expressed genes were identified for which variation in mRNA levels could be related to specific features of physiol. variation.  The tumors could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorYsVvqq_EyLVg90H21EOLACvtfcHk0livFgusPUuxvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D&md5=f81e9b3e3d5e339ea463428b1c973f8d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F35021093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35021093%26sid%3Dliteratum%253Aachs%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DSorlie%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DRees%26aufirst%3DC.%2BA.%26aulast%3DPollack%26aufirst%3DJ.%2BR.%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DJohnsen%26aufirst%3DH.%26aulast%3DAkslen%26aufirst%3DL.%2BA.%26aulast%3DFluge%26aufirst%3DO.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DS.%2BX.%26aulast%3DL%25C3%25B8nning%26aufirst%3DP.%2BE.%26aulast%3DB%25C3%25B8rresen-Dale%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DBotstein%26aufirst%3DD.%26atitle%3DMolecular%2520portraits%2520of%2520human%2520breast%2520tumours%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D747%26epage%3D752%26doi%3D10.1038%2F35021093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polyak, K.</span></span> <span> </span><span class="NLM_article-title">Heterogeneity in breast cancer</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">3786</span>– <span class="NLM_lpage">3788</span>, <span class="refDoi"> DOI: 10.1172/JCI60534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1172%2FJCI60534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=21965334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12ht7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=3786-3788&author=K.+Polyak&title=Heterogeneity+in+breast+cancer&doi=10.1172%2FJCI60534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneity in breast cancer</span></div><div class="casAuthors">Polyak, Kornelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3786-3788</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Breast cancer is a heterogeneous disease.  There is a high degree of diversity between and within tumors as well as among cancer-bearing individuals, and all of these factors together det. the risk of disease progression and therapeutic resistance.  Advances in technologies such as whole-genome sequencing and functional viability screens now allow us to analyze tumors at unprecedented depths.  However, translating this increasing knowledge into clin. practice remains a challenge in part due to tumor evolution driven by the diversity of cancer cell populations and their microenvironment.  The articles in this Review series discuss recent advances in our understanding of breast tumor heterogeneity, therapies tailored based on this knowledge, and future ways of assessing and treating heterogeneous tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtmFGt9inzXrVg90H21EOLACvtfcHk0liRlc1VzVTU-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12ht7vP&md5=df8082e7d6dda725d6c23569da5ea065</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1172%2FJCI60534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI60534%26sid%3Dliteratum%253Aachs%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DHeterogeneity%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D3786%26epage%3D3788%26doi%3D10.1172%2FJCI60534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, R. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradishar, W. J.</span></span> <span> </span><span class="NLM_article-title">Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1007/s10549-018-4697-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1007%2Fs10549-018-4697-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29417298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVygsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2018&pages=397-406&author=R.+L.+B.+Costaauthor=H.+S.+Hanauthor=W.+J.+Gradishar&title=Targeting+the+PI3K%2FAKT%2FmTOR+pathway+in+triple-negative+breast+cancer%3A+a+review&doi=10.1007%2Fs10549-018-4697-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review</span></div><div class="casAuthors">Costa, Ricardo L. B.; Han, Hyo Sook; Gradishar, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Triple-neg. breast cancer (TNBC) accounts for approx. 20% of breast cancer cases.  Although there have been advances in the treatment of hormone receptor-pos. and human epidermal growth factor receptor 2-pos. breast cancers, targeted therapies for TNBC remain unavailable.  In this narrative review, we summarize recent discoveries related to the underlying biol. of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) pathway in TNBC, examine clin. progress to date, and suggest rational future approaches for investigational therapies in TNBC.  Results: As with other subtypes of breast cancer, aberrations in the PI3K/AKT/mTOR pathway are common in TNBC.  Preclin. data support the notion that these aberrations predict TNBC inhibition by targeted agents.  In a recently published phase 2 clin. trial, an AKT inhibitor (ipatasertib) improved outcomes in a subset of patients with metastatic TNBC when combined with paclitaxel in the first-line setting.  In addn., new compds. with distinct specificity and potency targeting different PI3K/AKT/mTOR components and cognate mols. (e.g., mitogen-activated protein kinase) are being developed.  These agents present a wide range of toxicity profiles and early efficacy signals, which must be considered prior to the advancement of new agents in later-phase clin. trials.  Conclusions: The development of drugs targeting the PI3K/AKT/mTOR pathway for the treatment of TNBC is an evolving field that should take into account the efficacies and toxicities of new agents in addn. to their interactions with different cancer pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_aSITy3SaC7Vg90H21EOLACvtfcHk0liRlc1VzVTU-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVygsL8%253D&md5=2b79ebda8f1037d8aab960b9a8dafff6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs10549-018-4697-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-018-4697-y%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DR.%2BL.%2BB.%26aulast%3DHan%26aufirst%3DH.%2BS.%26aulast%3DGradishar%26aufirst%3DW.%2BJ.%26atitle%3DTargeting%2520the%2520PI3K%252FAKT%252FmTOR%2520pathway%2520in%2520triple-negative%2520breast%2520cancer%253A%2520a%2520review%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2018%26volume%3D169%26spage%3D397%26epage%3D406%26doi%3D10.1007%2Fs10549-018-4697-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarthy, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyr, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietenpol, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">2750</span>– <span class="NLM_lpage">2767</span>, <span class="refDoi"> DOI: 10.1172/JCI45014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1172%2FJCI45014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=21633166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=2750-2767&author=B.+D.+Lehmannauthor=J.+A.+Bauerauthor=X.+Chenauthor=M.+E.+Sandersauthor=A.+B.+Chakravarthyauthor=Y.+Shyrauthor=J.+A.+Pietenpol&title=Identification+of+human+triple-negative+breast+cancer+subtypes+and+preclinical+models+for+selection+of+targeted+therapies&doi=10.1172%2FJCI45014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies</span></div><div class="casAuthors">Lehmann, Brian D.; Bauer, Joshua A.; Chen, Xi; Sanders, Melinda E.; Chakravarthy, A. Bapsi; Shyr, Yu; Pietenpol, Jennifer A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2750-2767</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a highly diverse group of cancers, and subtyping is necessary to better identify mol.-based therapies.  In this study, we analyzed gene expression (GE) profiles from 21 breast cancer data sets and identified 587 TNBC cases.  Cluster anal. identified 6 TNBC subtypes displaying unique GE and ontologies, including 2 basal-like (BL1 and BL2), an immunomodulatory (IM), a mesenchymal (M), a mesenchymal stem-like (MSL), and a luminal androgen receptor (LAR) subtype.  Further, GE anal. allowed us to identify TNBC cell line models representative of these subtypes.  Predicted "driver" signaling pathways were pharmacol. targeted in these cell line models as proof of concept that anal. of distinct GE signatures can inform therapy selection.  BL1 and BL2 subtypes had higher expression of cell cycle and DNA damage response genes, and representative cell lines preferentially responded to cisplatin.  M and MSL subtypes were enriched in GE for epithelial-mesenchymal transition, and growth factor pathways and cell models responded to NVP-BEZ235 (a PI3K/mTOR inhibitor) and dasatinib (an abl/src inhibitor).  The LAR subtype includes patients with decreased relapse-free survival and was characterized by androgen receptor (AR) signaling.  LAR cell lines were uniquely sensitive to bicalutamide (an AR antagonist).  These data may be useful in biomarker selection, drug discovery, and clin. trial design that will enable alignment of TNBC patients to appropriate targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbhoQQUFogW7Vg90H21EOLACvtfcHk0liRlc1VzVTU-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVKgu78%253D&md5=c3681c79e0b972f16f6d5a5ecdc99fec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI45014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45014%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DB.%2BD.%26aulast%3DBauer%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DChakravarthy%26aufirst%3DA.%2BB.%26aulast%3DShyr%26aufirst%3DY.%26aulast%3DPietenpol%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520human%2520triple-negative%2520breast%2520cancer%2520subtypes%2520and%2520preclinical%2520models%2520for%2520selection%2520of%2520targeted%2520therapies%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D2750%26epage%3D2767%26doi%3D10.1172%2FJCI45014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anders, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, L. A.</span></span> <span> </span><span class="NLM_article-title">Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer</span>. <i>Clin. Breast Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">S73</span>– <span class="NLM_lpage">S81</span>, <span class="refDoi"> DOI: 10.3816/CBC.2009.s.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.3816%2FCBC.2009.s.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19596646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlWgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=S73-S81&author=C.+K.+Andersauthor=L.+A.+Carey&title=Biology%2C+metastatic+patterns%2C+and+treatment+of+patients+with+triple-negative+breast+cancer&doi=10.3816%2FCBC.2009.s.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer</span></div><div class="casAuthors">Anders, Carey K.; Carey, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Breast Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S73-S81</span>CODEN:
                <span class="NLM_cas:coden">CBCLB7</span>;
        ISSN:<span class="NLM_cas:issn">1526-8209</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group, LP</span>)
        </div><div class="casAbstract">A review.  Of the estd. 1 million cases of breast cancer diagnosed annually worldwide, it is estd. that over 170,000 will harbor the triple-neg. (estrogen receptor/progesterone receptor/HER2-neg.) phenotype.  Most, though not all, triple-neg. breast cancers will be basal-like on gene expression microarrays.  The basal-like mol. subtype exhibits a unique mol. profile and set of risk factors, aggressive and early pattern of metastasis, limited treatment options, and poor prognosis.  Large population-based studies have identified a higher proportion of triple-neg. breast tumors among premenopausal African American women, and a suggestion that increased parity, younger age at first-term pregnancy, shorter duration of breast feeding, and elevated hip-to-waist ratio might be particular risk factors.  When BRCA1 mutation carriers develop breast cancer, it is usually basal-like; given the central role of BRCA1 in DNA repair, this could have profound therapeutic implications.  When diagnosed, triple-neg. breast cancers illustrate preferential relapse in visceral organs, including the central nervous system.  Although initial response to chemotherapy might be more profound, relapse is early and common among triple-neg. breast cancers compared with luminal breast cancers.  The armamentarium of "targeted therapeutics" for triple-neg. breast cancer is evolving and includes strategies to inhibit angiogenesis, epidermal growth factor receptor, and other kinases.  Finally, the pos. assocn. between triple-neg. breast cancer and BRCA mutations makes inhibition of poly(ADP-ribose) polymerase-1 an attractive therapeutic strategy that is in active study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbA5DSLInPtLVg90H21EOLACvtfcHk0ljFLnXgMpPYQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlWgt7w%253D&md5=2e95f61ee46bd7b3fb6cc27c66299cd7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3816%2FCBC.2009.s.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCBC.2009.s.008%26sid%3Dliteratum%253Aachs%26aulast%3DAnders%26aufirst%3DC.%2BK.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26atitle%3DBiology%252C%2520metastatic%2520patterns%252C%2520and%2520treatment%2520of%2520patients%2520with%2520triple-negative%2520breast%2520cancer%26jtitle%3DClin.%2520Breast%2520Cancer%26date%3D2009%26volume%3D9%26spage%3DS73%26epage%3DS81%26doi%3D10.3816%2FCBC.2009.s.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garimella, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowitz, S.</span></span> <span> </span><span class="NLM_article-title">Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer</span>. <i>Breast Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/BD-2010-0307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.3233%2FBD-2010-0307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=35-48&author=K.+J.+Chavezauthor=S.+V.+Garimellaauthor=S.+Lipkowitz&title=Triple+negative+breast+cancer+cell+lines%3A+one+tool+in+the+search+for+better+treatment+of+triple+negative+breast+cancer&doi=10.3233%2FBD-2010-0307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3233%2FBD-2010-0307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FBD-2010-0307%26sid%3Dliteratum%253Aachs%26aulast%3DChavez%26aufirst%3DK.%2BJ.%26aulast%3DGarimella%26aufirst%3DS.%2BV.%26aulast%3DLipkowitz%26aufirst%3DS.%26atitle%3DTriple%2520negative%2520breast%2520cancer%2520cell%2520lines%253A%2520one%2520tool%2520in%2520the%2520search%2520for%2520better%2520treatment%2520of%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DBreast%2520Dis.%26date%3D2011%26volume%3D32%26spage%3D35%26epage%3D48%26doi%3D10.3233%2FBD-2010-0307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. W.</span></span> <span> </span><span class="NLM_article-title">Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2018.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.intimp.2018.09.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=30342344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFCgsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2018&pages=279-283&author=W.+H.+Wangauthor=H.+Y.+Xuauthor=Z.+M.+Zhaoauthor=G.+M.+Zhangauthor=F.+W.+Lin&title=Dynamic+and+significant+changes+of+T-cell+subgroups+in+breast+cancer+patients+during+surgery+and+chemotherapy&doi=10.1016%2Fj.intimp.2018.09.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy</span></div><div class="casAuthors">Wang, Wen-Hui; Xu, Hong-Yan; Zhao, Zhong-Min; Zhang, Guang-Mei; Lin, Feng-Wu</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-283</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer and its surgical treatment and chemotherapy have great impact on the immune system.  This study aimed to monitor the various T cells in breast cancer patients and evaluate the immune functions.  The percentages of the CD3+, CD4+, CD8+, CD45RA+, and CD45RO+ T cells were measured using flow cytometry.  Another 200 healthy women were used as control.  The percentages of CD45RO+ T cells and CD4+CD25+ (Treg) cells were significantly higher in stage II/III malignancies vs. stage I, and was significantly higher in stage I malignancies vs. the normal control (P < 0.05).  The preoperative percentages of CD3+ and CD4+ T cells were significantly reduced after 3 cycles and after 6 cycles of chemotherapy (P < 0.05).  In patients with stage II/III malignancies, there was a higher percentage of CD45RO+ T cells than CD45RA+ T cells, which was reversed after surgery.  After 6 chemotherapy cycles, the percentage of Treg cells was significantly reduced in comparison with that before the chemotherapy in the patients with stage II/III malignancies.  Patients with breast cancer had significantly suppressed immune functions.  Surgical removal of the tumor may improve the immune functions.  Chemotherapy significantly reduced the percentages of CD3+ and CD4+ T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTCUWE3IxqFrVg90H21EOLACvtfcHk0ljFLnXgMpPYQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFCgsrjN&md5=42a37c189558e12fe64a1b4e640723c8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2018.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2018.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BH.%26aulast%3DXu%26aufirst%3DH.%2BY.%26aulast%3DZhao%26aufirst%3DZ.%2BM.%26aulast%3DZhang%26aufirst%3DG.%2BM.%26aulast%3DLin%26aufirst%3DF.%2BW.%26atitle%3DDynamic%2520and%2520significant%2520changes%2520of%2520T-cell%2520subgroups%2520in%2520breast%2520cancer%2520patients%2520during%2520surgery%2520and%2520chemotherapy%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2018%26volume%3D65%26spage%3D279%26epage%3D283%26doi%3D10.1016%2Fj.intimp.2018.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balko, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2016.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fnrclinonc.2016.66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=27184417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=674-690&author=G.+Bianchiniauthor=J.+M.+Balkoauthor=I.+A.+Mayerauthor=M.+E.+Sandersauthor=L.+Gianni&title=Triple-negative+breast+cancer%3A+challenges+and+opportunities+of+a+heterogeneous+disease&doi=10.1038%2Fnrclinonc.2016.66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span></div><div class="casAuthors">Bianchini, Giampaolo; Balko, Justin M.; Mayer, Ingrid A.; Sanders, Melinda E.; Gianni, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">674-690</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy is the primary established systemic treatment for patients with triple-neg. breast cancer (TNBC) in both the early and advanced-stages of the disease.  The lack of targeted therapies and the poor prognosis of patients with TNBC have fostered a major effort to discover actionable mol. targets to treat patients with these tumors.  Massively parallel sequencing and other 'omics' technologies have revealed an unexpected level of heterogeneity of TNBCs and have led to the identification of potentially actionable mol. features in some TNBCs, such as germline BRCA1/2 mutations or 'BRCAness', the presence of the androgen receptor, and several rare genomic alterations.  Whether these alterations are mol. 'drivers', however, has not been clearly established.  A subgroup of TNBCs shows a high degree of tumor-infiltrating lymphocytes that also correlates with a lower risk of disease relapse and a higher likelihood of benefit from chemotherapy.  Proof-of-principle studies with immune-checkpoint inhibitors in advanced-stage TNBC have yielded promising results, indicating the potential benefit of immunotherapy for patients with TNBC.  In this Review, we discuss the most relevant mol. findings in TNBC from the past decade and the most promising therapeutic opportunities derived from these data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHF3dPbmmkIbVg90H21EOLACvtfcHk0ljFLnXgMpPYQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D&md5=1844e2d72f6321238d275cddc745ba1c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.66%26sid%3Dliteratum%253Aachs%26aulast%3DBianchini%26aufirst%3DG.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DGianni%26aufirst%3DL.%26atitle%3DTriple-negative%2520breast%2520cancer%253A%2520challenges%2520and%2520opportunities%2520of%2520a%2520heterogeneous%2520disease%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D13%26spage%3D674%26epage%3D690%26doi%3D10.1038%2Fnrclinonc.2016.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nurgali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagoe, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abalo, R.</span></span> <span> </span><span class="NLM_article-title">Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">245</span> <span class="refDoi"> DOI: 10.3389/fphar.2018.00245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.3389%2Ffphar.2018.00245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29623040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKnsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=K.+Nurgaliauthor=R.+T.+Jagoeauthor=R.+Abalo&title=Editorial%3A+adverse+effects+of+cancer+chemotherapy%3A+anything+new+to+improve+tolerance+and+reduce+sequelae%3F&doi=10.3389%2Ffphar.2018.00245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?</span></div><div class="casAuthors">Nurgali, Kulmira; Jagoe, R. Thomas; Abalo, Raquel</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245/1-245/3</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review discussing longer-term toxicity from cancer chemotherapy.  It also discusses impact of cancer chemotherapy on sensory functioning such as hearing, approaches to maintain fertility during and after treatment and the broad long-term impact of systemic anti-cancer treatment on health and aging in cancer survivor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHaOY45xlot7Vg90H21EOLACvtfcHk0lhglTnkrSd9CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKnsr7O&md5=960717fc0c56e29e1bbadd4c931f80f7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00245%26sid%3Dliteratum%253Aachs%26aulast%3DNurgali%26aufirst%3DK.%26aulast%3DJagoe%26aufirst%3DR.%2BT.%26aulast%3DAbalo%26aufirst%3DR.%26atitle%3DEditorial%253A%2520adverse%2520effects%2520of%2520cancer%2520chemotherapy%253A%2520anything%2520new%2520to%2520improve%2520tolerance%2520and%2520reduce%2520sequelae%253F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26doi%3D10.3389%2Ffphar.2018.00245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turchi, J. J.</span></span> <span> </span><span class="NLM_article-title">Chemotherapy induced DNA damage response: convergence of drugs and pathways</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.4161/cbt.23761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.4161%2Fcbt.23761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=23380594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvFOrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=379-389&author=D.+Woodsauthor=J.+J.+Turchi&title=Chemotherapy+induced+DNA+damage+response%3A+convergence+of+drugs+and+pathways&doi=10.4161%2Fcbt.23761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy induced DNA damage response: convergence of drugs and pathways</span></div><div class="casAuthors">Woods, Derek; Turchi, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-389</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics target rapidly dividing cancer cells by directly or indirectly inducing DNA damage.  Upon recognizing DNA damage, cells initiate a variety of signaling pathways collectively referred to as the DNA damage response (DDR).  Interestingly, the pathways used to elicit this response are as varied as the types of DNA damage induced.  However, the activation of these various pathways has similar results including DNA repair, suppression of global general translation, cell cycle arrest and, ultimately, either cell survival or cell death.  This review will focus on a series of chemotherapy-induced DNA lesions and highlight recent advances in our understanding of the DDR, the DNA repair pathways it activates and the cellular consequences of these converging pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBzViNyUg_FrVg90H21EOLACvtfcHk0lhglTnkrSd9CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvFOrtr8%253D&md5=2e8747c1e59190e291bd3d3d3f63f82d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4161%2Fcbt.23761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.23761%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DD.%26aulast%3DTurchi%26aufirst%3DJ.%2BJ.%26atitle%3DChemotherapy%2520induced%2520DNA%2520damage%2520response%253A%2520convergence%2520of%2520drugs%2520and%2520pathways%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2013%26volume%3D14%26spage%3D379%26epage%3D389%26doi%3D10.4161%2Fcbt.23761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teles, R. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moralles, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, M. R.</span></span> <span> </span><span class="NLM_article-title">Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2321</span>– <span class="NLM_lpage">2336</span>, <span class="refDoi"> DOI: 10.2147/IJN.S164355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.2147%2FIJN.S164355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29713164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOrt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2321-2336&author=R.+H.+G.+Telesauthor=H.+F.+Morallesauthor=M.+R.+Cominetti&title=Global+trends+in+nanomedicine+research+on+triple+negative+breast+cancer%3A+a+bibliometric+analysis&doi=10.2147%2FIJN.S164355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis</span></div><div class="casAuthors">Teles, Ramon Handerson Gomes; Moralles, Herick Fernando; Cominetti, Marcia Regina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2321-2336</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Nanotechnol. has emerged as a promising tool in the clinic to combat several difficult-to-manage diseases, such as cancer, which is the second leading cause of death worldwide.  Chemotherapeutic drugs present several limitations such as undesired side effects, low specificity, resistance, and high relapse rates.  Triple neg. breast cancer (TNBC) is caused by cells that lack specific receptors in their membrane, such as estrogen (ER+) and progesterone (PR+) receptors, or by cells that do not express the amplification of human epidermal growth factor receptor-2 (HER-2+).  This cancer type has poor prognosis, high relapse rates, and no targeted therapies.  Thus, this study aimed to investigate the trends of nanotechnol. research in TNBC and compare the contribution of research from different regions, institutions, and authors.  A search of the studies published between 2012 and 2017, related to nanotechnol. and TNBC, with different keyword combinations, was performed in the Scopus database.  The keywords found in this search were grouped into four clusters, in which "breast cancer" was the most mentioned (1,133 times) and the word "MCF-7 cell line" is one of the latest hotspots that appeared in the year 2016.  A total of 1,932 articles, which were cited 26,450 times, were identified.  The USA accounted for 28.36% of the articles and 27.61% of the citations; however, none of its centers appeared in the list of 10 most productive ones in terms of publications.  The journals Biomaterials and International Journal of Nanomedicine had the highest no. of publications.  The USA and China had the highest no. of articles produced and cited; however, the highest av. citation per article was from Singapore.  The studies focused on the research of antineoplastic agents in animal models and cell culture, and these were the most used topics in research with nanotechnol. and TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3yO0UsGSuP7Vg90H21EOLACvtfcHk0lhglTnkrSd9CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOrt7vP&md5=fc9c65a395a977eb03a6d2c93a0f3df1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2147%2FIJN.S164355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S164355%26sid%3Dliteratum%253Aachs%26aulast%3DTeles%26aufirst%3DR.%2BH.%2BG.%26aulast%3DMoralles%26aufirst%3DH.%2BF.%26aulast%3DCominetti%26aufirst%3DM.%2BR.%26atitle%3DGlobal%2520trends%2520in%2520nanomedicine%2520research%2520on%2520triple%2520negative%2520breast%2520cancer%253A%2520a%2520bibliometric%2520analysis%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2018%26volume%3D13%26spage%3D2321%26epage%3D2336%26doi%3D10.2147%2FIJN.S164355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesar, J. M.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of breast cancer</span>. <i>Am. J. Health-Syst. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2228</span>, <span class="refDoi"> DOI: 10.2146/ajhp070663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.2146%2Fajhp070663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19020189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFChs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=2221-2228&author=A.+Thomsenauthor=J.+M.+Kolesar&title=Chemoprevention+of+breast+cancer&doi=10.2146%2Fajhp070663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of breast cancer</span></div><div class="casAuthors">Thomsen, Annelise; Kolesar, Jill M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2221-2228</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  Purpose: The risk factors for and risk assessment of breast cancer, recommendations for risk redn., and roles of tamoxifen and raloxifene in the prevention of breast cancer are discussed.  Summary: Breast cancer either may be a familial syndrome or develop sporadically.  In familial syndromes, cancer occurs in multiple family members and the risk factors are primarily genetic.  The majority of breast cancers are sporadic, and risk factors are primarily related to estrogen exposure.  Recommendation strategies for reducing breast cancer risk include engaging in a healthy lifestyle by decreasing alc. consumption, following a low-fat diet enriched with fruits and vegetables, exercising, and reducing wt. if obese.  Breast self-examns., clin. breast examns., and screening mammogs. are strategies for the early detection of breast cancer.  Recommendations for the use of tamoxifen for risk redn. are intended only for women who are at an increased risk for the development of breast cancer as assessed by the Gail model.  One study found a significantly increased risk of cardiovascular events and hypertriglyceridemia in the tamoxifen group compared to placebo.  Raloxifene is also intended for women at high risk for breast cancer.  During clin. trials, hot flashes, influenzalike syndromes, peripheral edema, and leg cramps were reported more frequently in patients receiving raloxifene when compared with patients receiving placebo, and the risk of thromboembolic disease was 3.1 times higher in the raloxifene group compared with the placebo.  Conclusion: Tamoxifen and raloxifene are both indicated for and equally effective in the prevention of breast cancer in women at high risk for development of the disease.  Raloxifene may have a more favorable adverse-effect profile, with fewer thromboembolic events and less uterine hyperplasia when compared with tamoxifen.  Despite being at high risk, many women decide against breast cancer chemoprevention with either tamoxifen or raloxifene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYQDR9F7L5XLVg90H21EOLACvtfcHk0ljbJ_WH8UHhhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFChs7zO&md5=376d467a0d6eba04c176b7db98afc0dc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2146%2Fajhp070663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp070663%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DA.%26aulast%3DKolesar%26aufirst%3DJ.%2BM.%26atitle%3DChemoprevention%2520of%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2008%26volume%3D65%26spage%3D2221%26epage%3D2228%26doi%3D10.2146%2Fajhp070663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(95)90405-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2F0092-8674%2895%2990405-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=7834742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaK2MXjtlGnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=225-236&author=T.+Hunter&title=Protein+kinases+and+phosphatases%3A+the+yin+and+yang+of+protein+phosphorylation+and+signaling&doi=10.1016%2F0092-8674%2895%2990405-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling</span></div><div class="casAuthors">Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-36</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 127 refs.  Protein phosphorylation plays a cardinal role in regulating many cellular processes in eukaryotes.  In particular, protein phosphorylation is a major factor in signal transduction pathways.  Processes that are reversibly controlled by protein phosphorylation require not only a protein kinase but also a protein phosphatase.  Target proteins are phosphorylated at specific sites by one or more protein kinases, and these phosphates are removed by specific protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw8tLm7EuSmbVg90H21EOLACvtfcHk0ljbJ_WH8UHhhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtlGnsrs%253D&md5=5262cb6e7a5175a97a11c8d87d8993c0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990405-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990405-0%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DProtein%2520kinases%2520and%2520phosphatases%253A%2520the%2520yin%2520and%2520yang%2520of%2520protein%2520phosphorylation%2520and%2520signaling%26jtitle%3DCell%26date%3D1995%26volume%3D80%26spage%3D225%26epage%3D236%26doi%3D10.1016%2F0092-8674%2895%2990405-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenner, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anyanwu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olefsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusari, J.</span></span> <span> </span><span class="NLM_article-title">Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">19810</span>– <span class="NLM_lpage">19816</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.33.19810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1074%2Fjbc.271.33.19810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=8702689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaK28XltVKrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=19810-19816&author=K.+A.+Kennerauthor=E.+Anyanwuauthor=J.+M.+Olefskyauthor=J.+Kusari&title=Protein-tyrosine+phosphatase+1B+is+a+negative+regulator+of+insulin-+and+insulin-like+growth+factor-I-stimulated+signaling&doi=10.1074%2Fjbc.271.33.19810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling</span></div><div class="casAuthors">Kenner, Kathleen A.; Anyanwu, Ezenta; Olefsky, Jerrold M.; Kusari, Jyotirmoy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">19810-19816</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">To understand the physiol. role of protein-tyrosine phosphatase 1B (PTPase 1B) in insulin and insulin-like factor-I (IGF-I) signaling, we established clonal cell lines overexpressing wild type or inactive mutant (C215S) PTPase 1B in cells overexpressing insulin (Hirc) or IGF-I (CICFR) receptors.  PTPase 1B overexpression in transfected cells was verified by immunoblot anal. with a monoclonal PTPase 1B antibody.  Subfractionation of parental cells demonstrated that greater than 90% of PTPase activity was localized in the Triton X-100-sol. particulate (P1) (P1) cell fraction.  PTPase activity in the P1 fraction of cells overexpressing wild type PTPase 1B was 3-6-fold higher than parental cells but was unaltered in all fractions from C215S PTPase 1B-contg. cells.  The overexpression of wild type and C215S PTPase 1B had no effects on intrinsic receptor kinase activity, growth rate, or general cell morphol.  The effects of PTPase 1B overexpression on cellular protein tyrosine phosphorylation were examd. by anti-phosphotyrosine immunoblot anal.  No differences were apparent under basal conditions, but hormone-stimulated receptor autophosphorylation and/or insulin receptor substrate tyrosine phosphorylation were inhibited in cells overexpressing wild type PTPase 1B and increased in cells expressing mutant PTPase 1B, in comparison with parental cells.  Metabolic signaling, assessed by ligand-stimulated [14C]glucose incorporation into glycogen, was also inhibited in cells overexpressing active PTPase 1B and enhanced in cells contg. C215S PTPase 1B and enhanced in cells contg. C215S PTPase 1B.  These data strongly suggest that PTPase 1B acts as a neg. regulator of insulin and IGF-I signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorJdPrqCOpkLVg90H21EOLACvtfcHk0ljbJ_WH8UHhhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVKrsrg%253D&md5=042402074a5006449c23f5e00d80a810</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.33.19810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.33.19810%26sid%3Dliteratum%253Aachs%26aulast%3DKenner%26aufirst%3DK.%2BA.%26aulast%3DAnyanwu%26aufirst%3DE.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DKusari%26aufirst%3DJ.%26atitle%3DProtein-tyrosine%2520phosphatase%25201B%2520is%2520a%2520negative%2520regulator%2520of%2520insulin-%2520and%2520insulin-like%2520growth%2520factor-I-stimulated%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D19810%26epage%3D19816%26doi%3D10.1074%2Fjbc.271.33.19810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ping, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, X. W.</span></span> <span> </span><span class="NLM_article-title">PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT</span>. <i>Tumour Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">13479</span>– <span class="NLM_lpage">13487</span>, <span class="refDoi"> DOI: 10.1007/s13277-016-5245-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1007%2Fs13277-016-5245-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=27465552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BC2s3ltV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=13479-13487&author=X.+Liuauthor=Q.+Chenauthor=X.+G.+Huauthor=X.+C.+Zhangauthor=T.+W.+Fuauthor=Q.+Liuauthor=Y.+Liangauthor=X.+L.+Zhaoauthor=X.+Zhangauthor=Y.+F.+Pingauthor=X.+W.+Bian&title=PTP1B+promotes+aggressiveness+of+breast+cancer+cells+by+regulating+PTEN+but+not+EMT&doi=10.1007%2Fs13277-016-5245-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT</span></div><div class="casAuthors">Liu Xue; Chen Qian; Hu Xu-Gang; Zhang Xian-Chao; Fu Ti-Wei; Liu Qing; Liang Yan; Zhao Xi-Long; Zhang Xia; Ping Yi-Fang; Bian Xiu-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">13479-13487</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metastasis is a complicated, multistep process and remains the major cause of cancer-related mortality.  Exploring the molecular mechanisms underlying tumor metastasis is crucial for development of new strategies for cancer prevention and treatment.  In this study, we found that protein tyrosine phosphatase 1B (PTP1B) promoted breast cancer metastasis by regulating phosphatase and tensin homolog (PTEN) but not epithelial-mesenchymal transition (EMT).  By detecting PTP1B expression of the specimens from 128 breast cancer cases, we found that the level of PTP1B was higher in breast cancer tissues than the corresponding adjacent normal tissues.  Notably, PTP1B was positively associated with lymph node metastasis (LNM) and estrogen receptor (ER) status.  In vitro, disturbing PTP1B expression obviously attenuated cell migration and invasion.  On the contrary, PTP1B overexpression significantly increased migration and invasion of breast cancer cells.  Mechanistically, PTP1B knockdown upregulated PTEN, accompanied with an abatement of AKT phosphorylation and the expression of matrix metalloproteinase 2 (MMP2) and MMP7.  Conversely, forced expression of PTP1B reduced PTEN and increased AKT phosphorylation as well as the expression of MMP2 and MMP7.  Notably, neither EMT nor stemness of breast cancer cells was regulated by PTP1B.  We also found that PTP1B acted as an independent prognostic factor and predicted poor prognosis in ER-positive breast cancer patients.  Taken together, our findings provide advantageous evidence for the development of PTP1B as a potential therapeutic target for breast cancer, especially for ER-positive breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGjCxvJ807GIJKJbLTgsvCfW6udTcc2eYwuZXHEDEedrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3ltV2mtQ%253D%253D&md5=27c3509a84eff5d4e73a0fd936688c3c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs13277-016-5245-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-016-5245-1%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DX.%2BG.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DFu%26aufirst%3DT.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPing%26aufirst%3DY.%2BF.%26aulast%3DBian%26aufirst%3DX.%2BW.%26atitle%3DPTP1B%2520promotes%2520aggressiveness%2520of%2520breast%2520cancer%2520cells%2520by%2520regulating%2520PTEN%2520but%2520not%2520EMT%26jtitle%3DTumour%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D13479%26epage%3D13487%26doi%3D10.1007%2Fs13277-016-5245-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206</span>. <i>Cancer Cell Int.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>, <span class="NLM_elocation-id">275</span> <span class="refDoi"> DOI: 10.1186/s12935-019-0958-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1186%2Fs12935-019-0958-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=31695578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BB3MjmtVekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&author=Y.+Liauthor=Q.+Zengauthor=J.+Qiuauthor=T.+Pangauthor=J.+Xianauthor=X.+Zhang&title=Long+non-coding+RNA+UCA1+promotes+breast+cancer+by+upregulating+PTP1B+expression+via+inhibiting+miR-206&doi=10.1186%2Fs12935-019-0958-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206</span></div><div class="casAuthors">Li Yi; Zeng Qingan; Qiu Jiliang; Pang Ting; Xian Jianzhong; Zhang Xuexia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer cell international</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275</span>
        ISSN:<span class="NLM_cas:issn">1475-2867</span>.
    </div><div class="casAbstract">Background:  The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) is involved in various cancers and often functions through microRNAs.  The pro-survival protein PTP1B is known to play important roles in cancer development.  However, the connection between UCA1 and PTP1B in breast cancer is not well studied.  Methods:  In this study, we first evaluated the correlation between UCA1 level and PTP1B expression in breast tissues, which showed the expression of PTP1B were much higher in the breast tumor tissues than in the peritumor normal tissues.  The UCA1 level was positively associated with PTP1B expression in breast tumor tissues.  Results:  We observed that UCA1 could up-regulate PTP1B expression in breast cancer cells.  We also found that miR-206 could inhibit the expression of PTP1B by directly binding to the 3'-UTR of its mRNA.  Interestingly, UCA1 could increase the expression of PTP1B through sequestering miR-206 at post-transcriptional level.  The results also suggested that UCA1-induced PTP1B expression facilitated the proliferation of breast cancer cells.  Conclusions:  We conclude that UCA1 can up-regulates PTP1B to enhance cell proliferation through sequestering miR-206 in breast cancer.  Our finding provides new insights into the mechanism of breast cancer regulation by UCA1, which could be a potential target for breast cancer treatment.Trial registration 2012N5hSYSU48573.  Registered at Oct 12, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCYqLxS6eNXLZpSb_XWfMrfW6udTcc2eYwuZXHEDEedrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjmtVekug%253D%253D&md5=ce715c25b9b7a38c39ad60d05474e4df</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs12935-019-0958-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12935-019-0958-z%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DT.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DLong%2520non-coding%2520RNA%2520UCA1%2520promotes%2520breast%2520cancer%2520by%2520upregulating%2520PTP1B%2520expression%2520via%2520inhibiting%2520miR-206%26jtitle%3DCancer%2520Cell%2520Int.%26date%3D2019%26volume%3D19%26doi%3D10.1186%2Fs12935-019-0958-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">1136</span>– <span class="NLM_lpage">1153</span>, <span class="refDoi"> DOI: 10.1111/febs.14724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1111%2Ffebs.14724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=30548198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFymsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2019&pages=1136-1153&author=M.+Yuauthor=Z.+Liuauthor=Y.+Liuauthor=X.+Zhouauthor=F.+Sunauthor=Y.+Liuauthor=L.+Liauthor=S.+Huaauthor=Y.+Zhaoauthor=H.+Gaoauthor=Z.+Zhuauthor=M.+Naauthor=Q.+Zhangauthor=R.+Yangauthor=J.+Zhangauthor=Y.+Yaoauthor=X.+Chen&title=PTP1B+markedly+promotes+breast+cancer+progression+and+is+regulated+by+miR-193a-3p&doi=10.1111%2Ffebs.14724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p</span></div><div class="casAuthors">Yu, Mengchao; Liu, Zhijian; Liu, Yuan; Zhou, Xinyan; Sun, Feng; Liu, Yanqing; Li, Liuyi; Hua, Shiyu; Zhao, Yi; Gao, Haidong; Zhu, Zhouting; Na, Muhan; Zhang, Qipeng; Yang, Rong; Zhang, Jianguo; Yao, Yongzhong; Chen, Xi</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1136-1153</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase PTP1B, which is encoded by PTPN1, is a ubiquitously expressed nonreceptor protein tyrosine phosphatase.  PTP1B has long been known to neg. regulate insulin and leptin receptor signaling.  Recently, it was reported to be aberrantly expressed in cancer cells and to function as an important oncogene.  In this study, we found that PTP1B protein levels are dramatically increased in breast cancer (BC) tissues and that PTP1B promotes the proliferation, and suppresses the apoptosis, of both HER2-pos. and triple-neg. BC cell lines.  Bioinformatics anal. identified that the miRNA, miR-193a-3p, might potentially target PTP1B.  We demonstrate that miR-193a-3p regulates PTP1B in BC cells and that it regulates the proliferation and apoptosis of BC cells by targeting PTP1B, both in vitro and in vivo.  In conclusion, this study confirms that PTP1B acts as an oncogene in BC and demonstrates that miR-193a-3p can serve as a tumor suppressor gene in BC by targeting PTP1B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAN9o5Mp_5mLVg90H21EOLACvtfcHk0lhzdL6xl4P81w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFymsLnP&md5=e5baf3e61c576dd40f5477f45a3fcc7d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14724%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DNa%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DPTP1B%2520markedly%2520promotes%2520breast%2520cancer%2520progression%2520and%2520is%2520regulated%2520by%2520miR-193a-3p%26jtitle%3DFEBS%2520J.%26date%3D2019%26volume%3D286%26spage%3D1136%26epage%3D1153%26doi%3D10.1111%2Ffebs.14724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilmarsdottir, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldorsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kricker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingthorsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsdottir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maelandsmo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudjonsson, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PTP1B disrupts cell-cell adhesion and induces anoikis in breast epithelial cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e2769</span> <span class="refDoi"> DOI: 10.1038/cddis.2017.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fcddis.2017.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=28492548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=B.+Hilmarsdottirauthor=E.+Briemauthor=S.+Halldorssonauthor=J.+Krickerauthor=S.+Ingthorssonauthor=S.+Gustafsdottirauthor=G.+M.+Maelandsmoauthor=M.+K.+Magnussonauthor=T.+Gudjonsson&title=Inhibition+of+PTP1B+disrupts+cell-cell+adhesion+and+induces+anoikis+in+breast+epithelial+cells&doi=10.1038%2Fcddis.2017.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PTP1B disrupts cell-cell adhesion and induces anoikis in breast epithelial cells</span></div><div class="casAuthors">Hilmarsdottir, Bylgja; Briem, Eirikur; Halldorsson, Skarphedinn; Kricker, Jennifer; Ingthorsson, Saevar; Gustafsdottir, Sigrun; Maelandsmo, Gunhild M.; Magnusson, Magnus K.; Gudjonsson, Thorarinn</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2769</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is a well-known inhibitor of insulin signaling pathways and inhibitors against PTP1B are being developed as promising drug candidates for treatment of obesity.  PTP1B has also been linked to breast cancer both as a tumor suppressor and as an oncogene.  Furthermore, PTP1B has been shown to be a regulator of cell adhesion and migration in normal and cancer cells.  In this study, we analyzed the PTP1B expression in normal breast tissue, primary breast cells and the breast epithelial cell line D492.  In normal breast tissue and primary breast cells, PTP1B is widely expressed in both epithelial and stromal cells, with highest expression in myoepithelial cells and fibroblasts.  PTP1B is widely expressed in branching structures generated by D492 when cultured in 3D reconstituted basement membrane (3D rBM).  Inhibition of PTP1B in D492 and another mammary epithelial cell line HMLE resulted in reduced cell proliferation and induction of anoikis.  These changes were seen when cells were cultured both in monolayer and in 3D rBM.  PTP1B inhibition affected cell attachment, expression of cell adhesion proteins and actin polymn.  Moreover, epithelial to mesenchymal transition (EMT) sensitized cells to PTP1B inhibition.  A mesenchymal sublines of D492 and HMLE (D492M and HMLEmes) were more sensitive to PTP1B inhibition than D492 and HMLE.  Reversion of D492M to an epithelial state using miR-200c-141 restored resistance to detachment induced by PTP1B inhibition.  In conclusion, we have shown that PTP1B is widely expressed in the human breast gland with highest expression in myoepithelial cells and fibroblasts.  Inhibition of PTP1B in D492 and HMLE affects cell-cell adhesion and induces anoikis-like effects.  Finally, cells with an EMT phenotype are more sensitive to PTP1B inhibitors making PTP1B a potential candidate for further studies as a target for drug development in cancer involving the EMT phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4YxdYzIsprVg90H21EOLACvtfcHk0li5LqoGLYSMGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1KisLg%253D&md5=f1a676e78a2454cb868e01cf056a8ac8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.177%26sid%3Dliteratum%253Aachs%26aulast%3DHilmarsdottir%26aufirst%3DB.%26aulast%3DBriem%26aufirst%3DE.%26aulast%3DHalldorsson%26aufirst%3DS.%26aulast%3DKricker%26aufirst%3DJ.%26aulast%3DIngthorsson%26aufirst%3DS.%26aulast%3DGustafsdottir%26aufirst%3DS.%26aulast%3DMaelandsmo%26aufirst%3DG.%2BM.%26aulast%3DMagnusson%26aufirst%3DM.%2BK.%26aulast%3DGudjonsson%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520PTP1B%2520disrupts%2520cell-cell%2520adhesion%2520and%2520induces%2520anoikis%2520in%2520breast%2520epithelial%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fcddis.2017.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soysal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermann, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oertli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillanders, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viehl, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muenst, S.</span></span> <span> </span><span class="NLM_article-title">PTP1B expression is an independent positive prognostic factor in human breast cancer</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1007/s10549-012-2373-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1007%2Fs10549-012-2373-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=23242616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=637-644&author=S.+Soysalauthor=E.+C.+Obermannauthor=F.+Gaoauthor=D.+Oertliauthor=W.+E.+Gillandersauthor=C.+T.+Viehlauthor=S.+Muenst&title=PTP1B+expression+is+an+independent+positive+prognostic+factor+in+human+breast+cancer&doi=10.1007%2Fs10549-012-2373-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">PTP1B expression is an independent positive prognostic factor in human breast cancer</span></div><div class="casAuthors">Soysal, S.; Obermann, E. C.; Gao, F.; Oertli, D.; Gillanders, W. E.; Viehl, C. T.; Muenst, S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">637-644</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is a non-transmembrane protein tyrosine phosphatase that has come into focus as a crit. regulator of multiple signaling pathways.  The role of PTP1B in breast cancer remains unclear with evidence suggesting that PTP1B can exert both tumor-suppressing and tumor-promoting effects.  To better define the role of PTP1B in human breast cancer, and its relationship with HER2, we performed immunohistochem. studies on a large cohort of functionally annotated primary breast cancer specimens. 683 of 1,402 (49 %) evaluable primary breast cancers are pos. for PTP1B.  There is no statistically significant assocn. between PTP1B expression and age, tumor size, T stage, histol. grade, lymph node status, or histol. subtype.  Of note, there is no significant assocn. between PTP1B expression and HER2 expression (PTP1B expression 53.1 % in HER2+ cancers vs. 47.5 % in HER2- cancers, p = 0.0985).  However, PTP1B expression is significantly assocd. with estrogen receptor expression (PTP1B expression 50.7 % in ER+ cancers vs. 43.1 % in ER- cancers, p = 0.0137) and intrinsic mol. subtype (PTP1B expression 53.9 % in the luminal B HER2+ subtype and 37.9 % in the basal-like subtype).  Of note, multivariate analyses demonstrate that PTP1B is an independent predictor of improved survival in breast cancer (HR 0.779, p = 0.006).  Taken together, we demonstrate in the largest study to date that (1) PTP1B is commonly expressed in breast cancer, (2) there is no assocn. or functional impact of PTP1B expression in HER2+ breast cancer, and (3) PTP1B expression in breast cancer is assocd. with significantly improved clin. outcome.  Until addnl. studies are performed, caution should be exercised in using PTP1B inhibitors in human breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopQ5L2QnqK1LVg90H21EOLACvtfcHk0li5LqoGLYSMGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVCjsA%253D%253D&md5=23be07e6bb2ccb35939880b728b7626f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10549-012-2373-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-012-2373-1%26sid%3Dliteratum%253Aachs%26aulast%3DSoysal%26aufirst%3DS.%26aulast%3DObermann%26aufirst%3DE.%2BC.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DOertli%26aufirst%3DD.%26aulast%3DGillanders%26aufirst%3DW.%2BE.%26aulast%3DViehl%26aufirst%3DC.%2BT.%26aulast%3DMuenst%26aufirst%3DS.%26atitle%3DPTP1B%2520expression%2520is%2520an%2520independent%2520positive%2520prognostic%2520factor%2520in%2520human%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2013%26volume%3D137%26spage%3D637%26epage%3D644%26doi%3D10.1007%2Fs10549-012-2373-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiener, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglehart, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berchuck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bast, R. C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1093/jnci/86.5.372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1093%2Fjnci%2F86.5.372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=7905928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADyaK2c7ktF2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1994&pages=372-378&author=J.+R.+Wienerauthor=B.+J.+Kernsauthor=E.+L.+Harveyauthor=M.+R.+Conawayauthor=J.+D.+Iglehartauthor=A.+Berchuckauthor=R.+C.+Bast&title=Overexpression+of+the+protein+tyrosine+phosphatase+PTP1B+in+human+breast+cancer%3A+association+with+p185c-erbB-2+protein+expression&doi=10.1093%2Fjnci%2F86.5.372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression</span></div><div class="casAuthors">Wiener J R; Kerns B J; Harvey E L; Conaway M R; Iglehart J D; Berchuck A; Bast R C Jr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-8</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">BACKGROUND:  The p185c-erbB-2 growth factor receptor protein tyrosine kinase (PTK) is overexpressed in one third of human breast cancer patients and indicates a poor prognosis in these patients.  Protein tyrosine phosphatases (PTPs) may balance PTK activity as part of normal growth-regulation pathways.  PTP1B is an intracellular PTP that is involved in linkage between signal transduction pathways and may interface with inappropriate PTK activity in transformed cells.  PURPOSE:  The aim of this study was to determine if PTP1B is overexpressed in human mammary tumors and to determine if such overexpression is associated with the overexpression of the p185c-erbB-2 receptor PTK.  METHODS:  Our samples were frozen sections from 29 human mammary tumors (19 pure infiltrating, two pure intraductal, and eight combined intraductal and infiltrating) and nine sections from normal breast tissue.  The sections were immunohistochemically stained for PTP1B and p185c-erbB-2, and the results were analyzed statistically for association between overexpression of the two proteins.  Northern blot analysis was used to assess if PTP1B overexpression was coincident with increased transcription of the PTP1B gene.  RESULTS:  Overexpression of the PTP1B protein was observed in 72.4% of the tumor sections compared with normal epithelium, with maximal expression occurring in 37.9% of the tumors.  All of the tumor subtypes, including the pure intraductal lesions, overexpressed PTP1B.  Statistical analyses demonstrated a significant association between PTP1B overexpression and breast cancer (P < .038) and between the overexpression of PTP1B and the overexpression of p185c-erbB-2 (P < .006).  PTP1B messenger RNA steady-state transcription was consistently increased in tumors versus normal tissues.  CONCLUSIONS:  PTP1B overexpression is a common phenotypic manifestation in human breast cancers and is associated with over-expression of p185c-erbB-2.  Steady-state PTP1B transcription is increased in tumor tissue.  IMPLICATIONS:  Further studies are needed to determine if PTP1B overexpression balances or augments PTK activity.  PTP1B overexpression might also be evaluated as a clinical prognostic factor in human breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQ1ypzMAcFxbjnyZkbE8yXfW6udTcc2eaSCOuCsXOYsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7ktF2ltA%253D%253D&md5=ed821ac6ef3ef6014ceb83c7746fe9a2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F86.5.372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F86.5.372%26sid%3Dliteratum%253Aachs%26aulast%3DWiener%26aufirst%3DJ.%2BR.%26aulast%3DKerns%26aufirst%3DB.%2BJ.%26aulast%3DHarvey%26aufirst%3DE.%2BL.%26aulast%3DConaway%26aufirst%3DM.%2BR.%26aulast%3DIglehart%26aufirst%3DJ.%2BD.%26aulast%3DBerchuck%26aufirst%3DA.%26aulast%3DBast%26aufirst%3DR.%2BC.%26atitle%3DOverexpression%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520PTP1B%2520in%2520human%2520breast%2520cancer%253A%2520association%2520with%2520p185c-erbB-2%2520protein%2520expression%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1994%26volume%3D86%26spage%3D372%26epage%3D378%26doi%3D10.1093%2Fjnci%2F86.5.372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arias-Romero, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villamar-Cruz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernoff, J.</span></span> <span> </span><span class="NLM_article-title">Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">4582</span>– <span class="NLM_lpage">4588</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1158%2F0008-5472.CAN-08-4001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19435911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=4582-4588&author=L.+E.+Arias-Romeroauthor=S.+Sahaauthor=O.+Villamar-Cruzauthor=S.+C.+Yipauthor=S.+P.+Ethierauthor=Z.+Y.+Zhangauthor=J.+Chernoff&title=Activation+of+Src+by+protein+tyrosine+phosphatase+1B+is+required+for+ErbB2+transformation+of+human+breast+epithelial+cells&doi=10.1158%2F0008-5472.CAN-08-4001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells</span></div><div class="casAuthors">Arias-Romero, Luis E.; Saha, Sayanti; Villamar-Cruz, Olga; Yip, Shu-Chin; Ethier, Stephen P.; Zhang, Zhong-Yin; Chernoff, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4582-4588</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase (PTP) 1B plays a major role in inhibiting signaling from the insulin and leptin receptors.  Recently, PTP1B was found to have an unexpected pos. role in ErbB2 signaling in a mouse model of breast cancer, but the mechanism underlying this effect has been unclear.  Using human breast epithelial cells grown in a three-dimensional matrix, we found that PTP1B, but not the closely related enzyme T-cell PTP, is required for ErbB2 transformation in vitro.  Activation of ErbB2, but not ErbB1, increases PTP1B expression, and increased expression of PTP1B activates Src and induces a Src-dependent transformed phenotype.  These findings identify a mol. mechanism by which PTP1B links an important oncogenic receptor tyrosine kinase to signaling pathways that promote aberrant cell division and survival in human breast epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpesj7LqeWTrVg90H21EOLACvtfcHk0ljd5i_onOu7nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFGltLc%253D&md5=d396f049f65eae14e41be5b1cb9c0870</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4001%26sid%3Dliteratum%253Aachs%26aulast%3DArias-Romero%26aufirst%3DL.%2BE.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DVillamar-Cruz%26aufirst%3DO.%26aulast%3DYip%26aufirst%3DS.%2BC.%26aulast%3DEthier%26aufirst%3DS.%2BP.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DChernoff%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520Src%2520by%2520protein%2520tyrosine%2520phosphatase%25201B%2520is%2520required%2520for%2520ErbB2%2520transformation%2520of%2520human%2520breast%2520epithelial%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D4582%26epage%3D4588%26doi%3D10.1158%2F0008-5472.CAN-08-4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julien, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. L.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1038/ng1963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fng1963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=17259984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=338-346&author=S.+G.+Julienauthor=N.+Dubeauthor=M.+Readauthor=J.+Penneyauthor=M.+Paquetauthor=Y.+Hanauthor=B.+P.+Kennedyauthor=W.+J.+Mullerauthor=M.+L.+Tremblay&title=Protein+tyrosine+phosphatase+1B+deficiency+or+inhibition+delays+ErbB2-induced+mammary+tumorigenesis+and+protects+from+lung+metastasis&doi=10.1038%2Fng1963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis</span></div><div class="casAuthors">Julien, Sofi G.; Dube, Nadia; Read, Michelle; Penney, Janice; Paquet, Marilene; Han, Yongxin; Kennedy, Brian P.; Muller, William J.; Tremblay, Michel L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We investigated the role of protein tyrosine phosphatase 1B (PTP1B) in mammary tumorigenesis using both genetic and pharmacol. approaches.  It has been previously shown that transgenic mice with a deletion mutation in the region of Erbb2 encoding its extracellular domain (referred to as NDL2 mice, for 'Neu deletion in extracellular domain 2') develop mammary tumors that progress to lung metastasis.  However, deletion of PTP1B activity in the NDL2 transgenic mice either by breeding with Ptpn1-deficient mice or by treatment with a specific PTP1B inhibitor results in significant mammary tumor latency and resistance to lung metastasis.  In contrast, specific overexpression of PTP1B in the mammary gland leads to spontaneous breast cancer development.  The regulation of ErbB2-induced mammary tumorigenesis by PTB1B occurs through the attenuation of both the MAP kinase (MAPK) and Akt pathways.  This report provides a rationale for the development of PTP1B as a new therapeutic target in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqihGXIv6TTrVg90H21EOLACvtfcHk0ljd5i_onOu7nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOksbk%253D&md5=a682a67da810c4c1692eb657cd267709</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fng1963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1963%26sid%3Dliteratum%253Aachs%26aulast%3DJulien%26aufirst%3DS.%2BG.%26aulast%3DDube%26aufirst%3DN.%26aulast%3DRead%26aufirst%3DM.%26aulast%3DPenney%26aufirst%3DJ.%26aulast%3DPaquet%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DKennedy%26aufirst%3DB.%2BP.%26aulast%3DMuller%26aufirst%3DW.%2BJ.%26aulast%3DTremblay%26aufirst%3DM.%2BL.%26atitle%3DProtein%2520tyrosine%2520phosphatase%25201B%2520deficiency%2520or%2520inhibition%2520delays%2520ErbB2-induced%2520mammary%2520tumorigenesis%2520and%2520protects%2520from%2520lung%2520metastasis%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D338%26epage%3D346%26doi%3D10.1038%2Fng1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span> <span> </span><span class="NLM_article-title">Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1002/med.20079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1002%2Fmed.20079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=17039461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1GjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=553-573&author=S.+Leeauthor=Q.+Wang&title=Recent+development+of+small+molecular+specific+inhibitor+of+protein+tyrosine+phosphatase+1B&doi=10.1002%2Fmed.20079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B</span></div><div class="casAuthors">Lee, Seokjoon; Wang, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">553-573</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs), a large family of signaling enzymes, play essential roles in intracellular signal transduction by regulating the cellular level of tyrosine phosphorylation to control cell growth and differentiation, metab., cell migration, gene transcription, ion-channel activity, immune response, cell apoptosis, and bone development.  Among all PTPs, protein tyrosine phosphatase 1B (PTP1B) plays a seminal role in cellular signaling and in many human diseases, including cancer, diabetes, and obesity.  Therefore, small mol. inhibitors of PTP1B can be promising drug candidates.  Because of the structural homologies in many families of PTPs, it is a challenging task to find inhibitors specific to each PTP.  Recent studies suggested that secondary binding pockets or peripheral binding sites around the conserved active site should be exploited to design novel potent and selective PTP1B inhibitors.  In this review, we discuss the structural and biol. features of small mol. PTP1B-specific inhibitors, with particular emphasis on small mol. inhibitors targeting PTP1B over the other PTPs that have been synthesized in the past 4 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46I4_bW5HFrVg90H21EOLACvtfcHk0ljd5i_onOu7nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1GjsLs%253D&md5=e2d9fe426fc11f39ef9341e6b2227de1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fmed.20079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20079%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DRecent%2520development%2520of%2520small%2520molecular%2520specific%2520inhibitor%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2007%26volume%3D27%26spage%3D553%26epage%3D573%26doi%3D10.1002%2Fmed.20079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koveal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akshinthala, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kragelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauss, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackledge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthuswamy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fnchembio.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=24845231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=558-566&author=N.+Krishnanauthor=D.+Kovealauthor=D.+H.+Millerauthor=B.+Xueauthor=S.+D.+Akshinthalaauthor=J.+Krageljauthor=M.+R.+Jensenauthor=C.+M.+Gaussauthor=R.+Pageauthor=M.+Blackledgeauthor=S.+K.+Muthuswamyauthor=W.+Petiauthor=N.+K.+Tonks&title=Targeting+the+disordered+C+terminus+of+PTP1B+with+an+allosteric+inhibitor&doi=10.1038%2Fnchembio.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span></div><div class="casAuthors">Krishnan, Navasona; Koveal, Dorothy; Miller, Daniel H.; Xue, Bin; Akshinthala, Sai Dipikaa; Kragelj, Jaka; Jensen, Malene Ringkjoebing; Gauss, Carla-Maria; Page, Rebecca; Blackledge, Martin; Muthuswamy, Senthil K.; Peti, Wolfgang; Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">PTP1B, a validated therapeutic target for diabetes and obesity, has a crit. pos. role in HER2 signaling in breast tumorigenesis.  Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chem. properties of the active site.  We define a new mechanism of allosteric inhibition that targets the C-terminal, noncatalytic segment of PTP1B.  We present what is to our knowledge the first ensemble structure of PTP1B contg. this intrinsically disordered segment, within which we identified a binding site for the small-mol. inhibitor MSI-1436.  We demonstrate binding to a second site close to the catalytic domain, with cooperative effects between the two sites locking PTP1B in an inactive state.  MSI-1436 antagonized HER2 signaling, inhibited tumorigenesis in xenografts and abrogated metastasis in the NDL2 mouse model of breast cancer, validating inhibition of PTP1B as a therapeutic strategy in breast cancer.  This new approach to inhibition of PTP1B emphasizes the potential of disordered segments of proteins as specific binding sites for therapeutic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo526if7ja9XbVg90H21EOLACvtfcHk0lgQDl1dJ-Oq0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D&md5=10a460f3a5deafb9f7c206246d67a29b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1528%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DKoveal%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DAkshinthala%26aufirst%3DS.%2BD.%26aulast%3DKragelj%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DBlackledge%26aufirst%3DM.%26aulast%3DMuthuswamy%26aufirst%3DS.%2BK.%26aulast%3DPeti%26aufirst%3DW.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DTargeting%2520the%2520disordered%2520C%2520terminus%2520of%2520PTP1B%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fnchembio.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeram, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Phloroglucinol derivatives with protein tyrosine phosphatase 1B inhibitory activities from eugenia <i>jambolana</i> seeds</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b01073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b01073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Ois7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=544-550&author=F.+Liuauthor=T.+Yuanauthor=W.+Liuauthor=H.+Maauthor=N.+P.+Seeramauthor=Y.+Liauthor=L.+Xuauthor=Y.+Muauthor=X.+Huangauthor=L.+Li&title=Phloroglucinol+derivatives+with+protein+tyrosine+phosphatase+1B+inhibitory+activities+from+eugenia+jambolana+seeds&doi=10.1021%2Facs.jnatprod.6b01073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phloroglucinol Derivatives with Protein Tyrosine Phosphatase 1B Inhibitory Activities from Eugenia jambolana Seeds</span></div><div class="casAuthors">Liu, Feifei; Yuan, Tao; Liu, Wei; Ma, Hang; Seeram, Navindra P.; Li, Yuanyuan; Xu, Li; Mu, Yu; Huang, Xueshi; Li, Liya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">544-550</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Fifteen new phloroglucinol derivs., jamunones A-O (I, 2-8 and 10-16, resp.), along with one known analog spiralisone C (9), were isolated from Eugenia jambolana seeds.  Their structures were elucidated by detailed NMR and mass spectrometry spectroscopic data interpretation.  Compds. I-9, 11, 12, and 14-16 inhibited protein tyrosine phosphatase 1B activity with IC50 values ranging from 0.42 to 3.2 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjn3JjzTywjLVg90H21EOLACvtfcHk0lgQDl1dJ-Oq0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Ois7c%253D&md5=8513f4b26908157e58b339b4dab6c22b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b01073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b01073%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DYuan%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DSeeram%26aufirst%3DN.%2BP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DPhloroglucinol%2520derivatives%2520with%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitory%2520activities%2520from%2520eugenia%2520jambolana%2520seeds%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D544%26epage%3D550%26doi%3D10.1021%2Facs.jnatprod.6b01073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span> <span> </span><span class="NLM_article-title">New phloroglucinol derivatives from the fruit tree <i>Syzygium jambos</i> and their cytotoxic and antioxidant activities</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">10257</span>– <span class="NLM_lpage">10262</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.5b04293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.5b04293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2htrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=10257-10262&author=G.+Q.+Liauthor=Y.+B.+Zhangauthor=P.+Wuauthor=N.+H.+Chenauthor=Z.+N.+Wuauthor=L.+Yangauthor=R.+X.+Qiuauthor=G.+C.+Wangauthor=Y.+L.+Li&title=New+phloroglucinol+derivatives+from+the+fruit+tree+Syzygium+jambos+and+their+cytotoxic+and+antioxidant+activities&doi=10.1021%2Facs.jafc.5b04293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">New Phloroglucinol Derivatives from the Fruit Tree Syzygium jambos and Their Cytotoxic and Antioxidant Activities</span></div><div class="casAuthors">Li, Guo-Qiang; Zhang, Yu-Bo; Wu, Peng; Chen, Neng-Hua; Wu, Zhong-Nan; Yang, Li; Qiu, Rui-Xia; Wang, Guo-Cai; Li, Yao-Lan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10257-10262</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Seven new phloroglucinol derivs. (1-7) were isolated from the fruit tree Syzygium jambos together with four known triterpenoids (8-11) and two known flavones (12 and 13).  According to the spectroscopic analyses (IR, electrospray ionization mass spectrometry (ESIMS), high-resoln. ESIMS, 1D and 2D NMR), the structures of compds. 1-7 were elucidated as jambone A (1), jambone B (2), jambone C (3), jambone D (4), jambone E (5), jambone F (6), and jambone G (7).  All the isolates were detd. for their cytotoxic activities on melanoma cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, and compds. 10 and 11 showed potent activities.  Moreover, compds. 1, 2, 4-7, 12, and 13 exhibited weak antioxidant activities under ferric-reducing antioxidant power and 2,2-diphenyl-1-picryhydrazyl radical-scavenging assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqFTIBX4PySbVg90H21EOLACvtfcHk0li2I-KtHRnV5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2htrfL&md5=b2d25f37b5f934df2f44cb8da3e42a80</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.5b04293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.5b04293%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%2BB.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DN.%2BH.%26aulast%3DWu%26aufirst%3DZ.%2BN.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DR.%2BX.%26aulast%3DWang%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BL.%26atitle%3DNew%2520phloroglucinol%2520derivatives%2520from%2520the%2520fruit%2520tree%2520Syzygium%2520jambos%2520and%2520their%2520cytotoxic%2520and%2520antioxidant%2520activities%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2015%26volume%3D63%26spage%3D10257%26epage%3D10262%26doi%3D10.1021%2Facs.jafc.5b04293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Acylphloroglucinol derivatives from the leaves of <i>Syzygium samarangense</i> and their cytotoxic activities</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2018.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.fitote.2018.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29879460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWqsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2018&pages=1-6&author=J.+Yangauthor=J.+C.+Suauthor=X.+P.+Leiauthor=X.+J.+Huangauthor=D.+M.+Zhangauthor=W.+C.+Yeauthor=Y.+Wang&title=Acylphloroglucinol+derivatives+from+the+leaves+of+Syzygium+samarangense+and+their+cytotoxic+activities&doi=10.1016%2Fj.fitote.2018.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Acylphloroglucinol derivatives from the leaves of Syzygium samarangense and their cytotoxic activities</span></div><div class="casAuthors">Yang, Jiao; Su, Jun-Cheng; Lei, Xue-Ping; Huang, Xiao-Jun; Zhang, Dong-Mei; Ye, Wen-Cai; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Samarones A-D (1-4), four new acylphloroglucinol derivs. bearing a C17 alkyl side chain, along with five known analogs (5-9), were isolated from the leaves of Syzygium samarangense.  Their structures were characterized on the basis of extensive spectroscopic methods including HR-ESI-MS/MS anal.  The cytotoxic activities of compds. 1-3 and 5-9 against HepG2 and MDA-MB-231 cells were also evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBCyLzNcT8urVg90H21EOLACvtfcHk0li2I-KtHRnV5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWqsL7I&md5=866f36b3d25c239b5556fdd8d396dd0f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2018.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DJ.%2BC.%26aulast%3DLei%26aufirst%3DX.%2BP.%26aulast%3DHuang%26aufirst%3DX.%2BJ.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DYe%26aufirst%3DW.%2BC.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DAcylphloroglucinol%2520derivatives%2520from%2520the%2520leaves%2520of%2520Syzygium%2520samarangense%2520and%2520their%2520cytotoxic%2520activities%26jtitle%3DFitoterapia%26date%3D2018%26volume%3D129%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.fitote.2018.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tringali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piatelli, M.</span></span> <span> </span><span class="NLM_article-title">Two chrome derivatives from the brown alga <i>Zonaria tournefortii</i></span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1512</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)87145-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2FS0040-4039%2800%2987145-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaL38XksFamsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1982&pages=1509-1512&author=C.+Tringaliauthor=M.+Piatelli&title=Two+chrome+derivatives+from+the+brown+alga+Zonaria+tournefortii&doi=10.1016%2FS0040-4039%2800%2987145-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Two chromone derivatives from the brown alga Zonaria tournefortii</span></div><div class="casAuthors">Tringali, Corrado; Piattelli, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1509-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Two minor lipid components of Z. tournefortii were identified as the chromones I [R = (all-Z)-(CH:CHCH2)5Me; (CH2)11Me] by spectroscopic and chem. means.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9xlX_B0cYrVg90H21EOLACvtfcHk0li2I-KtHRnV5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XksFamsr0%253D&md5=90b87cbbc7f732200a2712858cb7407c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2987145-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252987145-2%26sid%3Dliteratum%253Aachs%26aulast%3DTringali%26aufirst%3DC.%26aulast%3DPiatelli%26aufirst%3DM.%26atitle%3DTwo%2520chrome%2520derivatives%2520from%2520the%2520brown%2520alga%2520Zonaria%2520tournefortii%26jtitle%3DTetrahedron%2520Lett.%26date%3D1982%26volume%3D23%26spage%3D1509%26epage%3D1512%26doi%3D10.1016%2FS0040-4039%2800%2987145-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Derivatives of natural product agrimophol as disruptors of intrabacterial pH homeostasis in mycobacterium tuberculosis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1104</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFOltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1087-1104&author=J.+Wuauthor=R.+Muauthor=M.+Sunauthor=N.+Zhaoauthor=M.+Panauthor=H.+Liauthor=Y.+Dongauthor=Z.+Sunauthor=J.+Baiauthor=M.+Huauthor=C.+F.+Nathanauthor=B.+Javidauthor=G.+Liu&title=Derivatives+of+natural+product+agrimophol+as+disruptors+of+intrabacterial+pH+homeostasis+in+mycobacterium+tuberculosis&doi=10.1021%2Facsinfecdis.8b00325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives of Natural Product Agrimophol as Disruptors of Intrabacterial pH Homeostasis in Mycobacterium tuberculosis</span></div><div class="casAuthors">Wu, Jie; Mu, Ran; Sun, Mingna; Zhao, Nan; Pan, Miaomiao; Li, Hongshuang; Dong, Yi; Sun, Zhaogang; Bai, Jie; Hu, Minwan; Nathan, Carl F.; Javid, Babak; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1087-1104</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This article reports the rational medicinal chem. of a natural product, agrimophol (1), as a new disruptor of intrabacterial pH (pHIB) homeostasis in Mycobacterium tuberculosis (Mtb).  Through the systematic investigation of the structure-activity relationship of 1, scaffold-hopping of the diphenylmethane scaffold, pharmacophore displacement strategies, and studies of the structure-metab. relationship, a new deriv. 5a was achieved.  Compd. 5a showed 100-fold increased potency in the ability to reduce pHIB to pH 6.0 and similarly improved mycobactericidal activity compared with 1 against both Mycobacterium bovis-BCG and Mtb.  Compd. 5a possessed improved metabolic stability in human liver microsomes and hepatocytes, lower cytotoxicity, higher selectivity index, and similar pKa value to natural 1.  This study introduces a novel scaffold to an old drug, resulting in improved mycobactericidal activity through decreasing pHIB, and may contribute to the crit. search for new agents to overcome drug resistance and persistence in the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplR-adMUe3cLVg90H21EOLACvtfcHk0li2I-KtHRnV5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFOltLk%253D&md5=24c31d1257e6d7b313f8e7a71e53caff</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00325%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26aulast%3DJavid%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DDerivatives%2520of%2520natural%2520product%2520agrimophol%2520as%2520disruptors%2520of%2520intrabacterial%2520pH%2520homeostasis%2520in%2520mycobacterium%2520tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1087%26epage%3D1104%26doi%3D10.1021%2Facsinfecdis.8b00325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adlington, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. L.</span></span> <span> </span><span class="NLM_article-title">A short biomimetic synthesis of the meroterpenoids guajadial and psidial A</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1021/ol100138k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100138k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlahs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1676-1679&author=A.+L.+Lawrenceauthor=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=V.+Leeauthor=J.+A.+Kershawauthor=A.+L.+Thompson&title=A+short+biomimetic+synthesis+of+the+meroterpenoids+guajadial+and+psidial+A&doi=10.1021%2Fol100138k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Short Biomimetic Synthesis of the Meroterpenoids Guajadial and Psidial A</span></div><div class="casAuthors">Lawrence, Andrew L.; Adlington, Robert M.; Baldwin, Jack E.; Lee, Victor; Kershaw, Jessica A.; Thompson, Amber L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1676-1679</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The biosynthesis of the meroterpenoid guajadial was previously hypothesized to occur via a hetero-Diels-Alder reaction between caryophyllene and an o-quinone methide.  This hypothesis has been verified via the biomimetic synthesis of guajadial (I) and psidial A (II) in an aq. three-component coupling reaction, between caryophyllene, benzaldehyde, and diformylphloroglucinol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHkMpvGvrHybVg90H21EOLACvtfcHk0lg0nBPZR5Yzmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlahs7k%253D&md5=67e8b0e6e0b2a85ed8514aa293346020</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol100138k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100138k%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DA.%2BL.%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DV.%26aulast%3DKershaw%26aufirst%3DJ.%2BA.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26atitle%3DA%2520short%2520biomimetic%2520synthesis%2520of%2520the%2520meroterpenoids%2520guajadial%2520and%2520psidial%2520A%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1676%26epage%3D1679%26doi%3D10.1021%2Fol100138k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. X.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis of rottlerin and its two subunits</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1856</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2016.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.tetlet.2016.03.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Ghu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1856-1859&author=Y.+F.+Liauthor=B.+Yuauthor=R.+X.+Wang&title=Efficient+synthesis+of+rottlerin+and+its+two+subunits&doi=10.1016%2Fj.tetlet.2016.03.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of rottlerin and its two subunits</span></div><div class="casAuthors">Li, Yangfeng; Yu, Biao; Wang, Renxiao</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1856-1859</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Rottlerin (I), a natural product isolated from Mallotus philippensis, is assocd. with a range of biol. activities.  Its chem. structure features two different substituted phloroglucinol units linked by a methylene group.  In this study, we accomplished a total synthesis of rottlerin using phenol-aldehyde condensation as the key reaction.  By our method, gram-scale prepn. of the two structural subunits was achieved, and rottlerin was obtained in a longest eight linear step with 20% overall yield.  Our study provides a practical soln. for obtaining the sample of rottlerin in an efficient way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO85P_zYKm2rVg90H21EOLACvtfcHk0lg0nBPZR5Yzmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Ghu7s%253D&md5=3c5dd2ecd04661b995a7ac28e5c2f39b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2016.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2016.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DR.%2BX.%26atitle%3DEfficient%2520synthesis%2520of%2520rottlerin%2520and%2520its%2520two%2520subunits%26jtitle%3DTetrahedron%2520Lett.%26date%3D2016%26volume%3D57%26spage%3D1856%26epage%3D1859%26doi%3D10.1016%2Fj.tetlet.2016.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkhalifa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qusa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyprian, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Sayed, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alali, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Moustafa, A.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalil, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>187</i></span>, <span class="NLM_elocation-id">111954</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.ejmech.2019.111954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=31838326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVajsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2020&author=D.+Elkhalifaauthor=A.+B.+Siddiqueauthor=M.+Qusaauthor=F.+S.+Cyprianauthor=K.+El+Sayedauthor=F.+Alaliauthor=A.-E.+Al+Moustafaauthor=A.+Khalil&title=Design%2C+synthesis%2C+and+validation+of+novel+nitrogen-based+chalcone+analogs+against+triple+negative+breast+cancer&doi=10.1016%2Fj.ejmech.2019.111954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer</span></div><div class="casAuthors">Elkhalifa, Dana; Siddique, Abu Bakar; Qusa, Mohammed; Cyprian, Farhan S.; El Sayed, Khalid; Alali, Feras; Al Moustafa, Ala-Eddin; Khalil, Ashraf</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111954</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Great strides have been made in triple neg. breast cancer (TNBC) treatment, which represents 20% of total predicted annual US breast cancer (BC) cases.  Despite the development of several therapeutics, TNBC patients have poor overall survival rate, compared to other BC patients, justifying the urgent need to discover new entities for use to control TNBC.  Chalcones are important natural products with diverse bioactivities including anticancer effects.  This study aimed to design, synthesize and validate novel chalcone leads as potential therapies for TNBC.  Fourteen novel chalcone analogs were designed and synthesized comprising alicyclic amines (pyrrolidine, morpholine and piperidine) or nitrogen mustard (Bis-(2-chloroethyl) amine) substituents.  Among them, compd. I, ((E)-3-(4-(Bis(2-chloroethyl) amino) phenyl)-1-(3-methoxyphenyl) prop-2-en-1-one) was identified as the most effective against TNBC and other BC phenotypes, with anti-proliferative IC50 values ranging between 3.94 and 9.22μM against the TNBC cell lines MDA-MB-231 and MDA-MB-468, as well as against the estrogen pos. MCF-7 cell line.  Chalcone I effectively suppressed the colony formation capacity of MDA-MB-231, MDA-MB-468, and MCF-7 cell lines at 5 and 10μM treatment concns.  Furthermore, compd. I has significantly inhibited cell invasion and migration of MDA-MB-231 and MCF-7 BC cell lines.  Addnl., compd. I had significantly promoted apoptosis by upregulating BAX and downregulating Bcl-2 proteins.  Compd. I induced significant cell cycle arrest of TNBC cells at the G2/M phase.  It also induced a reversal of Epithelial Mesenchymal Transition (EMT) by upregulating the epithelial markers E-cadherin and Pan-cadherin and downregulating FAK.  Furthermore, it had dramatically diminished new vessel formation (vasculogenesis) in chick chorioallantoic membrane (CAM) model by 60.20 ± 8.47%.  Chalcone I inhibited 46.41 ± 0.71% of the TNBC MAD-MB-231 cells growth in a nude mouse orthotopic xenograft model in comparison with vehicle control treated animals.  Collectively, this study results propose chalcone I as a promising lead mol. for the control of TNBC as well as other breast cancer phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo80wRmt8RwLrVg90H21EOLACvtfcHk0lg0nBPZR5Yzmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVajsrjE&md5=0318b763a58511302de96b6a2553864f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111954%26sid%3Dliteratum%253Aachs%26aulast%3DElkhalifa%26aufirst%3DD.%26aulast%3DSiddique%26aufirst%3DA.%2BB.%26aulast%3DQusa%26aufirst%3DM.%26aulast%3DCyprian%26aufirst%3DF.%2BS.%26aulast%3DEl%2BSayed%26aufirst%3DK.%26aulast%3DAlali%26aufirst%3DF.%26aulast%3DAl%2BMoustafa%26aufirst%3DA.-E.%26aulast%3DKhalil%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520validation%2520of%2520novel%2520nitrogen-based%2520chalcone%2520analogs%2520against%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D187%26doi%3D10.1016%2Fj.ejmech.2019.111954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Organometallic Gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3478</span>– <span class="NLM_lpage">3490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3478-3490&author=K.+B.+Huangauthor=F.+Y.+Wangauthor=X.+M.+Tangauthor=H.+W.+Fengauthor=Z.+F.+Chenauthor=Y.+C.+Liuauthor=Y.+N.+Liuauthor=H.+Liang&title=Organometallic+Gold%28III%29+complexes+similar+to+tetrahydroisoquinoline+induce+ER-stress-mediated+apoptosis+and+pro-death+autophagy+in+A549+cancer+cells&doi=10.1021%2Facs.jmedchem.7b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span></div><div class="casAuthors">Huang, Ke-Bin; Wang, Feng-Yang; Tang, Xiao-Ming; Feng, Hai-Wen; Chen, Zhen-Feng; Liu, Yan-Cheng; Liu, You-Nian; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3478-3490</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gold(III) cyclometalated benzeneethanamine chelate complexes exhibit high cytotoxic activity towards lung cancer cells, causing ER-controlled apoptosis and autophagy, exhibiting less toxicity compared to cisplatin.  Agents inducing both apoptosis and autophagic death can be effective chemotherapeutic drugs.  In our present work, we synthesized two organometallic gold(III) complexes harboring C-N ligands that structurally resemble tetrahydroisoquinoline (THIQ): Cyc-Au-1 (AuL1Cl2, HL1 = 3,4-dimethoxyphenethylamine) and Cyc-Au-2 (AuL2Cl2, HL2 = 1,3-benzodioxole-5-ethanamine).  In screening their in vitro activity, we found both gold complexes exhibited lower toxicity, lower resistance factors, and better anticancer activity than those of cisplatin.  The organometallic gold(III) complexes accumulate in mitochondria and induce elevated ROS and an ER stress response through mitochondrial dysfunction.  These effects ultimately result in simultaneous apoptosis and autophagy.  Importantly, compared to cisplatin, Cyc-Au-2 exhibits lower toxicity and better anticancer activity in a murine tumor model.  To the best of our knowledge, Cyc-Au-2 is the first organometallic Au(III) compd. that induces apoptosis and autophagic death.  On the basis of our results, we believe Cyc-Au-2 to be a promising anticancer agent or lead compd. for further anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIcN1K09UUe7Vg90H21EOLACvtfcHk0lg29CVP0Z6PDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D&md5=08921b2a076c3cf07260611ab629fe93</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01694%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BB.%26aulast%3DWang%26aufirst%3DF.%2BY.%26aulast%3DTang%26aufirst%3DX.%2BM.%26aulast%3DFeng%26aufirst%3DH.%2BW.%26aulast%3DChen%26aufirst%3DZ.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BC.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DOrganometallic%2520Gold%2528III%2529%2520complexes%2520similar%2520to%2520tetrahydroisoquinoline%2520induce%2520ER-stress-mediated%2520apoptosis%2520and%2520pro-death%2520autophagy%2520in%2520A549%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3478%26epage%3D3490%26doi%3D10.1021%2Facs.jmedchem.7b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial membrane permeabilization in cell death</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1152/physrev.00013.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1152%2Fphysrev.00013.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=17237344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVahu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=99-163&author=G.+Kroemerauthor=L.+Galluzziauthor=C.+Brenner&title=Mitochondrial+membrane+permeabilization+in+cell+death&doi=10.1152%2Fphysrev.00013.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial membrane permeabilization in cell death</span></div><div class="casAuthors">Kroemer, Guido; Galluzzi, Lorenzo; Brenner, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-163</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Irresp. of the morphol. features of end-stage cell death (that may be apoptotic, necrotic, autophagic, or mitotic), mitochondrial membrane permeabilization (MMP) is frequently the decisive event that delimits the frontier between survival and death.  Thus mitochondrial membranes constitute the battleground on which opposing signals combat to seal the cell's fate.  Local players that det. the propensity to MMP include the pro- and antiapoptotic members of the Bcl-2 family, proteins from the mitochondrial permeability transition pore complex, as well as a plethora of interacting partners including mitochondrial lipids.  Intermediate metabolites, redox processes, sphingolipids, ion gradients, transcription factors, as well as kinases and phosphatases link lethal and vital signals emanating from distinct subcellular compartments to mitochondria.  Thus mitochondria integrate a variety of proapoptotic signals.  Once MMP has been induced, it causes the release of catabolic hydrolases and activators of such enzymes (including those of caspases) from mitochondria.  These catabolic enzymes as well as the cessation of the bioenergetic and redox functions of mitochondria finally lead to cell death, meaning that mitochondria coordinate the late stage of cellular demise.  Pathol. cell death induced by ischemia/reperfusion, intoxication with xenobiotics, neurodegenerative diseases, or viral infection also relies on MMP as a crit. event.  The inhibition of MMP constitutes an important strategy for the pharmaceutical prevention of unwarranted cell death.  Conversely, induction of MMP in tumor cells constitutes the goal of anticancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0e6l_KkfcfrVg90H21EOLACvtfcHk0lg29CVP0Z6PDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVahu7k%253D&md5=ad216e4f60d7a70fb946534242c07e5b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00013.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00013.2006%26sid%3Dliteratum%253Aachs%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DMitochondrial%2520membrane%2520permeabilization%2520in%2520cell%2520death%26jtitle%3DPhysiol.%2520Rev.%26date%3D2007%26volume%3D87%26spage%3D99%26epage%3D163%26doi%3D10.1152%2Fphysrev.00013.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnoletto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bononi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missiroli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patergnani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimessi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieckowski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-ros crosstalk in the control of cell death and aging</span>. <i>J. Signal Transduction</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>, <span class="NLM_elocation-id">329635</span> <span class="refDoi"> DOI: 10.1155/2012/329635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1155%2F2012%2F329635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=22175013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FnvFSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&author=S.+Marchiauthor=C.+Giorgiauthor=J.+M.+Suskiauthor=C.+Agnolettoauthor=A.+Bononiauthor=M.+Bonoraauthor=E.+De+Marchiauthor=S.+Missiroliauthor=S.+Patergnaniauthor=F.+Polettiauthor=A.+Rimessiauthor=J.+Duszynskiauthor=M.+R.+Wieckowskiauthor=P.+Pinton&title=Mitochondria-ros+crosstalk+in+the+control+of+cell+death+and+aging&doi=10.1155%2F2012%2F329635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-ros crosstalk in the control of cell death and aging</span></div><div class="casAuthors">Marchi Saverio; Giorgi Carlotta; Suski Jan M; Agnoletto Chiara; Bononi Angela; Bonora Massimo; De Marchi Elena; Missiroli Sonia; Patergnani Simone; Poletti Federica; Rimessi Alessandro; Duszynski Jerzy; Wieckowski Mariusz R; Pinton Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of signal transduction</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">329635</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are highly reactive molecules, mainly generated inside mitochondria that can oxidize DNA, proteins, and lipids.  At physiological levels, ROS function as "redox messengers" in intracellular signalling and regulation, whereas excess ROS induce cell death by promoting the intrinsic apoptotic pathway.  Recent work has pointed to a further role of ROS in activation of autophagy and their importance in the regulation of aging.  This review will focus on mitochondria as producers and targets of ROS and will summarize different proteins that modulate the redox state of the cell.  Moreover, the involvement of ROS and mitochondria in different molecular pathways controlling lifespan will be reported, pointing out the role of ROS as a "balance of power," directing the cell towards life or death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRL6rNrbwOxBcjl5L8hwNX0fW6udTcc2eYG5-2kXZo6Mrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FnvFSmsA%253D%253D&md5=4c45343fd1c1cd9c5ee543f4c2524618</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1155%2F2012%2F329635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F329635%26sid%3Dliteratum%253Aachs%26aulast%3DMarchi%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DC.%26aulast%3DSuski%26aufirst%3DJ.%2BM.%26aulast%3DAgnoletto%26aufirst%3DC.%26aulast%3DBononi%26aufirst%3DA.%26aulast%3DBonora%26aufirst%3DM.%26aulast%3DDe%2BMarchi%26aufirst%3DE.%26aulast%3DMissiroli%26aufirst%3DS.%26aulast%3DPatergnani%26aufirst%3DS.%26aulast%3DPoletti%26aufirst%3DF.%26aulast%3DRimessi%26aufirst%3DA.%26aulast%3DDuszynski%26aufirst%3DJ.%26aulast%3DWieckowski%26aufirst%3DM.%2BR.%26aulast%3DPinton%26aufirst%3DP.%26atitle%3DMitochondria-ros%2520crosstalk%2520in%2520the%2520control%2520of%2520cell%2520death%2520and%2520aging%26jtitle%3DJ.%2520Signal%2520Transduction%26date%3D2012%26volume%3D2012%26doi%3D10.1155%2F2012%2F329635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span> <span> </span><span class="NLM_article-title">Alteronol induces cell cycle arrest and apoptosis via increased reactive oxygen species production in human breast cancer T47D cells</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1111/jphp.12879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1111%2Fjphp.12879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29411391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=516-524&author=B.+Renauthor=D.+Liauthor=L.+Siauthor=Y.+Dingauthor=J.+Hanauthor=X.+Chenauthor=Q.+Zheng&title=Alteronol+induces+cell+cycle+arrest+and+apoptosis+via+increased+reactive+oxygen+species+production+in+human+breast+cancer+T47D+cells&doi=10.1111%2Fjphp.12879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Alteronol induces cell cycle arrest and apoptosis via increased reactive oxygen species production in human breast cancer T47D cells</span></div><div class="casAuthors">Ren, Boxue; Li, Defang; Si, Lingling; Ding, Yangfang; Han, Jichun; Chen, Xiaoyu; Zheng, Qiusheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">516-524</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objective : Emerging evidence showed that alteronol has a potential antitumor effect in several tumor cells.  However, the antitumor effect of alteronol on breast cancer has not been reported.  This study investigated the mechanisms of alteronol-induced cell proliferation inhibition in human breast cancer T47D cells.  Methods : After treatment with alteronol, T47D cell proliferation was examd. by MTT assay.  The cell cycle distribution, cell apoptosis, reactive oxygen species level and mitochondrial membrane potential were evaluated via flow cytometry.  Next, the protein levels of cyclin B1, cdc2, p21, p-cyclin B1, p-cdc2, p53, Bax, Bcl-2 and cytochrome c were analyzed using Western blot anal.  Meanwhile, the mRNA levels of cyclin B1, cdc2, p21 and p53 were examd. by qRT-PCR.  Key findings : Our data showed that alteronol inhibited the proliferation of T47D cells via inducing G2-phase arrest and cell apoptosis.  Compared with control group, alteronol significantly increased ROS level and triggered mitochondrial dysfunction in alteronol-treated T47D cells.  Further studies showed that the mRNA and protein levels of cdc2 and cyclin B1 were downregulated, while the mRNA and protein levels of p21, p53, p-cyclin B1, p-cdc2 and cytochrome c were upregulated.  In addn., the expression level of Bax was increased, and the expression level of Bcl-2 was decreased.  Conclusions : Alteronol induced T47D cell cycle arrest and cell apoptosis through increasing ROS prodn. and triggering mitochondrial dysfunction, and subsequently inhibiting T47D cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryp_p0gkYoIrVg90H21EOLACvtfcHk0li5WWH6sKd5tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2nuro%253D&md5=ad3950fe23bfc673b21e841833c7bd52</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12879%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DSi%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DQ.%26atitle%3DAlteronol%2520induces%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520via%2520increased%2520reactive%2520oxygen%2520species%2520production%2520in%2520human%2520breast%2520cancer%2520T47D%2520cells%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2018%26volume%3D70%26spage%3D516%26epage%3D524%26doi%3D10.1111%2Fjphp.12879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span> <span> </span><span class="NLM_article-title">The course of uncarinic acid E-induced apoptosis of HepG2 cells from damage to DNA and p53 activation to mitochondrial release of cytochrome c</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1644</span>, <span class="refDoi"> DOI: 10.1248/bpb.29.1639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1248%2Fbpb.29.1639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=16880619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWgsrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=1639-1644&author=M.+Zhaoauthor=T.+Guoauthor=M.+Wangauthor=Q.+Zhaoauthor=Y.+Liuauthor=X.+Sunauthor=H.+Wangauthor=Y.+Hou&title=The+course+of+uncarinic+acid+E-induced+apoptosis+of+HepG2+cells+from+damage+to+DNA+and+p53+activation+to+mitochondrial+release+of+cytochrome+c&doi=10.1248%2Fbpb.29.1639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The course of uncarinic acid E-induced apoptosis of HepG2 cells from damage to DNA and p53 activation to mitochondrial release of cytochrome c</span></div><div class="casAuthors">Zhao, Minghong; Guo, Tao; Wang, Minwei; Zhao, Qingchun; Liu, Yanxia; Sun, Xuehui; Wang, Huailiang; Hou, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1639-1644</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Uncarinic acid E, an active component isolated from Gelsemium elegans BENTH, has been reported to exhibit antitumor effects, but little is known about its mol. mechanisms of action.  In this study, the growth inhibitory activity of uncarinic acid E for HepG2 cells is in time- and dose-dependent manner.  HepG2 cells treated with uncarinic acid E exhibited several typical characteristics of apoptosis through photomicroscopical observation, DNA agarose gel electrophoresis.  The inhibitory effect of uncarinic acid E on HepG2 cells was partially reversed by the inhibitors of pan-caspase, caspase-3 and caspase-6.  The protein expression ratio of Bcl-xL/Bax and Bcl-2/Bax was down-regulated and uncarinic acid E-induced apoptosis involves the initial phase mediated by the balance among Bcl-xL, Bcl-2 and Bax proteins, resulting in cytochrome c release from the mitochondria.  Uncarinic acid E significantly increased the expression of p53 proteins indicates that p53 plays a pivotal role in the initiation phase of uncarinic acid E-induced HepG2 cell apoptosis.  The phosphatidylinositol 3-kinase (PI3-K) family inhibitor wortmanin and the MEK inhibitor (PD98059) rescued the viability loss induced by uncarinic acid E through the expression of p53.  Taken together, uncarinic acid E induces apoptosis in HepG2 cells via accumulation of p53, alters the Bax/Bcl-2 ratio, and activates caspases, resulting in cytochrome c release from the mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAdCBZq--aOLVg90H21EOLACvtfcHk0li5WWH6sKd5tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWgsrrM&md5=cba7a7c85e8093ca694b168695c86815</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1248%2Fbpb.29.1639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.29.1639%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DY.%26atitle%3DThe%2520course%2520of%2520uncarinic%2520acid%2520E-induced%2520apoptosis%2520of%2520HepG2%2520cells%2520from%2520damage%2520to%2520DNA%2520and%2520p53%2520activation%2520to%2520mitochondrial%2520release%2520of%2520cytochrome%2520c%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2006%26volume%3D29%26spage%3D1639%26epage%3D1644%26doi%3D10.1248%2Fbpb.29.1639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriwacki, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of apoptosis induction by inhibition of the anti-apoptotic Bcl-2 proteins</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">20327</span>– <span class="NLM_lpage">20332</span>, <span class="refDoi"> DOI: 10.1073/pnas.0808036105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1073%2Fpnas.0808036105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=19074266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=20327-20332&author=J.+E.+Chipukauthor=J.+C.+Fisherauthor=C.+P.+Dillonauthor=R.+W.+Kriwackiauthor=T.+Kuwanaauthor=D.+R.+Green&title=Mechanism+of+apoptosis+induction+by+inhibition+of+the+anti-apoptotic+Bcl-2+proteins&doi=10.1073%2Fpnas.0808036105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins</span></div><div class="casAuthors">Chipuk, Jerry E.; Fisher, John C.; Dillon, Christopher P.; Wriwacki, Richard W.; Kuwana, Tomomi; Green, Douglas R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">20327-20332</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Normal cellular lifespan is contingent upon preserving outer mitochondrial membrane (OMM) integrity, as permeabilization promotes apoptosis.  BCL-2 family proteins control mitochondrial outer membrane permeabilization (MOMP) by regulating the activation of the pro-apoptotic BCL-2 effector mols., BAX and BAK.  Sustainable cellular stress induces proteins (e.g., BID, BIM, and cytosolic p53) capable of directly activating BAX and/or BAK, but these direct activators are sequestered by the anti-apoptotic BCL-2 proteins (e.g., BCL-2, BCL-xL, and MCL-1).  In the event of accumulated or marked cellular stress, a coordinated effort between previously sequestered and nascent BH3-only proteins inhibits the anti-apoptotic BCL-2 repertoire to promote direct activator protein-mediated MOMP.  We examd. the effect of ABT-737, a BCL-2 antagonist, and PUMA, a BH3-only protein that inhibits the entire anti-apoptotic BCL-2 repertoire, with cells and mitochondria that sequestered direct activator proteins.  ABT-737 and PUMA cooperated with sequestered direct activator proteins to promote MOMP and apoptosis, which in the absence of ABT-737 or PUMA did not influence OMM integrity or cellular survival.  Our data show that the induction of apoptosis by inhibition of the anti-apoptotic BCL-2 repertoire requires "covert" levels of direct activators of BAX and BAK at the OMM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgZPMXKLAR_7Vg90H21EOLACvtfcHk0li5WWH6sKd5tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWlsA%253D%253D&md5=88312b9fdcaeaeea4a13cc0846650536</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0808036105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0808036105%26sid%3Dliteratum%253Aachs%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DFisher%26aufirst%3DJ.%2BC.%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DKriwacki%26aufirst%3DR.%2BW.%26aulast%3DKuwana%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DMechanism%2520of%2520apoptosis%2520induction%2520by%2520inhibition%2520of%2520the%2520anti-apoptotic%2520Bcl-2%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D20327%26epage%3D20332%26doi%3D10.1073%2Fpnas.0808036105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuzil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. J.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of ’mitocan’-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>580</i></span>,  <span class="NLM_fpage">5125</span>– <span class="NLM_lpage">5129</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2006.05.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.febslet.2006.05.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=16979626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=5125-5129&author=J.+Neuzilauthor=X.+F.+Wangauthor=L.+F.+Dongauthor=P.+Lowauthor=S.+J.+Ralph&title=Molecular+mechanism+of+%E2%80%99mitocan%E2%80%99-induced+apoptosis+in+cancer+cells+epitomizes+the+multiple+roles+of+reactive+oxygen+species+and+Bcl-2+family+proteins&doi=10.1016%2Fj.febslet.2006.05.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins</span></div><div class="casAuthors">Neuzil, Jiri; Wang, Xiu-Fang; Dong, Lan-Feng; Low, Pauline; Ralph, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">580</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5125-5129</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mitochondria have emerged recently as effective targets for novel anti-cancer drugs referred to as 'mitocans'.  We propose that the mol. mechanism of induction of apoptosis by mitocans, as exemplified by the drug α-tocopheryl succinate, involves generation of reactive oxygen species (ROS).  ROS then mediate the formation of disufide bridges between cytosolic Bax monomers, resulting in the formation of mitochondrial outer membrane channels.  ROS also cause oxidn. of cardiolipin, triggering the release of cytochrome c and its translocation via the activated Bax channels.  This model may provide a general mechanism for the action of inducers of apoptosis and anticancer drugs, mitocans, targeting mitochondria via ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dJ4e6bOuoLVg90H21EOLACvtfcHk0ljBg0QYP8acYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGntr8%253D&md5=c34a58ee8e0683e057712c3d74b497a8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2006.05.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2006.05.072%26sid%3Dliteratum%253Aachs%26aulast%3DNeuzil%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DDong%26aufirst%3DL.%2BF.%26aulast%3DLow%26aufirst%3DP.%26aulast%3DRalph%26aufirst%3DS.%2BJ.%26atitle%3DMolecular%2520mechanism%2520of%2520%25E2%2580%2599mitocan%25E2%2580%2599-induced%2520apoptosis%2520in%2520cancer%2520cells%2520epitomizes%2520the%2520multiple%2520roles%2520of%2520reactive%2520oxygen%2520species%2520and%2520Bcl-2%2520family%2520proteins%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D5125%26epage%3D5129%26doi%3D10.1016%2Fj.febslet.2006.05.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span> <span> </span><span class="NLM_article-title">Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">11748</span>– <span class="NLM_lpage">11756</span>, <span class="refDoi"> DOI: 10.1021/ja505212y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja505212y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=11748-11756&author=P.+Huangauthor=D.+Wangauthor=Y.+Suauthor=W.+Huangauthor=Y.+Zhouauthor=D.+Cuiauthor=X.+Zhuauthor=D.+Yan&title=Combination+of+small+molecule+prodrug+and+nanodrug+delivery%3A+amphiphilic+drug-drug+conjugate+for+cancer+therapy&doi=10.1021%2Fja505212y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug-Drug Conjugate for Cancer Therapy</span></div><div class="casAuthors">Huang, Ping; Wang, Dali; Su, Yue; Huang, Wei; Zhou, Yongfeng; Cui, Daxiang; Zhu, Xinyuan; Yan, Deyue</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11748-11756</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">All drugs for cancer therapy face several transportation barriers on their tortuous journey to the action sites.  To overcome these barriers, an effective drug delivery system for cancer therapy is imperative.  Here, we develop a drug self-delivery system for cancer therapy, in which anticancer drugs can be delivered by themselves without any carriers.  To demonstrate this unique approach, an amphiphilic drug-drug conjugate (ADDC) has been synthesized from the hydrophilic anticancer drug irinotecan (Ir) and the hydrophobic anticancer drug chlorambucil (Cb) via a hydrolyzable ester linkage.  The amphiphilic Ir-Cb conjugate self-assembles into nanoparticles in water and exhibits longer blood retention half-life compared with the free drugs, which facilitates the accumulation of drugs in tumor tissues and promotes their cellular uptake.  A benefit of the nanoscale characteristics of the Ir-Cb ADDC nanoparticles is that the multidrug resistance (MDR) of tumor cells can be overcome efficiently.  After cellular internalization, the ester bond between hydrophilic and hydrophobic drugs undergoes hydrolysis to release free Ir and Cb, resulting in an excellent anticancer activity in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre8pgZaWvbY7Vg90H21EOLACvtfcHk0ljBg0QYP8acYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git73M&md5=48fd2f3715825ffa9bbfb32f06b5626c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fja505212y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja505212y%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DD.%26atitle%3DCombination%2520of%2520small%2520molecule%2520prodrug%2520and%2520nanodrug%2520delivery%253A%2520amphiphilic%2520drug-drug%2520conjugate%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D11748%26epage%3D11756%26doi%3D10.1021%2Fja505212y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänicke, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Osthoff, K.</span></span> <span> </span><span class="NLM_article-title">Many cuts to ruin: a comprehensive update of caspase substrates</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fsj.cdd.4401160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=12655297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12murs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=76-100&author=U.+Fischerauthor=R.+U.+J%C3%A4nickeauthor=K.+Schulze-Osthoff&title=Many+cuts+to+ruin%3A+a+comprehensive+update+of+caspase+substrates&doi=10.1038%2Fsj.cdd.4401160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Many cuts to ruin: a comprehensive update of caspase substrates</span></div><div class="casAuthors">Fischer, U.; Jaenicke, R. U.; Schulze-Osthoff, K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-100</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Apoptotic cell death is executed by the caspase-mediated cleavage of various vital proteins.  Elucidating the consequences of this endoproteolytic cleavage is crucial for an understanding of cell death and other biol. processes.  Many caspase substrates are just cleaved as bystanders, because they happen to contain a caspase cleavage site in their sequence.  Several targets, however, have a discrete function in propagation of the cell death process.  Many structural and regulatory proteins are inactivated by caspases, whereas other substrates can be activated.  In most cases, the consequences of this gain-of-function are poorly understood.  Caspase substrates can regulate the key morphol. changes in apoptosis.  Several caspase substrates also act as transducers and amplifiers that det. the apoptotic threshold and cell fate.  This review summarizes the known caspase substrates comprising a bewildering list of >280 different proteins.  The authors highlight some recent aspects inferred by the cleavage of certain proteins in apoptosis.  The authors also discuss emerging themes of caspase cleavage in other forms of cell death and, in particular, in apparently unrelated processes, such as cell cycle regulation and cellular differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO-3y3NL036bVg90H21EOLACvtfcHk0ljBg0QYP8acYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12murs%253D&md5=40058cba0ab6217667ed4c8011ba1ddf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401160%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DU.%26aulast%3DJ%25C3%25A4nicke%26aufirst%3DR.%2BU.%26aulast%3DSchulze-Osthoff%26aufirst%3DK.%26atitle%3DMany%2520cuts%2520to%2520ruin%253A%2520a%2520comprehensive%2520update%2520of%2520caspase%2520substrates%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D76%26epage%3D100%26doi%3D10.1038%2Fsj.cdd.4401160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez
de Castro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárcer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malumbres, M.</span></span> <span> </span><span class="NLM_article-title">A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">912</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgm019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1093%2Fcarcin%2Fbgm019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=899-912&author=I.+Perez%0Ade+Castroauthor=G.+C%C3%A1rcerauthor=M.+Malumbres&title=A+census+of+mitotic+cancer+genes%3A+new+insights+into+tumor+cell+biology+and+cancer+therapy&doi=10.1093%2Fcarcin%2Fbgm019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgm019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgm019%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%2Bde%2BCastro%26aufirst%3DI.%26aulast%3DC%25C3%25A1rcer%26aufirst%3DG.%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DA%2520census%2520of%2520mitotic%2520cancer%2520genes%253A%2520new%2520insights%2520into%2520tumor%2520cell%2520biology%2520and%2520cancer%2520therapy%26jtitle%3DCarcinogenesis%26date%3D2006%26volume%3D28%26spage%3D899%26epage%3D912%26doi%3D10.1093%2Fcarcin%2Fbgm019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartwell, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span> <span> </span><span class="NLM_article-title">Cell cycle control and cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1126/science.7997877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1126%2Fscience.7997877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=7997877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADyaK2MXislCjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1994&pages=1821-1828&author=L.+H.+Hartwellauthor=M.+B.+Kastan&title=Cell+cycle+control+and+cancer&doi=10.1126%2Fscience.7997877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle control and cancer</span></div><div class="casAuthors">Hartwell, Leland H.; Kastan, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">5192</span>),
    <span class="NLM_cas:pages">1821-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 102 refs.  Multiple genetic changes occur during the evolution of normal cells into cancer cells.  This evolution is facilitated in cancer cells by loss of fidelity in the processes that replicate, repair, and segregate the genome.  Recent advances in our understanding of the cell cycle reveal how fidelity is normally achieved by the coordinated activity of cyclin-dependent kinases, checkpoint controls, and repair pathways and how this fidelity can be abrogated by sp. genetic changes.  These insights suggest mol. mechanisms for cellular transformation and may help to identify potential targets for improved cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNraoG5m-ETrVg90H21EOLACvtfcHk0liPa5tfGg75SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXislCjsr8%253D&md5=8d6833068841c075f52a77a6d0f08c17</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.7997877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7997877%26sid%3Dliteratum%253Aachs%26aulast%3DHartwell%26aufirst%3DL.%2BH.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DCell%2520cycle%2520control%2520and%2520cancer%26jtitle%3DScience%26date%3D1994%26volume%3D266%26spage%3D1821%26epage%3D1828%26doi%3D10.1126%2Fscience.7997877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, K. B.</span></span> <span> </span><span class="NLM_article-title">Pattern of cellular quiescence over the hibernation cycle in liver of thirteen-lined ground squirrels</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1726</span>, <span class="refDoi"> DOI: 10.4161/cc.19799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.4161%2Fcc.19799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=22510572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFemtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1714-1726&author=C.+W.+Wuauthor=K.+B.+Storey&title=Pattern+of+cellular+quiescence+over+the+hibernation+cycle+in+liver+of+thirteen-lined+ground+squirrels&doi=10.4161%2Fcc.19799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern of cellular quiescence over the hibernation cycle in liver of thirteen-lined ground squirrels</span></div><div class="casAuthors">Wu, Cheng-Wei; Storey, Kenneth B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1714-1726</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">We analyze the status of the cell cycle during hibernation in liver of thirteen-lined ground squirrels (Ictidomys tridecemlineatus) and examines the expression levels of cell cycle regulators over 6 stages of the torpor-arousal cycle.  Immunoblot anal. showed that the protein expression levels of cyclin D1 and cyclin E were reduced in liver (by 31% and 48%, resp.) during long-term torpor; however, during arousal from torpor, PCR anal. showed an upregulation of cyclin D1 transcript levels of ∼1.5-fold.  Protein expression of cyclin A and cyclin B1 were also elevated (1.57-fold and 2.44-fold, resp.) during early arousal from torpor, and in addn., cyclin A2 transcript levels increased by ∼1.8-fold during arousal.  Protein levels of 2 CKIs, p15INK4b and p21CIP1, each increased by ∼1.4-fold during torpor and transcript levels of p15INK4b also rose by 1.7-2.1 fold during torpor, whereas p21CIP1 transcripts increased by 1.5-1.7-fold.  A redn. in cyclin D and E protein expression coupled with upregulation of p15INK4b and p21CIP1 inhibitors during torpor reflects markers of cell cycle arrest during hibernation.  Elevated expression of cyclin A and B protein expression during arousal stages of torpor suggests cell cycle progression is reversibly arrested during torpor and is reinitiated upon return to euthermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKmZ-Uu23_y7Vg90H21EOLACvtfcHk0liPa5tfGg75SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFemtb0%253D&md5=cc8c0498777929a862d4b548fa2f90e6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.4161%2Fcc.19799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.19799%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3DStorey%26aufirst%3DK.%2BB.%26atitle%3DPattern%2520of%2520cellular%2520quiescence%2520over%2520the%2520hibernation%2520cycle%2520in%2520liver%2520of%2520thirteen-lined%2520ground%2520squirrels%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26spage%3D1714%26epage%3D1726%26doi%3D10.4161%2Fcc.19799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiskanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laiho, M.</span></span> <span> </span><span class="NLM_article-title">Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5888</span>– <span class="NLM_lpage">5896</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1204745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1038%2Fsj.onc.1204745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=11593394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlSgt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5888-5896&author=F.+Zhangauthor=M.+Taipaleauthor=A.+Heiskanenauthor=M.+Laiho&title=Ectopic+expression+of+Cdk6+circumvents+transforming+growth+factor-beta+mediated+growth+inhibition&doi=10.1038%2Fsj.onc.1204745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ectopic expression of Cdk6 circumvents transforming growth factor-β mediated growth inhibition</span></div><div class="casAuthors">Zhang, Fan; Taipale, Minna; Heiskanen, Annamari; Laiho, Marikki</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">5888-5896</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transforming growth factor-β (TGF-β) induced growth arrest of cells involves regulation of the activities of both D- and E-type cyclin kinase complexes thought to be mediated primarily by the regulation of p15InK4b and p27Kip1 cyclin kinase inhibitors.  We show here that TGF-β downregulates Cdk6 and that transient and stable expression of Cdk6 in Mv1Lu mink epithelial cells overrides TGF-β mediated arrest.  The main effect of the ectopic Cdk6 expression was to sequester TGF-β induced p15InK4b and to maintain more p27Kip1 in cyclin D-complexes preventing the complete shift of p27Kip1 to Cdk2 invoked by TGF-β.  This led to the presence of an active cyclin D-Cdk6-p27Kip1 complex and partially active cyclin E-Cdk2 complex and resulted in the failure of TGF-β to fully arrest Mv1Lu cell growth.  Though dominant neg. Cdk6, expressed similarly in the cells, sequestered both p15InK4b and p27Kip1, it lacks kinase activity and was unable to override the TGF-β arrest.  The results demonstrate that downregulation of Cdk6 kinase is required for the enforcement of the G1-phase arrest by TGF-β and results in changes in assocn. of the p15InK4b and p27Kip1 inhibitors with D- and E-type cyclin kinase complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uv_8st2rnLVg90H21EOLACvtfcHk0liPa5tfGg75SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlSgt7o%253D&md5=4ed340e36c53cee4b589cf2dcf84ea73</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1204745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1204745%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DHeiskanen%26aufirst%3DA.%26aulast%3DLaiho%26aufirst%3DM.%26atitle%3DEctopic%2520expression%2520of%2520Cdk6%2520circumvents%2520transforming%2520growth%2520factor-beta%2520mediated%2520growth%2520inhibition%26jtitle%3DOncogene%26date%3D2001%26volume%3D20%26spage%3D5888%26epage%3D5896%26doi%3D10.1038%2Fsj.onc.1204745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyomarsi, K.</span></span> <span> </span><span class="NLM_article-title">Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.4161/cbt.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.4161%2Fcbt.201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=37-46&author=S.+Akliauthor=K.+Keyomarsi&title=Cyclin+E+and+its+low+molecular+weight+forms+in+human+cancer+and+as+targets+for+cancer+therapy&doi=10.4161%2Fcbt.201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.4161%2Fcbt.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.201%26sid%3Dliteratum%253Aachs%26aulast%3DAkli%26aufirst%3DS.%26aulast%3DKeyomarsi%26aufirst%3DK.%26atitle%3DCyclin%2520E%2520and%2520its%2520low%2520molecular%2520weight%2520forms%2520in%2520human%2520cancer%2520and%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D37%26epage%3D46%26doi%3D10.4161%2Fcbt.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciemerych, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebel, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigematsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagozdzon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicinska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicinski, P.</span></span> <span> </span><span class="NLM_article-title">Mouse development and cell proliferation in the absence of D-cyclins</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.cell.2004.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=15315760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=477-491&author=K.+Kozarauthor=M.+A.+Ciemerychauthor=V.+I.+Rebelauthor=H.+Shigematsuauthor=A.+Zagozdzonauthor=E.+Sicinskaauthor=Y.+Gengauthor=Q.+Yuauthor=S.+Bhattacharyaauthor=R.+T.+Bronsonauthor=K.+Akashiauthor=P.+Sicinski&title=Mouse+development+and+cell+proliferation+in+the+absence+of+D-cyclins&doi=10.1016%2Fj.cell.2004.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse development and cell proliferation in the absence of D-cyclins</span></div><div class="casAuthors">Kozar, Katarzyna; Ciemerych, Maria A.; Rebel, Vivienne I.; Shigematsu, Hirokazu; Zagozdzon, Agnieszka; Sicinska, Ewa; Geng, Yan; Yu, Qunyan; Bhattacharya, Shoumo; Bronson, Roderick T.; Akashi, Koichi; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-491</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">D-type cyclins (cyclins D1, D2, and D3) are regarded as essential links between cell environment and the core cell cycle machinery.  We tested the requirement for D-cyclins in mouse development and in proliferation by generating mice lacking all D-cyclins.  We found that these cyclin D1-/-D2-/-D3-/- mice develop until mid/late gestation and die due to heart abnormalities combined with a severe anemia.  Our analyses revealed that the D-cyclins are critically required for the expansion of hematopoietic stem cells.  In contrast, cyclin D-deficient fibroblasts proliferate nearly normally but show increased requirement for mitogenic stimulation in cell cycle re-entry.  We found that the proliferation of cyclin D1-/-D2-/-D3-/- cells is resistant to the inhibition by p16INK4a, but it critically depends on CDK2.  Lastly, we found that cells lacking D-cyclins display reduced susceptibility to the oncogenic transformation.  Our results reveal the presence of alternative mechanisms that allow cell cycle progression in a cyclin D-independent fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCN6XBf-BR7Vg90H21EOLACvtfcHk0lhD6AcI2h1aAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlCmu7Y%253D&md5=ccdd86f0826fb0a9d064aa3bb064033c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DKozar%26aufirst%3DK.%26aulast%3DCiemerych%26aufirst%3DM.%2BA.%26aulast%3DRebel%26aufirst%3DV.%2BI.%26aulast%3DShigematsu%26aufirst%3DH.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DAkashi%26aufirst%3DK.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DMouse%2520development%2520and%2520cell%2520proliferation%2520in%2520the%2520absence%2520of%2520D-cyclins%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D477%26epage%3D491%26doi%3D10.1016%2Fj.cell.2004.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agami, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernards, R.</span></span> <span> </span><span class="NLM_article-title">Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00010-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2FS0092-8674%2800%2900010-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10929713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=55-66&author=R.+Agamiauthor=R.+Bernards&title=Distinct+initiation+and+maintenance+mechanisms+cooperate+to+induce+G1+cell+cycle+arrest+in+response+to+DNA+damage&doi=10.1016%2FS0092-8674%2800%2900010-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage</span></div><div class="casAuthors">Agami, Reuven; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-66</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">DNA damage causes stabilization of p53, leading to G1 arrest through induction of p21cip1.  As this process requires transcription, several hours are needed to exert this response.  We show that DNA damage causes an immediate and p53-independent G1 arrest, caused by rapid proteolysis of cyclin D1.  Degrdn. is mediated through a previously unrecognized destruction box in cyclin D1 and leads to a release of p21cip1 from CDK4 to inhibit CDK2.  Interference with cyclin D1 degrdn. prevents initiation of G1 arrest and renders cells more susceptible to DNA damage, indicating that cyclin D1 degrdn. is an essential component of the cellular response to genotoxic stress.  Thus, induction of G1 arrest in response to DNA damage is minimally a two step process: a fast p53-independent initiation of G1 arrest mediated by cyclin D1 proteolysis and a slower maintenance of arrest resulting from increased p53 stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrujLpuNeU2z7Vg90H21EOLACvtfcHk0lhD6AcI2h1aAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr8%253D&md5=949036323a3674e4a92bd2062d8c4b94</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900010-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900010-6%26sid%3Dliteratum%253Aachs%26aulast%3DAgami%26aufirst%3DR.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DDistinct%2520initiation%2520and%2520maintenance%2520mechanisms%2520cooperate%2520to%2520induce%2520G1%2520cell%2520cycle%2520arrest%2520in%2520response%2520to%2520DNA%2520damage%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D55%26epage%3D66%26doi%3D10.1016%2FS0092-8674%2800%2900010-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span> <span> </span><span class="NLM_article-title">The design strategy of selective PTP1B inhibitors over TCPTP</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3343</span>– <span class="NLM_lpage">3352</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.bmc.2016.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=27353889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3343-3352&author=X.+Liauthor=L.+Wangauthor=D.+Shi&title=The+design+strategy+of+selective+PTP1B+inhibitors+over+TCPTP&doi=10.1016%2Fj.bmc.2016.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The design strategy of selective PTP1B inhibitors over TCPTP</span></div><div class="casAuthors">Li, XiangQian; Wang, LiJun; Shi, DaYong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3343-3352</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) has already been well studied as a highly validated therapeutic target for diabetes and obesity.  However, the lack of selectivity limited further studies and clin. applications of PTP1B inhibitors, esp. over T-cell protein tyrosine phosphatase (TCPTP).  In this review, we enumerate the published specific inhibitors of PTP1B, discuss the structure-activity relationships by anal. of their X-ray structures or docking results, and summarize the characteristic of selectivity related residues and groups.  Furthermore, the design strategy of selective PTP1B inhibitors over TCPTP is also proposed.  We hope our work could provide an effective way to gain specific PTP1B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru3UMERwaHirVg90H21EOLACvtfcHk0lhD6AcI2h1aAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnt7nI&md5=d980fa1e807b115676652a702a2792c0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DD.%26atitle%3DThe%2520design%2520strategy%2520of%2520selective%2520PTP1B%2520inhibitors%2520over%2520TCPTP%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3343%26epage%3D3352%26doi%3D10.1016%2Fj.bmc.2016.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer</span>. <i>Oral Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.oraloncology.2018.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.oraloncology.2018.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=29496059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=56-63&author=M.+W.+Hanauthor=I.+S.+Ryuauthor=J.+C.+Leeauthor=S.+H.+Kimauthor=H.+W.+Changauthor=Y.+S.+Leeauthor=S.+Leeauthor=S.+W.+Kimauthor=S.+Y.+Kim&title=Phosphorylation+of+PI3K+regulatory+subunit+p85+contributes+to+resistance+against+PI3K+inhibitors+in+radioresistant+head+and+neck+cancer&doi=10.1016%2Fj.oraloncology.2018.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer</span></div><div class="casAuthors">Han, Myung Woul; Ryu, In Sun; Lee, Jong Cheol; Kim, Song Hee; Chang, Hyo Won; Lee, Yoon Sun; Lee, Seulkina; Kim, Seong Who; Kim, Sang Yoon</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Objectives: PI3K/Akt/mTOR pathway is commonly activated in most cancers and is correlated with resistance to anticancer therapies such as radiotherapy.  Therefore, PI3K is an attractive target for treating PI3K-assocd. cancers.  Material and Methods: We investigated the basal expression and the expression after treatment of PI3K inhibitor or Src inhibitor of PI3K/Akt pathway-related proteins in AMC-HN3, AMC-HN3R, HN30 and HN31 cells by performing immunoblotting anal.  The sensitivity to PI3K inhibitors or Src inhibitor was analyzed by MTT assay and clonogenic assay.  To det. the antitumoral activity of combination treatment with PI3K inhibitor and Src inhibitor, we used using xenograft mouse model.  Results: We found that PI3K regulatory subunit p85 was predominantly phosphorylated in radioresistant head and neck cancer cell line (HN31), which showed resistance to PI3K inhibitors.  Next, we investigated mechanism through which PI3K p85 phosphorylation modulated response to PI3K inhibitors.  Of note, constitutive activation of Src was found in HN31 cells and upon PI3K inhibitor treatment, restoration of p-Src was occurred.  Src inhibitor improved the efficacy of PI3K inhibitor treatment and suppressed the reactivation of both Src and PI3K p85 in HN31 cells.  Furthermore, downregulation of PI3K p85 expression by using a specific siRNA suppressed Src phosphorylation.  Conclusions: Together, our results imply the novel role of the PI3K regulatory subunit p85 in the development of resistance to PI3K inhibitors and suggest the presence of a regulatory loop between PI3K p85 and Src in radioresistant head and neck cancers with constitutively active PI3K/Akt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA8G__vi1cCbVg90H21EOLACvtfcHk0lioG0Zx5BqrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKju70%253D&md5=2d6cbc76681230cd71830f67f3db7516</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2018.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DM.%2BW.%26aulast%3DRyu%26aufirst%3DI.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DChang%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BY.%26atitle%3DPhosphorylation%2520of%2520PI3K%2520regulatory%2520subunit%2520p85%2520contributes%2520to%2520resistance%2520against%2520PI3K%2520inhibitors%2520in%2520radioresistant%2520head%2520and%2520neck%2520cancer%26jtitle%3DOral%2520Oncol.%26date%3D2018%26volume%3D78%26spage%3D56%26epage%3D63%26doi%3D10.1016%2Fj.oraloncology.2018.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollu, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazumdar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. H.</span></span> <span> </span><span class="NLM_article-title">Molecular pathways: targeting protein tyrosine phosphatases in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2136</span>– <span class="NLM_lpage">2142</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-0934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1158%2F1078-0432.CCR-16-0934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=28087641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFegtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=2136-2142&author=L.+R.+Bolluauthor=A.+Mazumdarauthor=M.+I.+Savageauthor=P.+H.+Brown&title=Molecular+pathways%3A+targeting+protein+tyrosine+phosphatases+in+cancer&doi=10.1158%2F1078-0432.CCR-16-0934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer</span></div><div class="casAuthors">Bollu, Lakshmi Reddy; Mazumdar, Abhijit; Savage, Michelle I.; Brown, Powel H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2136-2142</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The aberrant activation of oncogenic signaling pathways is a universal phenomenon in cancer and drives tumorigenesis and malignant transformation.  This abnormal activation of signaling pathways in cancer is due to the altered expression of protein kinases and phosphatases.  In response to extracellular signals, protein kinases activate downstream signaling pathways through a series of protein phosphorylation events, ultimately producing a signal response.  Protein tyrosine phosphatases (PTP) are a family of enzymes that hydrolytically remove phosphate groups from proteins.  Initially, PTPs were shown to act as tumor suppressor genes by terminating signal responses through the dephosphorylation of oncogenic kinases.  More recently, it has become clear that several PTPs overexpressed in human cancers do not suppress tumor growth; instead, they pos. regulate signaling pathways and promote tumor development and progression.  In this review, we discuss both types of PTPs: those that have tumor suppressor activities as well as those that act as oncogenes.  We also discuss the potential of PTP inhibitors for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHYatwDwEqM7Vg90H21EOLACvtfcHk0lioG0Zx5BqrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFegtLY%253D&md5=d35515e2f4934c3deb3255f14af59576</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-0934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-0934%26sid%3Dliteratum%253Aachs%26aulast%3DBollu%26aufirst%3DL.%2BR.%26aulast%3DMazumdar%26aufirst%3DA.%26aulast%3DSavage%26aufirst%3DM.%2BI.%26aulast%3DBrown%26aufirst%3DP.%2BH.%26atitle%3DMolecular%2520pathways%253A%2520targeting%2520protein%2520tyrosine%2520phosphatases%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D2136%26epage%3D2142%26doi%3D10.1158%2F1078-0432.CCR-16-0934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szczepankiewicz, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubben, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirousek, M. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">4087</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1021/ja0296733</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0296733" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=4087-4096&author=B.+G.+Szczepankiewiczauthor=G.+Liuauthor=P.+J.+Hajdukauthor=C.+Abad-Zapateroauthor=Z.+Peiauthor=Z.+Xinauthor=T.+H.+Lubbenauthor=J.+M.+Trevillyanauthor=M.+A.+Stashkoauthor=S.+J.+Ballaronauthor=H.+Liangauthor=F.+Huangauthor=C.+W.+Hutchinsauthor=S.+W.+Fesikauthor=M.+R.+Jirousek&title=Discovery+of+a+potent%2C+selective+protein+tyrosine+phosphatase+1B+inhibitor+using+a+linked-fragment+strategy&doi=10.1021%2Fja0296733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy</span></div><div class="casAuthors">Szczepankiewicz, Bruce G.; Liu, Gang; Hajduk, Philip J.; Abad-Zapatero, Cele; Pei, Zhonghua; Xin, Zhili; Lubben, Thomas H.; Trevillyan, James M.; Stashko, Michael A.; Ballaron, Stephen J.; Liang, Heng; Huang, Flora; Hutchins, Charles W.; Fesik, Stephen W.; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4087-4096</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatase 1B (PTP1B) is an enzyme that downregulates the insulin receptor.  Inhibition of PTP1B is expected to improve insulin action, and the design of small mol. PTP1B inhibitors to treat type II diabetes has received considerable attention.  In this work, NMR-based screening identified a nonselective competitive inhibitor of PTP1B.  A second site ligand was also identified by NMR-based screening and then linked to the catalytic site ligand by rational design. X-ray data confirmed that the inhibitor bound with the catalytic site in the native, "open" conformation.  The final compd. displayed excellent potency and good selectivity over many other phosphatases.  The modular approach to drug design described in this work should be applicable for the design of potent and selective inhibitors of other therapeutically relevant protein tyrosine phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAUdjzxyGdkrVg90H21EOLACvtfcHk0lioG0Zx5BqrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeks7o%253D&md5=ff294c94485d4aa4c7a890b018218c84</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja0296733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0296733%26sid%3Dliteratum%253Aachs%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DLubben%26aufirst%3DT.%2BH.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitor%2520using%2520a%2520linked-fragment%2520strategy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D4087%26epage%3D4096%26doi%3D10.1021%2Fja0296733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>205</i></span>, <span class="NLM_elocation-id">112648</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=10.1016%2Fj.ejmech.2020.112648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=32791401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsF2qtLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2020&author=D.+Yaoauthor=C.+Liauthor=J.+Jiangauthor=J.+Huangauthor=J.+Wangauthor=Z.+Heauthor=J.+Zhang&title=Design%2C+synthesis+and+biological+evaluation+of+novel+HDAC+inhibitors+with+improved+pharmacokinetic+profile+in+breast+cancer&doi=10.1016%2Fj.ejmech.2020.112648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer</span></div><div class="casAuthors">Yao, Dahong; Li, Chenyang; Jiang, Jin; Huang, Jian; Wang, Jinhui; He, Zhendan; Zhang, Jin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112648</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The dysfunction of histone deacetylase (HDACs) is closely related to tumorigenesis and development, which has been emerged as an attractive drug design target for cancer therapy.  In the present study, a series of novel HDAC inhibitors using a substituted quinazoline as the capping group and attaching 3,5-dimethylbenyl as a potential metabolic site protector have been designed and synthesized.  Compds. I and II demonstrated potent HDAC inhibitory activities and anti-proliferative effects against MDA-MB-231 cells.  In addn., I and II both could significantly increase the acetylation level of intracellular proteins, esp. in α-Tubulin and HSP90.  Compds. I and II displayed a slight different anti-tumor mechanism, I mainly induced apoptosis while II induced obviously ER-Stress.  Furthermore, I and II both induced autophagy and migration inhibition.  In pharmacokinetics assay, I showed a significant improvement of pharmacokinetic profile for oral administration.  Addnl., I presented more potent anti-proliferation and anti-migration activity than SAHA in zebrafish MDA-MB-231 cell line-derived xenograft model.  Together, these results demonstrate that I is a novel oral HDAC inhibitor with a potential capacity of treating breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpumrKnEFMqmbVg90H21EOLACvtfcHk0lhrzCwgQUnhHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsF2qtLzM&md5=277eeeb1f89c2ccc459770cf99106d68</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112648%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520HDAC%2520inhibitors%2520with%2520improved%2520pharmacokinetic%2520profile%2520in%2520breast%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D205%26doi%3D10.1016%2Fj.ejmech.2020.112648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NNY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NNY','PDB','1NNY'); return false;">PDB: 1NNY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00085">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80466"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00085?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00085</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic procedures, characterization data, and NMR spectra for all listed compounds; HPLC chromatogram of lead compounds; and some biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_001.pdf">jm1c00085_si_001.pdf (20.29 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00085/suppl_file/jm1c00085_si_002.csv">jm1c00085_si_002.csv (4.2 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NNY">1NNY</a> was used for modeling docking in PTP1B of JM. The authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00085&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00085%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00085" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993ba2fbfb2398","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
